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Abstract 
Earlier studies of the male pronucleus (MPN) formation in echinoderms have isolated 
fusogenic vesicles, known as MV1, essential for nuclear envelope (NE) assembly. MV1 
is a membrane compartment with elevated levels of phosphoinositides, a lipid-
modifying enzyme PLCγ and its upstream regulator SFK1. These are responsible for 
production of localised diacylglycerol (DAG) which facilitates membrane fusion. The 
fusion mechanism in mammalian NE assembly is uncharacterised. We hypothesise 
MV1-like vesicles are responsible for completing the NE in mammalian cells by sealing 
the NE gaps at telophase. 
 
To study the fusion mechanism in mammalian NE assembly, subcellular fractions 
analogous to MV1 were isolated from CHO and HeLa cells. However, these membrane 
fractions were rarely separated from the ER, Golgi and endosomes subfractions. 
Electron tomography confirmed the presence of membrane vesicles (MVs) in the 
vicinity of the NE gaps at telophase. Moreover, the quantity of these MVs was 
significantly higher in the regions of large gap versus regions without gap, suggesting 
a putative consumption of these MVs for gap closure. Furthermore, PtdIns(3,4,5)P3 and 
class I PI3 kinase were detected in endomembranes at the vicinity of the mammalian 
NE implying the presence of MV1-like vesicles. DAG-enriched MVs were detected in 
interphase cells using a miniSOG-conjugated C1aC1b domain; they may be involved in 
house-keeping fusion events.  
 
Using a chemically-induced dimerisation system and correlative light and electron 
microscopy, localised DAG production was demonstrated to be essential for 
mammalian NE assembly. Acute DAG depletion in the NE resulted in NE 
fragmentation. Fragmented NE was rescued by addition of exogenous DAG. Also, we 
show for the first time that Golgi-DAG depletion led to fragmented NE, signifying that 
the Golgi may produce fusogenic vesicles. Our findings show that the regulatory 
mechanisms involved in the MPN formation in fertilised echinoderm eggs are also 
conserved in mammalian NE assembly during mitosis. 
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 Introduction Chapter 1
 Membrane structure and functions 1.1
All cells are confined by a membrane and eukaryotic cells have many membrane-
enclosed organelles. A membrane is a lamellar bilayer of lipids associated with 
macromolecules such as carbohydrates and proteins. The fluid mosaic model (Singer 
and Nicolson, 1972) is traditionally used to describe the structure of a membrane. 
However, with the research advancement from different fields, the limitations of this 
model have been presented and today the model has been updated. A comprehensive 
review has discussed several novel aspects added to this model in order to describe 
membrane structure more accurately. For instance, the high density of proteins 
associated with the bilayer; the role of membrane curvature and its relation to lipid 
geometry; the existence of lateral heterogeneity in the membrane in addition to bilayer 
asymmetry (Goni, 2014). Membranes are well known for their selective permeability, 
however, apart from being barriers, membranes are involved in numerous cellular 
functions such as recognition and response to signal transduction, cell adhesion, cargo 
trafficking, and many others (Eyster, 2007, De Matteis and Godi, 2004, Murai, 2012). 
 
Unlike nucleotides, amino acids and carbohydrates, lipid molecules do not form strong 
chemical bonds in their macromolecular assembly, and this gives them a unique 
“softness” and a conformational complexity compared to other organic molecules. The 
major components of membranes are phospholipids. Figure 1.1 illustrates a general 
chemical structure of a phospholipid. The formation of membranes is a self-assembly 
process under normal cellular conditions due to the amphipathic nature of 
phospholipids. In aqueous media, the hydrophobic effect drives the polar head groups 
of phospholipids to align along the lipid-water interface, minimising the exposure of 
the hydrophobic fatty acid chains to water. This is the most energetically favourable 
arrangement for the lipid molecules (Figure 1.2). 
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Figure 1.1 The amphipathic property of phospholipids 
A glycerol backbone is bonded to two fatty acid molecules (R1 and R2) at the sn-1 and sn-2 positions. 
The sn-3 position of the glycerol is bound to a hydrophilic head group (R) though a phosphodiester 
bond. The physical properties of the lipids depend on the head groups and fatty acid chains. 
 
 
 
Figure 1.2 The structure of a double lipid bilayer 
The hydrogen bonding of water molecules repels the hydrophobic tails of lipids. To reduce the 
exposure of fatty acid chains in aqueous solution, lipids are aligned into a bilayer though dipole-
dipole interactions. Some cellular compartments are enclosed by a double lipid bilayer, such as 
mitochondria, chloroplasts and the nucleus. Size of molecules not in scale. 
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The effective shapes of lipids are highly diverse therefore they are able to form various 
structures. Figure 1.3 displays the possible macromolecular assemblies of lipids. 
Lamellar bilayer is the most energetically favourable structure at normal physiological 
conditions. Other macromolecular assemblies occur at specific lipid concentrations and 
thermodynamic conditions. The effective shape of a lipid is defined by the cross section 
area of the head group and the length and volume of the fatty acid chain(s), also 
known as the packing parameter (P). Hence, the effective shape of a lipid can be 
approximated as a cylindrical/conical shape.  
 
To form a lamellar layer without any curvature, the effective shape of the lipids should 
be cylindrical. When the effective shape of lipids deviates from a cylindrical volume to 
a cone/inverted-cone, voids appear in the lamellar layer and this is energetically 
unfavourable. Therefore, the lamellar layer has to compensate the voids in the 
structure, resulting in bending of the membrane. The tendency of membranes to bend 
and relax in a specific direction is known as spontaneous curvature, and will be 
introduced in section 1.4. 
 
In reality a biomembrane is a highly organised structure composed of proteins, 
polysaccharides and various lipid species with different packing parameters. 
Moreover, membrane compartments have distinctive morphologies and they are 
niches of different cellular functions. The cellular membranes per se act as sites for 
hundreds of enzymes to synthesise lipids. The newly synthesised lipids are then 
transported to their designated membrane through different mechanisms. Figure 1.4 
summarises the biosynthesis and trafficking of some major lipids. These highly 
regulated events reflect the necessity of the “right lipid composition” within a 
membrane in order to maintain the correct membrane structure and function. 
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Figure 1.3 The different macromolecular assemblies of lipid 
Lipids aggregate into different structures according to their packing parameter (P). The packing 
parameter is the cylindrical or conical volume of the fatty acid tail(s) (v) divided by the cross section 
area of the polar head group (a) and the length of the cylindrical or conical volume (l). 3D models 
adapted from Tresset (2009) and Holmberg (2003) 
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More importantly, membrane structures are constantly remodelled through different 
mechanisms, membrane fusion – merging of two membranes – is one of them. 
Membrane fusion is required in a wide range of cellular activities such as vesicle 
trafficking in exocytosis and endocytosis, fertilisation and synaptic transmission (De 
Matteis and Godi, 2004, Rizo and Rosenmund, 2008, Collas and Poccia, 2000). The 
mechanisms of membrane fusion will be covered in section 1.4. Recently, the 
implications of the specific physical properties of phospholipids on membrane fusion 
in biomembranes have been studied by several groups (Larijani et al., 2014, Rafikova et 
al., 2010). In this thesis, we investigated how membrane fusion is required for the 
formation of the nuclear envelope (NE), which is one of the most important cellular 
compartments in a eukaryotic cell. 
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Figure 1.4 Biosynthesis and trafficking of major membrane lipids 
Lipids can be classified into three major classes: the phospholipids (glycerophospholipids), 
sphingolipids and sterols. (Left) Phospholipids are synthesised in the ER and are transported through 
both vesicular and non-vesicular mechanisms. However, not much is known about the exact 
mechanisms. (Middle) Sphingolipids are initially synthesised in the ER, and are transported to the 
Golgi or other membranes. Some sphingolipids are recycled back to the ER for sphinoglipids and 
phospholipids synthesis. (Right) Sterols are mainly produced in the ER and then directly transported 
to the plasma membrane and mitochondria through protein carriers. Arrows indicate the direction of 
lipid transport and black ellipses indicate some key lipid carrier proteins. Adapted from Blom et al. 
(2011). © Cold Spring Harbor Laboratory Press. 
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 The nuclear envelope – a multi-functional and dynamic 1.2
subcompartment 
The NE is a complex membrane compartment (Figure 1.5). It is a physical barrier 
composed of double bilayers that separate the genome from the cytoplasm. The outer 
nuclear membrane (ONM) and the inner nuclear membrane (INM) are joined at the 
nuclear pore complexes (NPCs) which control the transportation between cytoplasm 
and nucleoplasm. The ONM is continuous with the ER. Underneath, the INM is a 
network of filamentous protein called nuclear lamina which provides mechanical 
support to the NE and interacts with many NE proteins.  
 
Irregularity of the NE is associated with various cancers including bladder (Borland et 
al., 1993), breast (Seker et al., 2002), papillary thyroid carcinoma (Fischer et al., 2001), 
head and neck (Maiolino et al., 2002) and many other examples reviewed in de Las 
Heras et al. (2013) and Zink et al. (2004). Abnormal NE phenotypes such as increased in 
malleability and lobulations have a prognostic significance. In addition, defects in NE 
proteins such as the lamins and nucleoporins (Nups) result in a group of diseases call 
laminopathies (Chi et al., 2009, Burke and Stewart, 2002, Broers et al., 2006, Hutchison, 
2014). NE associated proteins are also involved in chromosome organisation thus in 
genome stability (Dellaire et al., 2009). Recruitment of immunoglobulin heavy chain 
(Igh) loci to the INM results in its transcriptional repression, suggesting a role for INM 
and lamina proteins in gene regulation (Reddy et al., 2008). In addition, the NE may 
participate in calcium signalling, reviewed in Mauger (2012).  
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Figure 1.5 The nuclear envelope is a complex membrane compartment 
Structure of the NE: The outer nuclear membrane (ONM) is continuous with the ER and is connected 
with the inner nuclear membrane (INM) at the nuclear pore complex (NPC). The ONM shares similar 
biochemical content as the ER whereas the INM contains a unique population of NE proteins. The 
nuclear lamina underneath the INM serves to maintain nuclear stability and interacts with a large 
family of NE proteins (green) and chromatin associated proteins (pink). Type I and type II NE 
invaginations are special structural arrangements of the NE, regulated by various mechanisms 
(Malhas et al., 2011). Figure not in scale. 
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The NE is a dynamic compartment and its remodelling is highly regulated at different 
mitotic stages. During cell division, metazoans (higher eukaryotes) undergo “open” 
mitosis in which their NE breaks down and reassembles. In contrast, lower eukaryotes 
undergo “close” mitosis which does not require a NE breakdown (NEBD). Some cells 
undergo “semi-closed” mitosis wherein the NE is partially opened (syncytial cells in 
Drosophila melanogaster embryo) or NPCs are temporally disassembled for the access of 
mitotic spindles (fugus Aspergillus nidulans) prior to NE reassembly (De Souza et al., 
2004, Guttinger et al., 2009). The details of different mitotic strategies of eukaryotes are 
shown in Figure 1.6.  
 
 
 
Figure 1.6 Three mitotic strategies used in eukaryotes  
(A) Metazoans undergo open mitosis. The NE is disassembled completely and dissociated from the 
chromatin to allow the access of cytoplasmic spindles emanated from the microtubules-organising 
centre (MTOC). (B) In closed mitosis executed by lower eukaryotes, the NE remains intact. The MTOC 
is either inserted to the NE during mitosis or already existed in the NE. Nuclear spindles emanated 
from the MTOC then direct chromosome separation in a closed NE. (C) Early embryos of 
Caenorhabditis elegans (metazoans) and fungus Aspergillus nidulans (lower eukaryotes) undergo 
semi-closed mitosis. The NE either partially opens up near to centrosomes (Caenorhabditis elegans) 
or opens up through disassembly of NPC to allow the spindle microtubules bind to the chromosomes 
(Aspergillus nidulans). Adapted from Guttinger et al. (2009).  
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In our work, we have been interested in studying the NE reassembly of mammalian 
cells which undergo open mitosis. Figure 1.7 illustrates the completeness of the NE at 
different mitotic stages. Mammalian NE disassembles at prophase and this involves 
complicated molecular mechanisms including the stepwise disassembly of lamina, 
intervention of microtubules on the chromosomes (Georgatos et al., 1997) and dynein-
NE interaction (Gonczy, 2002). NE proteins are reabsorbed to the mitotic ER at this 
stage (Ellenberg, 2002). The NE reassembly starts at anaphase, and at this stage the 
mitotic ER has contact with the rim of separating chromosomes (Lu et al., 2011). The 
NE is completed at late telophase marked by the two intact daughter nuclei. Finally at 
cytokinesis the cytoplasm is separated between two daughter cells.  
 
The mechanism of NE reassembly is not fully understood although there are two 
independent models proposed in the field. The details of these two models will be 
described in the following section. Given the multiple functions and dynamics of the 
NE, the investigation of the architecture and molecular mechanism of NE reassembly is 
essential to understand its disease relevance. 
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Figure 1.7 NE at different mitotic stages of mammalian cells 
At prophase, chromosomes condense and the NE starts to disassemble. The disassembled NE and 
NE proteins retract to the mitotic ER. Chromatin alignment happens at metaphase and there is no 
NE at this stage. At anaphase, recent studies have indicated the contact of cisternal ER/pre-NE at 
the radial periphery of the separating chromosomes (see section 1.3.1). At telophase, the NE 
continues to reform around the decondensing chromosomes and the reassembly is completed at 
late telophase. At cytokinesis, the contractile ring composed of actin filaments and myosin cleaves 
the cytoplasm, resulting in two separated daughter cells.  
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 Two models of nuclear envelope assembly 1.3
The outer bilayer of the NE is linked to the ER and can be seen as an ER subunit. NE 
reassembly during mitosis is closely associated with the mitotic ER. The two proposed 
NE assembly models are based on two apparently contradictory observations: the first 
model is based on confocal imaging of NE proteins that redistribute to the mitotic ER 
in vivo and the second model is based on assembly of membrane vesicles derived from 
fragmentation of the ER in cytoplasmic homogenates and/or related in vivo 
experiments. These two models have several features in common and therefore should 
not be seen as mutually exclusive, as summarised in Figure 1.8.  
 
1.3.1 The ER envelopment model  
The critical component of the ER envelopment model is the presence of NE proteins in 
NE precursors such that these NE precursors can be targeted to chromosomes. There 
are thousands of NE transmembrane proteins (NETs) in the ONM and INM (Korfali et 
al., 2010, Wilkie et al., 2011). The NETs are relevant to various diseases such as 
dystrophies and laminopathies (Broers et al., 2006, Schirmer et al., 2003), and some of 
them such as Lem2 are required for normal NE morphology (Ulbert et al., 2006). In 
Xenopus cell-free assay, truncated recombinant LAP2β protein disrupts NE assembly 
(Gant et al., 1999) and NEP-B78 may be required for targeting vesicles to the 
decondensing chromatin as antibody against NEP-B78 disrupts NE reassembly 
(Drummond et al., 1999).  
 
In mammalian cells, NETs are absorbed by the mitotic ER after NE breakdown. For 
instance, lamin B receptor (LBR) that binds to heterochromatin is present in the mitotic 
ER (Yang et al., 1997a, Ellenberg et al., 1997). This allows the ER to be targeted to 
chromosomes (Collas et al., 1996, Ellenberg et al., 1997). The ER envelopment model 
suggests that mitotic ER tubules bind to chromosomes and the flattening of these ER 
tubules against the chromosome surface gives rise to the new NE; membrane fusion is 
not the principle mechanism of NE reassembly in this model (Anderson and Hetzer, 
2007).  
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In fact, the architecture of mitotic ER is a subject of debate. An exclusively tubular 
network of ER has been observed in mitotic cells and overexpression of reticulons 
(proteins that promote tubular ER) causes delay of NE formation (Anderson and 
Hetzer, 2008). However, there is no direct observation of tubule-to-cisternae ER 
organelle shaping at the chromosomes. On the other hand, recent studies have shown 
that the mitotic ER of various mammalian cell lines is composed primarily of extended 
cisternae using high resolution electron tomography (Lu et al., 2009). The contact 
between chromatin and cisternal ER has been shown to initiate NE assembly at 
anaphase (Lu et al., 2011). Cisternal ER has also been observed in Caenorhabditis elegans 
embryos. (Poteryaev et al., 2005). Given the above results, the targeting of the mitotic 
ER to the chromosomes has an obvious role in NE assembly.  
 
Nevertheless, for the mitotic ER to form a continuous membrane around the nucleus at 
least one gap must be sealed but in vitro data suggests that there are multiple gaps to 
be sealed during NE assembly (Wiese et al., 1997). NPCs have been thought to seal 
these gaps (Antonin et al., 2008, Burke, 2001), and depletion of nucleoporin POM121 
inhibits NE assembly in vitro. However, depletion of POM121 does not prevent NE 
assembly in vivo (Antonin et al., 2005). Moreover, the NE of echinoderm sperm does not 
have any nuclear pore (Longo and Anderson, 1969), meaning that NE assembly can be 
NPC-independent. In summary, the ER envelopment model suggests an assembly 
description but it lacks a definitive mechanism to explain how the necessary fusion 
occurs during completion of the NE. 
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Figure 1.8 Two major models of NE assembly 
(A) The ER envelopment model. The mitotic ER tubules are targeted to the chromosomes due to the 
presence of NE proteins that interact with the lamina/chromosomes, and flattening of the bound ER 
contribute to the NE. NPC is suggested to seal the gaps of ER envelopment. (B) The vesicle fusion 
model is based on the NE assembly assay of the echinoderm male pronucleus (MPN). MV1 vesicles 
bind to the nuclear envelope remnants (NER) and followed by binding of membrane vesicles 
originated from the ER (MV2β) and Golgi (MV2α). MV1 is enriched in poly-phosphoinositides and 
PLCγ. These machineries generate fusogenic lipids required for membrane fusion so that the 
vesicular NE precursors can undergo fusion in order to form a complete NE of the MPN.   
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1.3.2 The vesicle fusion model 
The vesicle fusion model postulates that fusion of membrane vesicles (MVs) and ER 
membranes are required for forming a complete NE, and fusogenic lipids play an 
important role in this model. The model is supported by both in vitro and in vivo 
evidence. Cell-free assays based on male pronucleus (MPN) formation of Xenopus and 
echinoderms (sea urchins) have isolated vesicles essential for NE reassembly (Collas 
and Poccia, 1996, Drummond et al., 1999). Moreover, early electron microscopy studies 
have visualised accumulation of MVs around the nucleus of fused pronuclei of 
echinoderms (Longo, 1972) and the presence of fusion intermediates in rabbit egg in 
vivo (Meyer and Longo, 1979).  
 
Moreover, detailed biochemical information has been provided by NE assembly cell-
free assay derived from MPN formation of echinoderms. In vivo, when a sperm nucleus 
enters the egg, its poreless NE is rapidly disassembled except that NERs remain at the 
tip and the base of the conical nucleus. The MPN formation is then followed by 
disassembly of the lamina, decondensation of the chromatin and reformation of the 
lamina and NE with NPC. The cell-free assay is highly similar to the in vivo process, in 
which demembranated sperm with NERs is supplied with membrane fractions 
separated from the fertilised egg homogenate to form a complete NE (Cameron and 
Poccia, 1994). Two populations of NE precursor termed MV1 and MV2, are essential 
for NE reassembly in the echinoderm cell-free assay in the presence of GTP (Collas and 
Poccia, 1996). 
 
MV1s are non-ER, non-Golgi derived vesicles that bind to the nuclear poles (NE 
remnants) of the sperm. MV2 can be further sub-fractionated into MV2α and MV2β, 
which are enriched in Golgi and ER marker respectively. MV2α binds exclusively to 
the nuclear poles of the sperm and is required for the fusion of MV2β to MV1. MV2β is 
analogous to the mitotic ER in the ER envelopment model, as both of which are the 
major NE precursors and contain LBR (Poccia and Collas, 1997).  
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More importantly, MV1 has a distinctive lipid-protein profile (Figure 1.9). MV1 is 
enriched in poly-phosphoinositides and PLCγ (Byrne et al., 2007, Larijani et al., 2001). 
PLCγ is able to generate DAG and IP3 from PtdIns(4,5)P2 wherein localised production 
of DAG but not IP3 is responsible for membrane fusion (Larijani et al., 2001). 
Furthermore, a protein-free lipid composition which mimics MV1 can substitute MV1 
for its binding and NE assembly function (Barona et al., 2005). PLCγ has been found to 
associate with a tyrosine kinase SFK (Byrne et al., 2009). Recently, the direct activation 
of PLCγ by SFK has been demonstrated using an amplified time-resolved FRET 
(Förster resonance energy transfer) (Byrne et al., 2014). Such protein-lipid interactions 
provide a mechanistic explanation for the model. 
 
Furthermore, PLCγ-enriched vesicles have been detected in vivo around the cortex of 
the egg, and the vesicles are distinguishable from the ER network. PLCγ-enriched 
vesicles come to the vicinity of the MPN at 2 min post-fertilisation during NE 
reassembly (Byrne et al., 2007). PLCγ-enriched vesicles are also present in the regions 
of karyomeres (individual chromosome with a NE) fusion (Byrne et al., 2014). This 
suggests that MV1 is a distinctive compartment in vivo and PLCγ-dependent fusion is 
required for NE formation. In summary, the vesicle fusion model emphasises on the 
localised production of DAG in the NE precursors. These precursors can be vesicles or 
other membrane structures with protein markers interacting with the chromosomes 
and lamina.  
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Figure 1.9 MV1 has distinctive lipid and protein profile compared to MV2 
(A) Total membrane fraction (MV0) was separated by sucrose gradient into different fractions (MVs), 
and the binding property of MVs towards the decondensed nuclei was tested in the cell-free assay. 
Top images indicate the nuclear pole (yellow) and the localisation of binding MVs (red). MV1 binds to 
the nuclear pole and MV2 binds to the rest of the decondensed nuclei after the binding of MV1. LC-
ESI-MS/MS was used to determine the phospholipid quantities of MV1 and MV2, that are expressed 
in mole percentage (n = 3 or 4). MV1 is highly enriched in poly-phosphoinositide species especially 
PtdInsP2 (25 fold) and PtdInP3 compared to MV2. (B) Equal volume of samples was separated by 
SDS-PAGE and PLCγ probed by Western blotting. Densitometry was used to calculate the proportion 
of PLCγ per MV fraction showing that MV1 has >100 fold PLCγ enrichment compared to MV2; 
densitometry protocol is described in Byrne et al. (2007). PLCγ can catalyse PtdInsP2 into DAG (a 
fusogenic lipid) and IP3. The presence of PLCγ and PtdInsP2 on MV1 suggests a conceivable 
production of DAG and therefore fusogenicity. Adapted from Byrne et al. (2007). 
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1.3.3 The reconcilable model 
There are several common features between the two models. First, the ER contributes 
to the majority of the NE in both models. Second, both models suggest the presence of 
NE transmembrane proteins (NETs) in the NE precursors so that the NE precursors can 
be targeted to the chromatin. For instance, LBR is detected at the mitotic ER in 
mammalian cells and also at the MVs in echinoderms cell-free assay.  
 
The formation of the NE by ER coalescence should not be seen contradictory to vesicles 
binding and fusion. The ER vesicles in the cell-free assay are the result of 
homogenisation, although ER vesiculation has also been reported in mitosis (Jesch and 
Linstedt, 1998), as well as at the level of the NE and Golgi (Liu et al., 2003). Hence, apart 
from tubular or cisternal mitotic ER, vesicular ER may also bind to chromosomes and 
contributes to NE reassembly. At the same time, non-ER vesicles which do not contain 
LBR have been isolated and are required for NE reassembly and membrane fusion. 
Together, mammalian NE reassembly may involve simultaneously ER envelopment 
and vesicle fusion (homotypic and heterotypic).  
 
The vesicles fusion model provides a molecular mechanism on how fusion can occur 
and such a mechanism can be incorporated to the morphological description provided 
by the ER envelopment model.  
 
 Mechanism of membrane fusion 1.4
Membrane fusion is a complex process which involves participation of both lipids and 
proteins, but the contribution of lipids and proteins in membrane fusion is usually 
studied separately. Nevertheless, the underlying principle of fusion is changing the 
curvature of membranes. As mentioned earlier, the effective shape of non-lamellar 
lipids gives them a tendency to be curved and this is known as the spontaneous (or 
intrinsic) curvature. 
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The shape of membranes varies. In order to define a 3D membrane structure, the total 
curvature (J) and the Gaussian curvature (K) are used to represent sphere, tubule, 
saddle and other more complicated structures (Figure 1.10-A). To simplify this, the 
spontaneous curvature of a membrane is usually described by its principle curvature 
(C) in 2D. In this case, the ratio of the curvature radius (R) to the thickness of the 
membrane (d) is used to describe the degree of curvature (Figure 1.10-B). Moreover, 
according to whether the membrane bends towards the polar head groups or the fatty 
acid chains, membrane curvature can be positive, neutral or negative (Figure 1.10-C). 
 
Membrane fusion is an unfavourable energetic event. First, the membranes are 
stabilised by strong hydrophobic forces. Second, electrostatic forces from the polar 
head groups repulse opposing membranes (Chernomordik and Kozlov, 2005). In 
general, there are three distinctive steps in membrane fusion: the adhesion of 
membrane, hemifusion and pore formation (Burger, 2000, Goni, 2014). There are two 
membrane fusion models which differ in the arrangement of hemifusion intermediates. 
However, recent findings tend to agree with the progression as revealed in Figure 1.11. 
The latest hemifusion model, also known as stalk-pore hypothesis, suggests a stepwise 
mechanism for fusion to happen. Two adhered membranes overcome the energetic 
barrier of hydration by protruding a “dimple”, which is a single point minimising the 
surface area of hydration. Membrane tension is built when the dimples contact each 
other, and this is energetically favourable for the formation of a hemifusion stalk. The 
proximal layers of the membranes are joined and expand outward to form a 
hemifusion diaphragm. The expansion continues and creates a fusion pore. Finally the 
fusion pore opens, resulting in the exchange of material from two originally separated 
membrane compartments.  
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Figure 1.10 Geometric aspects of membrane curvature  
(A) The geometry of 3D membrane structure can be described by the radii (R1 & R2) of two 
perpendicular arcs (red and blue dashed lines). The reciprocal of the radii is known as the principle 
curvatures (C1 & C2) and the 3D structure can be mathematically represented with the total 
curvature (J = C1 + C2) and the Gaussian curvature (K = C1 x C2), details are described in Shibata et 
al. (2009). (B) The geometry of membrane curvature is simplified by considering only the curvature 
of an arc in 2D. When the radius of curvature (R) is much larger than the thickness of a membrane 
(d), the curvature is considered as small. Membrane compartments such as the Golgi cisternae or 
the ER sheets have small curvatures. When the radius of curvature is almost the same as the 
thickness of a membrane (R ≈ d), the curvature is considered as large. Vesicles and micelles have 
large membrane curvatures. (C) When a lipid monolayer bends towards the direction of polar head 
groups it is considered having negative curvature whereas when a lipid monolayer bends towards 
the direction of fatty acid chains it is considered having positive curvature. A perfectly flat lamellar 
membrane has zero curvature. 
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Extreme membrane curvature is necessary for the formation of hemifusion 
intermediates (Figure 1.11, red and green colours). However, it takes elevated energetic 
levels to generate a high degree of curvature (Shibata et al., 2009). To overcome the 
energetic barrier of membrane fusion, interplay between lipids and proteins is required 
in vivo.  
 
Membrane fusion has been observed in protein-free membranes. For instance, 
liposomes enriched in negatively curved phospholipids exhibit spontaneous fusion 
whereas incorporation of positively curved lipids in liposomes inhibits fusion 
(Chernomordik and Zimmerberg, 1995, Larijani and Dufourc, 2006). Therefore, the 
lipid composition of a membrane is critical for membrane fusion.  
 
 
 
Figure 1.11 Progression of membrane fusion through the hemifusion stalk  
Fusion can be dissected into multiple steps. (A) Two separate membranes approach each other and 
come into contact and there is a hydration barrier between the membranes. (B) Point-like protrusion, 
or dimple, overcomes the energetic barrier of hydration by diminishing the contacting surface area. 
(C) A hemifusion stalk is formed where the proximal leaflets are fused and distal leaflets remain 
unfused. (D) The hemifusion stalk expands and results in a hemifusion diaphragm. (E) Finally, the 
expanding hemifusion diaphragm becomes a fusion pore, resulting in a flow between two cellular 
compartments. Alternatively, the direct formation of fusion pore from hemifusion stalk has been 
proposed. However, theoretical calculations suggest that this is unlikely (Kozlovsky et al., 2002). Red 
indicates the region of negative curvature and green indicates the region of positive curvature in the 
hemifusion intermediates. Figure adapted from Poccia and Larijani (2009). 
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Nevertheless, protein machineries are usually involved in generating membrane 
curvature. Proteins either stabilise curved membranes or mechanically force a 
membrane to attain a specific shape (Frolov et al., 2011). Moreover, proteins can be 
targeted to membrane based on its lipid composition thus trigger a site-specific 
membrane fusion. Some proteins are able to facilitate fusion by making the transition 
from unfused membranes to hemifusion intermediates more thermodynamically 
favourable (Zimmerberg and Kozlov, 2006). The mechanisms of membrane fusion are 
case-specific co-operations between lipids and proteins. Below, the major mechanisms 
for protein and lipids to generate membrane curvature are described.  
 
 Generation of membrane curvature by proteins 1.5
There are several major mechanisms for proteins to generate membrane curvature that 
are illustrated in Figure 1.12. The most direct mechanism to alter membrane curvature 
is by mechanical force generated from the cytoskeleton. A typical example is the 
remodelling of membranes in cell motility where cytoskeletal proteins build up 
membrane tension affecting the local curvature (Raucher and Sheetz, 2000). Endocytic 
secretion also correlates with membrane tension manipulated by cytoskeleton (Dai et 
al., 1997). Alternatively, tubules can be pulled out from membrane sheets such as the 
Golgi, by the binding of kinesin, a microtubule motor.  
 
Protein scaffolding constrains the curvature of membranes through the rigidity of 
proteins. For instance, clathrin and its adaptor proteins maintain the spherical shape of 
vesicles (Fotin et al., 2004). Similarly, proteins from the dynamin family can form 
oligomers to confine a membrane into tubular shape (Hinshaw and Schmid, 1995, 
Neumann and Schmid, 2013). The role of BAR (Bin-Amphiphysin-Rvs) domains in 
changing membrane curvature is relatively well studied in which its dimer binds better 
to highly curved membranes (Peter et al., 2004). Recently, BAR domains have been 
shown to control the number and size of vesicles in chromaffin cells (Pinheiro et al., 
2014).  
 
Introduction 
41 
 
 
Figure 1.12 Mechanisms by which proteins generate membrane curvature 
(A) Proteins exerting external mechanical forces can alter the curvature and shape of a membrane. 
(B) A membrane can adapt to the shape of rigid proteins through direct and indirect scaffolding. (C) 
Curvature can be generated by insertion of an amphipathic helix in one of the monolayers of the 
membrane or through wedging of an integral protein. Figure redrawn from McMahon and Gallop 
(2005). 
 
 
In terms of membrane fusion, proteins from the SNARE family have been 
comprehensively studied. These proteins mediate fusion by their rigidity thus forcing 
two opposite membrane into proximity (Duman and Forte, 2003). SNAREs generate 
energy through protein-lipid and protein-protein interaction and recently SNAREs are 
seen by many investigators as a way to overcome fusion barriers at different occasions. 
For instance, SNAREs may couple at the hemifusion stalk for its elongation and 
widening. This accelerates the whole membrane fusion process (Risselada and 
Grubmuller, 2012). Moreover, inhibition of SNAREs by α-SNAP blocks NE membrane 
fusion in a Xenopus cell-free system, and this implies that NE fusion can be mediated 
by SNAREs (Baur et al., 2007).  
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In addition, membrane curvature can be altered by the local spontaneous curvature 
mechanism, based on the insertion of amphipathic moieties of proteins into the bilayer. 
A shallow insertion of amphipathic helices increases the positive curvature on a 
monolayer and such asymmetry creates an overall area difference thus a change in 
curvature (Campelo et al., 2008). For instance, epsin tubulates liposomes when its 
PtdIns(4,5)P2-binding ENTH domain penetrates into the outer leaflet of the bilayer. As 
the ENTH pushes the head groups of lipid apart, it triggers the membrane deformation 
(Ford et al., 2002). A protein superfamily known as reticulons makes use of both 
protein scaffolding and modification of local spontaneous curvature to maintain the 
tubular network of the ER (Voeltz et al., 2006). Reticulons usually have hydrophobic 
domains that penetrate the cytoplasmic leaflet of the ER. These hydrophobic domains 
can form “wedge-like” hairpins to stabilise the ER tubules (Sackmann, 2014). 
Furthermore, integral membrane proteins such as acetylcholine receptor and ion 
channels protein which have a conical shape can displace lipids around them, creating 
a curvature that matches the shape of the receptors. The effect of integral proteins on 
membrane curvature is even stronger when they cluster (Mackinnon, 2004, Unwin, 
2005). 
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 Generation of membrane curvature by lipids 1.6
Many studies regarding membrane fusion and membrane curvature have emphasised 
the impact of proteins whereas lipids are usually considered to have a subordinate 
role. In fact, lipids play a central role in changing membrane curvature by their 
polymorphic nature. As mentioned earlier, lipid species can be classified into three 
major groups. The categorisation is based on the identity of the polar headgroups 
bound to the glycerol (specific to phospholipids) or ceramide (specific to 
sphingolipids) backbone. The branching, length and functional groups of the fatty acid 
chain, the size and charge of the head groups, and the effective shape of lipids define 
the physical and biological properties of a biomembrane. Figure 1.13 illustrates how 
various membrane properties can be influenced by lipid composition. This section 
mainly illustrates how spontaneous curvature (effective shape) of lipids generates 
membrane curvature. 
 
Figure 1.14-A shows a curved membrane composed of lipids with positive, zero and 
negative spontaneous curvature and the corresponding lipid species that can be found 
in mammalian cells. Lipids alone can give rise to membrane curvature. However, a 
localised change of membrane composition is required for membrane fusion and this 
usually involves interplay between lipids and proteins. More importantly, the lipids 
have to be distributed asymmetrically between the membrane leaflets to generate 
curvature. The concept that spontaneous curvature of membrane is homeostatically 
regulated in live membranes is not new (Gruner, 1985). However, the detailed 
mechanism of asymmetric distribution in biomembranes is still being uncovered.  
  
Introduction 
44 
 
 
Figure 1.13 Polymorphic nature of lipids gives rise to various membrane properties 
Inherent chemical and geometry characteristics of lipid are super diverse wherein the combination of 
different headgroups and fatty acid chain is the key principle to produce such polymorphism. 
Adapted from Klose et al. (2013). 
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There are two major approaches to achieve the asymmetric distribution of lipids. The 
first is transportation of lipids and the second is biochemical modification of lipids 
(Figure 1.14). Lipid carrier protein can actively transport lipids from one leaflet of the 
membrane to the other (Farge and Devaux, 1992). ATP-dependent translocase 
transport PtdSer and PtdEtn from the exoplasmic to the cytosolic leaflet of mammalian 
erythrocytes (Bevers et al., 1999). Phospholipid flippases Drs2P flips PtdSer to the 
cytosolic leaflet of TGN and it is required for vesicles formation (Graham, 2004). Fatty 
acid chains and head group (effective shape) of lipids are prone to enzymatic activities. 
For instance, phospholipase A2 cleaves the fatty-acid chain of lipids at its sn-2 position 
and increases the spontaneous curvature of a lipid molecule; inhibition of 
phospholipase A2 activity blocks endocytic fusion (Mayorga et al., 1993, Brown et al., 
2003). Similarly, phospholipase C cleaves the headgroup of lipids and is required for 
membrane fusion (Goni and Alonso, 2000, Larijani et al., 2001).  
 
 
Figure 1.14 Asymmetric distribution of lipids generate membrane curvature 
(A) To generate membrane curvature, lipids of different spontaneous curvatures (effective shapes) 
are asymmetrically distributed in the two leaflets of a membrane. In mammalian cells, there is a 
wide variety of lipids to fulfil such function. (B) Membrane curvature can also be generated by 
transportation of lipids and biochemical modification of their fatty acid chains and headgroup.   
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Studies of lipid-protein interplay are emerging, such that cholesterol has been shown 
affecting the conformation of a viral fusion protein and mediates membrane curvature 
(Ivankin et al., 2012). Yet not much is known about the general fusion mechanisms in 
different organelles. 
 
1.6.1 Role of phosphoinositides in membrane fusion  
The role of phosphoinositides (PIs) and derivatives in membrane fusion is our major 
interest. PIs are special members in the phospholipid family due to their unique 
properties. The most abundant PI in mammalian cells is phosphatidylinositol (PtdIns), 
which makes up to 90% of the total PIs (Vanhaesebroeck et al., 2001). The 3-, 4-, and 5- 
positions of the inositol ring of PtdIns can be phosphorylated to generate seven distinct 
molecules. All seven molecules exist in higher eukaryotes, and they either serve as 
precursors of second messengers (Berridge and Irvine, 1984) or directly regulate 
signalling pathways (Liscovitch et al., 1994). The different phosphorylated forms of 
PtdIns are rapidly interconverted and are regulated by a massive network of kinases 
and phosphatases (Payrastre et al., 2001). The signalling role of PIs has been extensively 
studied whereas their structural role in membrane fusion mechanism is not fully 
understood (Larijani et al., 2014). 
 
The role of PIs in membrane fusion can be viewed from several aspects. First, PIs have 
been shown to have compartmental specificity using confocal microscopy, such that 
PtdInsP(3,5)P2 is localised in yeast vacuoles (Payrastre et al., 2001) and PtdIns4P is 
localised in the Golgi (Weixel et al., 2005). However, isolated membrane fractions 
usually contain multiple phosphorylated isoforms of PtdIns (Rawyler et al., 1982, Byrne 
et al., 2007), suggesting that the compartmental specificity is not solely depended on a 
single PI but the proportion of certain PIs in the membrane. The distinctive profile of 
PIs among different membranes appears to be the sign post for PI-modifying enzymes 
and associated small GTPases (Grosshans et al., 2006), in which small GTPase like Rab 
participates in several key steps of membrane fusion (Zerial and McBride, 2001).  
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In addition, PIs have been identified in exocytotic and endocytotic processes acting as 
the regulators of fusion machineries, where membrane fusion is a central element of 
exocytosis and endocytosis. For instance, the deficiency in PtdIns(4,5)P2-binding of 
exocyst Exo70 leads to blocking of exocytosis in mammalian cells and it indicates the 
importance of PtdIns(4,5)P2 in docking and fusion of secretory vesicles (Liu et al., 2007). 
Direct PtdIns(4,5)P2 depletion in the plasma membrane prevents endocytosis of the 
transferrin receptor (Varnai et al., 2006). Similarly, depletion of PtdIns3P and 
PtdIns(3,4,5)P3, and inhibition of the interaction between these PIs and their effectors 
result in malfunction of exocytosis and endocytosis (Huynh et al., 2003, Fili et al., 2006, 
Vieira et al., 2003).  
 
As mentioned previously, lipids with negative spontaneous curvature are required for 
membrane fusion. PIs play a structural role in providing the membrane curvature 
necessary for membrane fusion (Zhendre et al., 2011). Table 1.1 lists the spontaneous 
membrane curvature of some phospholipids and related derivatives. Among these 
lipids, DAG, a PtdIns(4,5)P2 derivative, has the most extreme negative curvature. 
Inclusion of DAG in model membranes facilitates vesicles fusion (Villar et al., 2001, 
Villar et al., 2000). Also, DAG circumvents the requirement of GTP hydrolysis in 
echinoderm NE assembly assay, indicating its downstream role in NE assembly (Byrne 
et al., 2005, Larijani et al., 2001, Dumas et al., 2010).  
 
Moreover, model membranes mimicking MV1 fusogenic vesicles, enriched in 
polyunsaturated PtdIns, are shown to have high fluidity using solid-state NMR 
spectroscopy (Larijani and Dufourc, 2006). Such character induces molecular disorder 
in the membrane and promotes fusion (Zhendre et al., 2011). Membrane fusion is 
associated with the enrichment of DAG effectors such as PLC. PLC is enriched at the 
sites that require membrane fusion, such as the region of phagocytosis (Botelho et al., 
2000) and contact point between female and male pronucleus (Byrne et al., 2014). This 
indicates that localised accumulation of DAG in vivo is a universal condition for 
membrane fusion. Therefore, to understand the mechanism of NE assembly, 
particularly the role of fusogenic vesicles during this process, we needed to identify the 
membrane compartments that were enriched in DAG, its phospholipid precursors, and 
related modifying enzymes.  
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Table 1.1 Spontaneous membrane curvature of phospholipids and derivatives 
Lipid Net Charge Spontaneous curvature, Å-1 References 
Lyso-PtdOH -1 + 0.05a,b (Kooijman et al., 2005) 
Lyso-PtdCho 0 + 0.026a (Kooijman et al., 2005) 
PtdSer -1 + 0.069b (Fuller et al., 2003) 
PtdIns -1 / / 
PtdCho 0 - 0.007a to - 0.005b  (Fuller et al., 2003) 
PtdOH -1 - 0.022b (Kooijman et al., 2005) 
Cholesterol* 0 - 0.037a to - 0.044b (Fuller et al., 2003) 
PtdEth 0 - 0.037a to - 0.045b (Fuller et al., 2003) 
DAG 0 - 0.090a  (Fuller et al., 2003) 
 
Values of spontaneous curvature are expressed as 1/R0p and were calculated in the presence of 
18:1/18:1-PtdEth in water (a) or pH 7 buffer (b); R0p is the radius of the curvature. *Cholesterol is a 
sterol lipid. Table adapted from Jethwa (2014).  
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 Membrane compartments involved in nuclear envelope assembly 1.7
Both the ER envelopment model and the vesicle fusion model suggest that mitotic ER 
is involved in NE assembly. The vesicle fusion model suggests that Golgi-originated 
vesicles (MV2α) and MV1 are additionally involved.  
 
1.7.1 The endoplasmic reticulum 
The morphological organisation of mitotic ER and the presence of NE proteins in 
mitotic ER in relation to NE assembly have been discussed above. The ER is a site for de 
novo phospholipid synthesis (Fagone and Jackowski, 2009). There are less than 10% PIs 
in the ER (van Meer and de Kroon, 2011) and the fate of these PIs during mitosis and 
how they may contribute to NE reassembly is unknown. The complexity of 
phospholipids organisation is of major importance. In mammalian cells, PIs are 
synthesised from CDP-DAG by phosphatidylinositol synthase (PIS), and PIS activity 
has been detected in the mobile vesicular fraction of ER (Kim et al., 2011, Imai and 
Gershengorn, 1987) and at the leading edge of tubular ER (English and Voeltz, 2013). 
Early studies have shown the synthesis of PtdIns(4,5)P2 in the ER and have suggested 
the possibility of two PtdIns(4,5)P2 pools, a PLC-sensitive one and a PLC-insensitive 
one (Helms et al., 1991). This may also imply a possibility to have two pools of DAG, 
serving different functions. In a recent study, depletion of DAG in unfertilised sea 
urchin eggs led to a tubule-to-sheet transition of the ER, and delays in karyomere 
fusion (Wang et al., 2013). Interestingly, both signalling molecule 1,2-DAG and its non-
signalling isomer 1,3-DAG prevented the morphological transition caused by DAG 
depletion, meaning that DAG is likely to have both signalling and structural role in 
organelle shaping and membrane fusion.  
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1.7.2 The Golgi apparatus  
The mammalian Golgi is a compartment specialised in transportation of both proteins 
and lipids through vesiculation (Shorter and Warren, 2002). The fate of mitotic Golgi is 
a subject of debate. In some studies, mitotic Golgi has been reported to breakdown into 
small tubuloreticular fragments (Lucocq, 1992, Lucocq et al., 1995) whereas others have 
revealed Golgi vesicles (Warren, 1993). Moreover, some groups have suggested that 
mitotic Golgi is dispersed into the ER (Zaal et al., 1999, Thyberg and Moskalewski, 
1992) but discrete vesicles of Golgi are also observed (Burke et al., 1982, Colanzi et al., 
2000). There is a general agreement in the field that mitotic Golgi is organised into 
tubulovesicular clusters during telophase and reforms on the opposite sides of the 
nucleus (Seemann et al., 2002, Wei and Seemann, 2009).  
 
In yeast, Golgi-associated vesicles trafficking is required to maintain NE shape 
(Webster et al., 2010) and mutation of epsilon-COP gene ANU2 which is involved in 
ER-to-Golgi transport can cause NE defect (Kimata et al., 1999). There may be a 
conserved role for mammalian Golgi in regulating the NE morphology.  
 
In terms of phospholipid profile, PtdIns4P is the predominant PI in the Golgi. PtdIns4P 
is a regulatory molecule but also an intermediate in the synthesis of several important 
PIs such as PtdIns(4,5)P2. The presence of PtdIns(4,5)P2 in the Golgi is suggested by the 
detection of PtdIns(4,5)P2 metabolising enzymes, such as inositol(5)phosphatase and 
OCRL (De Matteis et al., 2002). Although a direct hydrolysis of PtdIns(4,5)P2 to DAG in 
the Golgi is unlikely, PtdIns(4,5)P2 can activate PLD, which produces PtdOH required 
for DAG production (Cazzolli et al., 2006).  
 
In yeast, Golgi-DAG is produced by Pah1p from PtdOH (Karanasios et al., 2010). In 
mammalian cells, sphingomyelin synthases regulate Golgi-DAG levels using PtdCho 
as substrate (Villani et al., 2008). DAG is visualised at the curved tips of the Golgi stacks 
in mammalian cells (Peddie et al., 2014). Accumulation of DAG in the cytoplasmic 
leaflet of TGN membranes promotes vesicle fission (Bard and Malhotra, 2006) but 
whether there is a population of Golgi vesicles enriched in DAG and involved in NE 
assembly still requires investigation.   
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 Aim and objectives 1.8
MV1 fusogenic vesicles have been isolated from the echinoderm cell-free assay and its 
lipid-protein composition has been characterised. Moreover, localised DAG production 
is required for membrane fusion in both model membrane system and in vitro assays. 
Also, earlier studies from our group have revealed the involvement of 
phosphoinositides and their derivatives in mammalian NE assembly, especially their 
spatiotemporal distribution during mitosis (Hobday, 2012, Domart et al., 2012). 
Nevertheless, the role of fusogenic vesicles and their biochemical composition in 
mammalian cells is unknown. We hypothesise that MV1-like vesicles are required for 
mammalian NE reassembly and we aim to understand their function in membrane 
fusion. A major objective of this thesis is to address the NE fusion mechanism in 
mammalian cells by asking several key questions: 
 
1. Are there MV1-like vesicles/compartments required for mammalian NE assembly? 
2. What is the composition of MV1-likes vesicles? 
3. What is the role of DAG in mammalian NE assembly 
4. What is the origin of the MV1-like vesicles? 
 
Two approaches were used to study fusion mechanisms in mammalian NE assembly 
and the key steps are shown in Figure 1.15. The biochemical approach aimed at 
isolating MV1-like vesicles in order to reconstitute a fusion assay and to characterise 
isolated MV1-like vesicle by lipid mass spectrometry and proteomics. In parallel, a cell 
biology approach was used to identify and characterise MV1-like vesicles in vivo using 
high resolution imaging techniques. In addition, we modulated the DAG level in 
endomembranes and investigated its impact on NE assembly.  
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This thesis contains five Result Chapters and each chapter has its own brief 
introduction and discussion section. Chapter 3 describes the density gradient 
separation of MV1-like vesicles from other cellular compartments. Chapter 4 
investigates the localisation of PtdIns(3,4,5)P3 in mammalian cells and the performance 
of a PtdIns(3,4,5)P3-specific probe conjugated to miniSOG, a novel tag allowing EM 
visualisation. In Chapter 5, we studied the role of DAG in mammalian NE assembly by 
modulating the DAG levels at the NE/ER using a dimerisation device. Chapter 6 
identifies the presence of potential fusogenic vesicles and describes the photo-
conversion optimisation of the miniSOG tag. In Chapter 7, we modulated the DAG 
levels at the Golgi and determined its impact on NE assembly using serial block face 
scanning electron microscopy (SBF SEM). The major discoveries of this thesis and 
future direction of the study are summarised in the overall Discussion section.  
 
 
Figure 1.15 Parallel approaches to address fusion mechanisms in mammalian NE assembly 
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 Materials and Methods Chapter 2
 Antibodies 2.1
Details of primary and secondary antibodies and their working dilutions for different 
applications are listed in Table 2.1 and Table 2.2. 
 
 Buffers and Reagents 2.2
I. General biochemistry materials 
4X SDS loading buffer 0.01% (w/v) bromophenol blue, 20% (v/v) glycerol, 4% (w/v) 
SDS, 250 mM Tris base, pH 6.8; add 50 mM β-
mercaptoethanol prior to use 
20X MOPS running buffer 1 mM EDTA, 50 mM MOPS, 0.1% SDS, 50 mM Tris base, pH 
7.7; dilute to 1X in ddH2O prior to use 
BSA blocking buffer 3% BSA (w/v) in PBS-T 
Cell lysis buffer 0.5 mM EDTA, 150 mM NaCl, 10 mM Tris HCl, pH 7.5; add 1% 
(v/v) Triton X-100 and 1 protease inhibitor cocktail tablet 
(Complete, Mini, Roche) per 10 ml lysis buffer prior to use 
Phosphate buffered saline (PBS) 2.7 mM KCl, 2 mM KH2PO4, 137 mM NaCl, 10 mM Na2HPO4, 
pH 7.4 
Tris-buffered saline (TBS) 50 mM Tris-Cl, 150 mM NaCl, pH 7.4 
PBS-T 0.2% (v/v) Tween-20 in PBS 
10X immunoblot transfer buffer 1.9 M glycine, 250 mM Tris base; dilute in a ratio of 1:2:7 
transfer buffer: methanol: ddH2O prior to use 
Versene EDTA 0.02% (w/v) EDTA, 0.3 mM KH2PO4, 0.0003% (w/v) phenol red, 
27 mM NaCl, 1.62 mM Na2HPO4 
Wash buffer 2% (w/v) low-fat milk powder in PBS-T 
 
II. Subcellular fractionation materials (MV1-separating gradient) 
Homogenisation buffer (HB) 250 mM sucrose, 10 mM Tris, 17 µg/ml benzamidine; add 1 
mM AEBSF and 1 protease inhibitor cocktail tablet (Complete, 
Mini, Roche) per 10 ml buffer prior to use 
Membrane wash buffer (MWB) 1:4 HB:PBS (v/v) 
Known proteolytic activities targeted by Complete, Mini protease inhibitor tablets 
Protease Enzyme conc. (µg/ml) pH 
% inhibition immediately 
after addition 
Pancreas-extract 20 7.8 84 
Thermolysin 
(Metalloprotase) 
0.5 7.8 10 
Chyrmotrypsin 2 7.8 90 
Trypsin 2 7.8 81 
Papain 330 7.8 74 
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III. Subcellular fractionation materials (TGN-separating gradient) 
TGN-separating gradient HB 250 mM sucrose, 10 mM HEPES-KOH, pH 7.2, 1m M EDTA, and 1 
mM MgOAc; add 1 protease inhibitor cocktail tablet (Complete, 
Mini, Roche) per 10 ml buffer prior to use 
TGN-MWB 1:4 TGN-HB:TBS (v/v) 
TGN-separating gradient 0.3 M sucrose & 1.2 M sucrose, 10 mM HEPES-KOH pH 7.2 
 
IV. Nuclei isolation materials 
Nuclei Buffer A 0.5 mM DTT, 10 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, pH 7.9 
Nuclei Buffer S1 10 mM MgCl2, 0.25 M sucrose 
Nuclei Buffer S2 0.5 mM MgCl2, 0.35 M sucrose 
 
V. Molecular Biology materials 
6X loading buffer 0.25% bromophenol blue, 30% glycerol in water, 0.25% xylene 
cyanol FF 
50X tris acetate EDTA (TAE) 1 M acetic acid, 50 mM EDTA, 2 M Tris 
Lysogeny broth (LB) 0.5 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract 
LB agar 1.5 % (w/v) in LB medium 
SOC medium 20 mM glucose, 10 mM MgCl2, 10 mM MgSO4, 2.5 mM KCl, 10 
mM NaCl, 2% tryptone, 0.5% yeast extract 
Tris EDTA buffer (TE) 1 mM EDTA, 10 mM Tris base, pH 7.5 
 
VI. Cell Biology materials 
IF blocking buffer 3% (w/v) fatty acid free BSA, 0.05% saponin in PBS/TBS 
Tris buffered saline (TBS) 150 mM NaCl, 10 mM Tris Base, pH 7.4 
Trypsin/versene EDTA 0.05% (w/v) trypsin, 0.02% (w/v) EDTA, 0.3 mM KH2PO4, 0.0003% 
(w/v) phenol red, 27 mM NaCl, 1.62 mM Na2HPO4 
HBSS solution (Gibco) Components refer to catalog number 14025092 
 
VII. Electron microscopy and photo-oxidation materials 
Solution X 30 g Na2HPO4 in 1050 ml ddH2O (0.2 M) 
Solution Y 15 g NaH2PO4∙2H2O in 500 ml ddH2O (0.2 M) 
0.1 M phosphate buffer 202.5 ml solution X, 47.5 ml solution Y & 250 ml ddH2O, pH 7.4 
0.1 M cacodylate buffer 10.7 g sodium cacodylate in 500 ml ddH2O, pH 7.4 
DAB solution 2.5 mM diaminobenzidine in 0.1 M phosphate or cacodylate buffer 
Blocking buffer 20 mM aminotriazole, 50 mM glycine, 10 mM KCN, pH 7.4 
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Table 2.2 Details of secondary antibodies used 
Antibody Fluorophore Supplier Cat# Host IF 
Anti-GST antibody DyLight 650 Abcam Ab117497 Goat 1:250 
Anti-GST antibody DyLight 488 Abcam Ab117508 Goat 1:250 
Anti-Mouse IgG (H+L) AlexFluor 647 Molecular probes A21236 Goat 1:500 
Anti-Rabbit IgG (H+L) AlexFluor 647 Molecular probes A21244 Goat 1:500 
Anti-Mouse IgG (H+L) AlexFluor 546 Molecular probes A-11030 Goat 1:500 
Anti-Rabbit IgG (H+L) AlexFluor 546 Molecular probes A-11010 Goat 1:500 
Anti-Mouse Dylight 488 Jackson Lab 715-485-150 Donkey 1:250 
Anti-Rabbit Dylight 488 Jackson Lab 111-485-003 Donkey 1:250 
 
 
 Biochemistry – Subcellular fractionation and related experiments 2.3
2.3.1 Cell homogenate and postnuclear supernatant (PNS) preparation 
To obtain sufficient cells for subcellular fractionation, cells were cultured in six 500 cm2 
cell culture dishes (Corning) with a seeding density of ~15 x 106; see section 2.5.1 for 
cell maintenance. When reached 90% confluency, cells were dissociated from the 
culture dishes by adding 15 ml Versene/EDTA solution and washed with PBS or TBS 
before any homogenisation. There were approximately 1.5 x 108 cells used in each 
batch of homogenate/PNS preparation. 
 
2.3.2 Different homogenisation methods 
MV1 homogenisation method 
Cells were washed with 5 ml HB at 100xg, 4°C for 5 min and resuspended in 5 ml HB 
on ice for 5 min. Every 2.5 ml of the suspension was homogenised by passing through 
a 22G needles 10 times. The homogenate was centrifuged at 10,000xg, 4°C for 10 min to 
obtain the PNS. 
 
Gruenberg & Howell homogenisation method 
Cells were washed with 15 ml HB at 100xg, 4°C for 5 min and resuspended in 5 ml HB 
on ice for 5 min. Every 1 ml of the suspension was homogenised by a ball bearing cell 
cracker, with a ball size of 8.002 mm (9 µm clearance) for 6 times. The homogenate was 
centrifuged at 1,000xg, 4°C for 10 min to obtain the PNS, which was diluted 3 times in 
PBS and washed once before gradient separation.  
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MV1/Gruenberg & Howell combined homogenisation method 
Cells were washed with 15 ml HB pelleted at 100xg, 4°C for 5 min and resuspended in 
5 ml HB on ice for 5 min. Every 1 ml of the suspension was homogenised by a ball 
bearing cell cracker, with a ball size of 8.002 mm (9 µm clearance) for 6 times. The 
homogenate was centrifuged at 10,000xg, 4°C for 10 min to obtain the PNS.  
 
PIS-organelle-separating gradient homogenisation method 
Cells were washed with 15 ml HB and resuspended in 5 ml HB on ice for 5 min. Every 
2.5 ml of the suspension was homogenised by passing through a 25G needles 15 times. 
The homogenate was centrifuged at 2,000xg, 4°C for 5 min to obtain the PNS. 
 
TGN-separating gradient homogenisation method 
Cells were washed with 30 ml TGN-HB and resuspended in 5 ml TGN-HB. Every 1 ml 
of the suspension were homogenised by passing through a 22G needles 7 times and the 
homogenate was centrifuged at 1,700xg, 4°C for 10 min to obtain the PNS. The PNS 
was washed once before gradient separation. 
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2.3.3 Biochemical gradient fractionation 
The PNS/total membrane fraction was fractionated by different biochemical gradients: 
 
Sucrose density gradient (MV1-separating gradient) 
PNS collected from the MV1, Gruenberg & Howell, or the combined protocol were 
centrifuged at 150,000xg, 4°C for 2 h. The pellet (total membrane fraction) was gently 
resuspended in 0.5 ml MWB and loaded on a sucrose gradient. The sucrose gradient 
was prepared by mixing the 0.1 M and 2 M sucrose solution (5.5 ml each) in a two-
chamber gradient mixer (Fisher scientific) with constant stirring at the outlet chamber. 
The 0.1-2 M sucrose gradient was layered into an ultracentrifuge tube using a Densi-
flow fractionator. The loaded sucrose gradient was centrifuged at 150,000xg, 4°C for 20 
h. Separated fractions were collected gently by a micropipette. The fractions were 
washed once by MWB, resuspended in 75 µl MWB and analysed by Western blotting. 
 
OPTIPREP density gradient (PIS-organelle-separating gradient) 
OPTIPREP gradient was prepared as described by (Kim et al., 2011). The low and high 
concentration solutes were 10% and 25% OPTIPREP (Sigma) diluted with 0.25 M 
sucrose, 60 mM Tris/HCl and 6 mM EDTA respectively. The PNS-loaded gradient was 
centrifuged at 200,000xg, 4°C for 17 h in a SW40 rotor. Separated fractions were 
collected gently by a micropipette, washed once by MWB, resuspended in 75 µl MWB 
before Western blot analysis.  
 
Velocity gradient (TGN-separating gradient) 
The velocity gradient was prepared as described by (Celis, 1998), mixing 5.5 ml 0.3 M 
sucrose and 6 ml 1.2 M sucrose solutions using a tilted-tube-rotation gradient maker 
(Biocomp). The tilted rotations were: 1) 50° angle at 30 rpm for 10 min, 2) 80° angle at 
12 rpm for 1 min. The PNS-loaded gradient was spun at ~111,000xg, 4°C in a SW40 
rotor for an hour. The fractions were collected gently by a micropipette, washed once 
by MWB, resuspended in 75 µl MWB and analysed by Western blotting. 
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2.3.4 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Biochemical gradient-separated fractions or cell lysates (see 2.5.5) were analysed by 
SDS-PAGE. Samples were mixed with 4X SDS loading buffer in a 3:1 ratio and boiled at 
95°C for 10 min to denature the proteins. Afterwards, samples were loaded into a 4-
12% Bis-Tris gel (Invitrogen) alongside a protein ladder (PageRuler, Thermo Scientific). 
The electrophoresis was run at 125 V for 2 h until the dye front had reached the bottom 
of the gel. For proteins over 50 kDa MOPS running buffer was used whereas for 
proteins below 50 kDa MES running buffer was used. Protein of interest was detected 
by western blotting. 
 
Alternatively, proteins on the gel were visualised by incubation with GelCode reagent 
(Thermo Scientific), a coomassie blue (G-250-based) staining reagent. Gels were fixed 
in 50% methanol/7% acetic acid (v/v) in deionised water for 15 min and washed with 
deionised water for another 15 min. Fixed gels were incubated with GelCode on a 
shaker for 1 h and destained with deionised water overnight before image acquisition 
by scanner (Epson). 
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2.3.5 Western blot analysis 
After SDS-PAGE, proteins were transferred from the gel to an Immobilon-P PVDF 
membrane (Millipore). The methanol-equilibrated PVDF membrane was placed under 
the gel and was sandwiched by four transfer buffer-soaked 3-millimeter blotting 
papers on both sides. Proteins were transferred at 12 V for 2 h in a trans-blot semi-dry 
transfer apparatus (Biorad).  
 
The membrane was blocked with 3% BSA (w/v) in PBST for 1 h at room temperature 
before primary antibody incubation. Primary antibody was diluted in the blocking 
buffer according to the manufacturer’s protocol and incubated with the membrane at 
4°C for 16 h or at room temperature for 2 h, depending on antibodies. The membrane 
was then washed 5 times with washing buffer. After this, the membrane was incubated 
with secondary antibody diluted in 5% (w/v) low-fat milk powder in PBST for 1 h at 
room temperature. The membrane was washed 5 times with washing buffer and rinsed 
briefly with PBS before image acquisition.  
 
Equal volumes of ECL1 and ECL2 reagents (Amersham) were mixed, spread evenly on 
the membrane and incubated for 2 min to develop chemiluminescent signals with an 
emission of 428 nm. The signals were detected using an ImageQuant LAS 4000 system 
(GE Healthcare) and images were captured by the inbuilt CCD camera. The 
membranes were normally exposed for 1 to 5 min. 
 
 Molecular biology 2.4
2.4.1 DNA constructs 
DNA constructs provided by external sources are listed below. Details of 
oligonucleotides used in this study are listed in Table 2.5 and Table 2.6. 
 
Table 2.3 Constructs obtained from external laboratories or other investigators 
Construct Source Laboratory 
GST-GRP1PH Nick Leslie University of Dundee 
miniSOG Roger Tsien University of California San Diego 
GCNT1 Sharon Tooze London Research Institute 
ST6GALNAC1 Sharon Tooze London Research Institute 
GRASP65GRASP-GFP Yanzhuang Wang University of Michigan 
GRASP65GRASP.G2A-GFP Yanzhuang Wang University of Michigan 
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2.4.2 Oligonucleotides/primers 
All primers were synthesised by Sigma-Aldrich custom oligos service and HPLC-
purified, and were diluted in deionised water to 2.5 µM as working stocks. Design of 
primer followed the rules below: 
 
PCR primer: Typical length ranged from 30-50 base pair (bp) with at least 20 bp 
complementary to the target sequence; the melting temperature (Tm) should be 55-
65°C and the GC content (%GC) should be 45-65%. The 3' end of the primer should end 
with a guanine or a cytosine to enhance binding to the target sequence. The Tm 
difference between a pair of primers was minimised in most conditions, usually not 
over 3°C. The putative primers were analysed by oligo analysis tools so that they were 
designed to avoid self-complementarity and secondary structures. If secondary 
structures meant to exist, its Tm should be below the PCR annealing temperature. 
 
Sequencing primer: Typical length should be smaller than 25 bp and the Tm ranged 
from 55-65°C. 
 
Mutation primers: Rules of design followed the Stratagene Quickchange manual. The 
length was recommended to be within 25-45 bp to avoid formation of secondary 
structure. The Tm should be over 78°C and the %GC should be 40-60%, with at least one 
flanking guanine or cytosine at the 5' and 3' ends. The equation of the Tm for primer of 
substitution mutagenesis is 
81.5 + 0.45(%𝐺𝐶) −
675
𝑁
−%𝑚𝑖𝑠𝑡𝑚𝑎𝑡𝑐ℎ, 
where N is the number of base pairs. 
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2.4.3 Polymerase Chain reaction (PCR) 
Typical reaction mix and thermal cycler programme for PCR is shown below. To make 
DNA more labile for heat denaturation, DMSO was added to a replicate of each 
reaction. All PCRs were performed in MJ Research PTC-225 Peltier Thermal cycler with 
the annealing temperature ranging from 45-65°C, depending on the Tm of the primers. 
 
Table 2.7 Reaction mix for PCR 
 Volume (µl) 
Template DNA (200 ng/µl) 5 
Sense primer (2.5 µM) 5 
Anti-sence primer (2.5 µM) 5 
dNTP mix (40 mM each) 1 
Pfu buffer 10X 5 
Pfu Turbo (2.5 U/ml) (Stratagene) 1 
(DMSO) 2 if added 
H2O to 50 µl 
 
Table 2.8 Thermal cycler programme for PCR 
Step Programme Temp. (°C) Duration 
1 DNA denaturation 95 2 min 30 s 
2 DNA denaturation 95 50 s 
3 Annealing 55 2 min 
4 Extension 68 3 min (depending on the length of amplicon) 
5  - Go to step 2, x19 cycles 
6 Complete 4 ∞ 
 
2.4.4 Nucleotide sequencing 
Reaction mix for sequencing and its thermal cycler programme is shown below. The 
Big Dye Terminator (BDT) reagent and sequence analysis service were provided by in-
house facility. 
 
Table 2.9 Reaction mix for sequencing 
 Volume (µl) 
DNA (200 ng/µl) 1 
Sequencing primer (2.5 µM) 2 
BDT (ABI Prism) 8 
H2O to 20 µl 
 
Table 2.10 Thermal cycler programme for sequencing 
Step Programme Temp. (°C) Duration 
1 DNA denaturation 95 1 min 
2 DNA denaturation 95 10 s 
3 Annealing 45 1 min 
4 Extension 60 4 min 
5  - Go to step 2, x24 cycles 
6 Complete 4 ∞ 
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2.4.5 Site-direct mutagenesis 
To introduce point mutations, site-directed mutagenesis was performed according to 
the Stratagene Quickchange manual. Mutation primers were designed as described 
above. Reaction mix of mutagenesis and its thermal cycler programme is shown below. 
The annealing temperature ranged from 45-60°C, depending on the Tm of the primers. 
Reactions were limited to 12 cycles to minimise mutations introduced by the 
polymerase. 
 
Table 2.11 Reaction mix for mutagenesis 
 Volume (µl) 
DNA (10 ng/µl) 5 
Mutation primer sense (2.5 µM) 5 
Mutation primer anti-sense (2.5 µM) 5 
dNTP mix (40 mM each) 1 
Pfu buffer 10X 5 
Pfu Turbo (2.5 U/ml) (Stratagene) 1 
(DMSO) 2 if added 
H2O to 50 µl 
 
Table 2.12 Thermal cycler programme for mutagenesis 
Step Programme Temp. (°C) Duration 
1 DNA denaturation 95 2 min 
2 DNA denaturation 95 50 s 
3 Annealing 55 1 min 
4 Extension 68 8 min (depending on the length of plasmid) 
5  - Go to step 2, x12 cycles 
6 Complete 4 ∞ 
 
The completed mutagenesis reaction was incubated with 1 µl DpnI enzyme at 37°C for 
an hour. This ensures the original parental template (methylated) is digested and 
improves the bacterial transformation efficiency. The reaction was analysed by agarose 
gel electrophoresis, gel-extracted and purified before bacterial transformation (see 
below). 
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2.4.6 Restriction Digestion 
To specifically select a DNA fragment (insert) and place it into alternative plasmids, 
DNA of interest was digested by restriction enzyme(s). If two restriction enzymes are 
used (double digestion), a compatible enzyme buffer for both enzymes is required to 
maximise their enzymatic activity. Typical reaction mix for digestion is shown below. 
Reactions were incubated at 37°C for 1 h; agarose gel electrophoresis was used to check 
the size of digested DNA.  
 
Table 2.13 Reaction mix for restriction digestion 
 Volume (µl) 
DNA (1000 ng/µl) 5 
Restriction enzyme(s) 1 
10X Buffer  2 
10X BSA 2 
H2O to 20 µl 
 
2.4.7 Agarose gel electrophoresis 
Full-length plasmids or digestion products were analysed on a 0.8% (w/v) agarose gel 
made of 1X TAE buffer containing 0.5 µg/ml ethidium bromide. Reactions were mixed 
with 6X loading buffer in a 5:1 ratio and loaded into the wells of the agarose gel 
alongside a 1 kb DNA ladder (Invitrogen). Electrophoresis was run at 135 V in 0.5X 
TAE running buffer in a Mupid-One electrophoresis tank (Advance). DNA bands were 
visualised in a UV transilluminator with in-built camera (BioDoc-It imaging system, 
UVP). 
 
Gel extraction and purification 
The appropriate band was excised from the gel using a clean scalpel. The excised band 
was purified using a Qiagen QIAquick gel extraction kit according to the 
manufacturer’s protocol. 
  
Chapter 2 
68 
 
2.4.8 Ligation 
A ligation reaction contains two DNA fragments, the insert and vector 3 to 5 µg of 
each, were digested with the same restriction enzyme(s), gel-extracted and purified 
into water. To improve ligation efficiency, the vector was pre-incubated with 1 µl calf 
intestinal phosphatase (New England Biolabs) at 37°C for an hour to dephosphorylate 
its backbone before ligation. Reaction mix of ligation was ready for bacterial 
transformation after incubation at 16°C for 16 h. 
 
Table 2.14 Reaction mix for DNA ligation 
 Volume (µl) 
Digested and dephosphorylated vector 1 
Digested insert 1 or 6 
T4 DNA Ligase (NEB) 1.5 
10X Ligase buffer (NEB) 2 
H2O to 20 µl 
 
2.4.9 Subcloning 
The gel-purified PCR product was inserted to the pCR-Blunt II Topo cloning vector 
(Invitrogen) according to the manufacturer’s protocol. Four microliters of PCR product 
were mixed with 1 µl vector and 1 µl salt solution at room temperature for 5 min. The 
insert-including plasmids were transformed into chemically competent bacteria. 
 
Bacterial transformation 
Chemically competent E. coli strain DH5α Max Efficiency® (Invitrogen) and XL1-Blue 
(Stratagene) were used in routine cloning. Their genotypes are (F– Φ80lacZΔM15 
Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1) and 
(recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F ́ proAB lacI q Z ∆ M15 Tn 10 (Tet r)]) 
respectively. In a transformation, 2 µl DNA were mixed with 50 µl competent bacteria 
in a 14-milliliter round bottom tube (BD Falcon) on ice for 10 min. The bacteria were 
heat-shocked in a 42°C water bath for 45 s and then incubated on ice for 2 min. The 
bacteria were supplemented with 300 µl SOC medium and incubated in a shaking 
incubator at 37°C, 200 rpm for an hour. The whole volume of bacteria was spread onto 
LB-agar plates containing the appropriate antibiotics (50 µg/ml kanamycin or 100 
µg/ml ampicillin). The agar plates were inverted and incubated at 37°C overnight for 
colonies to develop.  
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Plasmid DNA extraction 
Single bacterial colonies were picked with a sterile pipette tip, spotted onto a LB-agar 
plate (referred as the reference plate) and tipped into 7 ml LB medium containing the 
appropriate antibiotics (50 µg/ml kanamycin or 100 µg/ml ampicillin). The reference 
plate and the bacteria inoculated medium were incubated at 37°C for 16 h, with the 
medium incubated in a shaking incubator at 200 rpm. Bacteria were pelleted by 
centrifugation at 3,500xg, 4°C for 10 min. The bacteria pellet was submitted to in-house 
facility for small-scale DNA preparations (minipreps). Minipreps were done using a 
Qiagen liquid handling robot and Machery-Nagel plasmid purification kits. 
 
Positive clones were either determined by restriction digestion or nucleotide 
sequencing (see above). The clones were then re-picked from the reference plate and 
cultured in 250 ml LB medium. The media were incubated in a shaking incubator as 
described above and the bacteria were harvested at 3,500xg, 4°C for 15 min. Large-scale 
DNA preparations (maxipreps) were done using the Qiagen Maxiprep Kit, purified 
plasmids were eluted in 500 µl TE buffer and stored at -20°C. The plasmid DNA 
concentration was measured and calculated with a NanoDrop spectrophotometer 
(Thermo Scientific) based on absorbance of the plasmid at 260 nm. Purified plasmids 
were sequenced afterwards. 
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 Cell Biology 2.5
2.5.1 Mammalian cell lines and their maintenance  
CHO and COS7 cell lines were obtained from Cancer Research UK Cell Services at 
Clare Hall. HeLa cell line was obtained from the American Type Culture Collection 
(ATCC), ATCC#: CCL-2. 
 
Cells were cultured in DMEM/10% (v/v) FCS (CHO and HeLa) or DMEM/10% (v/v) 
DCS (COS7), supplemented with penicillin (100 U/ml) and streptomycin (100 μg/ml). 
Culture media and serum were obtained from Gibco (Invitrogen). Frozen cell aliquots 
were kept in FCS supplemented with 10% DMSO as a cryoprotectant and stored in 
liquid nitrogen. For recovery, frozen aliquots were thawed in a 37°C water bath and 
immediately transferred into growth medium. Cells were incubated at 37°C, 10% CO2 
to 90% confluency and split at a ratio of 1:4 to 1:6 to the next passage. Cells between 
passage 10 and 25 were used. 
 
2.5.2 Transfection 
100,000 to 150,000 cells were seeded into a 35 mm glass-bottom dish, or MatTek dish, 
(MatTek Corporation, USA) or a single well of a 6-well plate followed by 1 day 
culturing before transfection. Chemical-based transfection was used (Lipofectamine 
LTX and Plus Reagent, Invitrogen). For each transfection reaction, 500 ng plasmid 
DNA was diluted in 200 μl OptiMEM medium; 4 μl Plus Reagent was added to the 
mixture, vortexed thoroughly and incubated at room temperature for 5 min. After that, 
4 μl Lipofectamine LTX was added, the transfection mix was vortexed again and 
incubated for 15 min at room temperature. Complete medium was aspirated from the 
cells and replaced with 2 ml antibotic-free medium, and the 200 μl transfection mix 
was added on top. Transfected cells were incubated at 37°C, 10% CO2 for 16 h. The 
medium was changed, replaced by 2 ml antibiotic-free medium and cells were let to 
recover for another 12-24 h before the experiments. 
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 Treatments of cells 2.5.3
Depending on the context and purpose, cells underwent different treatments before 
confocal imaging (section 2.6). 
 
EGF stimulation: Cells were stimulated with 100 ng/ml human recombinant 
epidermal growth factor (Calbiochem) at 37°C for 2 min.  
ER tracker labelling: Cells were incubated with ER tracker diluted in HBSS at a 
final concentration of 1 µM for 10 min at 37°C, 10% CO2. 
 
Depending on the purpose, treated cells were either scraped into 200 μl lysis buffer for 
Western blotting (section 2.3.5), or fixed with 4% (w/v) PFA in PBS for 10 min before 
immunofluorescence preparation (section 2.5.6), or directly imaged live. 
 
2.5.4 Rapalogue-induced enzyme recruitment 
The rapamycin analogue AP21967 (Clontech Laboratories, Inc.), or rapalogue, was 
used as a dimeriser to recruit lipid-modifying enzymes to specific cellular organelles. 
Recruitment was done by adding antibiotic-free medium supplemented with 
rapalogue to live cells. The final concentration of rapalogue was 500 nM. Rapalogue-
treated cells were examined every half hour until they reached the mitotic stage of 
interest. 
 
2.5.5 Cell lysate preparation  
After one PBS wash, cells were scraped into 200 µl lysis buffer and incubated on ice for 
5 min. The mixture was centrifuged at 10,000xg, 4°C for 10 min, the insoluble fraction 
was discarded and the soluble fraction (cell lysate) was retained. Cell lysates were snap 
frozen in liquid nitrogen and stored at -20°C before further sample preparation. 
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2.5.6 Immunofluorescence 
Cells were transfected, either treated or untreated, and fixed in 4% (w/v) PFA in PBS 
for 10 min. The cells were washed three times with 2 ml PBS and permeabilised with 
freshly prepared 0.5% saponin/3% fatty-acid free BSA (w/v) in PBS or TBS for 30 min 
wherein the fatty-acid free BSA was used to block the cells. Cells were washed once 
with PBS or TBS before primary antibody incubation. 
 
Commercial primary antibodies were diluted in 0.5% saponin/3% BSA/PBS or TBS in a 
1:50 to 1:100 ratio and recombinant proteins were diluted in the same solution (amount 
specified in result chapter). The primary antibody solution was added to the inner well 
of the MatTek dish. Unless specified in the manufacturer’s protocol, cells were 
incubated with primary antibodies or recombinant proteins at room temperature for 1 
h. After that, the primary antibody solution was aspirated and the cells were washed 
once with PBS or TBS. The cells were then incubated with secondary antibodies, 
diluted with the 0.5% saponin solution in 1:200 to 1:500 ratio, for an hour at room 
temperature. The secondary antibody solution was aspirated and the cells were 
washed once. The probed cells were kept in 2.5% (w/v) DABCO in PBS or TBS before 
imaging.  
 
Alternatively, cells were mounted in ~10 µl ProLong Gold antifade reagent and 
carefully sealed by a coverslip. If necessary, cells were incubated with Hoechst 33342 at 
a final concentration of 1 μg/ml for 10 min at room temperature before mounting. In 
every incubation step, the cells were covered by foil to protect the samples from light. 
 
 Commentary on the use of a lipophilic dye during immunofluorescence 2.5.7
It is a common approach to label cells with lipophilic dye for membrane visualisation 
due to its simplicity, and it is a rapid way to determine changes of membrane 
morphology in live cells upon various treatments. DiOC6 is a lipophilic dye usually 
used in live cells to reveal membrane structures like the NE, mitochondria network and 
ER (Koning et al., 1993).  
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However, if antibody co-labelling is required, permeabilisation with detergent such as 
saponin can attenuate the fluorescent signal of DiOC6 (Figure 2.1). Fixed cells pre-
stained with DiOC6 displayed a distinguishable fluorescence in the NE (yellow arrows) 
and mitochondria (magenta arrows) especially at the concentration of 2.5 and 5 µM 
(upper panels). When the cells pre-stained with DiOC6 were permeabilised with 0.5% 
saponin, the fluorescence of DiOC6 was diminished. It was difficult to image the 
mitochondria and NE with the given intensity of the fluorescence (lower panels), 
especially in 0.5 and 2.5 µM DiOC6-stained cells.  
 
 
Figure 2.1 Saponin attenuates the fluorescence of the lipophilic dye DiOC6 
Live COS7 cells were incubated with different concentrations of DiOC6 for 5 min and fixed with 4% 
PFA for 10 min. Cells were subsequently incubated with PBS buffer (upper panels) or permeabilised 
with 0.5% saponin/PBS for 30 min (lower panels) before confocal image acquisition. DiOC6 stained 
the NE (yellow arrows) and mitochondria (magenta), and the staining increased with the 
concentration of DiOC6. Permeabilised cells displayed a weakened fluorescent signal of DiOC6 and it 
was more difficult to identify the NE and mitochondria. Cells stained with higher concentration of 
DiOC6 preserved fluorescent signals better after permeabilisation. Scale bar, 10 µm. 
 
Solution 
To avoid losing the fluorescent signals of lipophilic dye such as DiOC6, it is 
recommended to label the cells after permeabilisation.  
Chapter 2 
74 
 
 Confocal microscopy 2.6
Confocal images were acquired on a Zeiss LSM Invert 710 microscope. A Zeiss Plane 
25x objective lens (NA=0.8) and a Zeiss Plan-Appochromat 63x oil immersion objective 
lens (NA=1.4) were used. A CoolLED PE-1 source was used to replace the mercury 
illumination. During the visualisation of multiple fluorophores, emission filters were 
used to avoid cross excitation between channels. The filtersets were chosen as listed 
below.  
 
Table 2.15 Filtersets of confocal microscope 
Fluorophore Laser wavelength Emission filter 
DyLight405, Hoechst33342 405 nm 420-480 nm band pass 
DiOC6, DyLight488, GFP  488 nm 505-530 nm band pass 
AlexFluor546, RFP,  543 nm 560-615 nm band pass 
AlexFluor647, DyLight649 633 nm 650 nm long pass 
 
For live cells imaging, complete medium was aspirated and replaced by phenol red-
free medium before imaging. During image acquisition, cells were maintained at 37°C, 
10% CO2 in a heated environmental chamber of constant humidity. Laser power and 
acquisition parameters (z-stacks, size of pinhole and time series) were adjusted to 
minimise laser damage on cells. 
 
Image processing 
Confocal images were acquired using Zeiss LSM software ZEN. The .lsm files were 
analysed using image processing software Zen 2011 or Volocity 6.3. Images were 
exported in .tiff format.  
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 Correlative light and electron microscopy (CLEM) 2.7
2.7.1 CLEM sample preparation 
Cells were grown on gridded glass coverslips in MatTek dishes. Live cells were 
transfected, treated and followed to the required stage of mitosis using confocal 
microscopy. 1 volume of of 8% FA in 0.2 M PB was added to the cells in the confocal 
microscope to halt the cell cycle prior to imaging for brightfield and fluorescence 
signals. The cell of interest was located according to the grid number of its field. 
Secondary fixation was performed in 1.5% GA/2% FA in 0.1 M PB for 30–60 min. After 
fixation, coverslips were carefully removed from the MatTek dishes and washed 
several times in 0.1M PB. The cells were post-fixed in 1.5% potassium ferricyanide/1% 
osmium tetroxide for 1 h, before rinsing in PB, and incubating in 1% tannic acid in 0.05 
M PB for 45 min to enhance membrane contrast. After a brief rinse in 1% sodium 
sulphate in 0.05 M PB, the coverslips were washed twice in distilled water, dehydrated 
through an ascending series of ethanol to 100% prior to infiltration with Epoxy resin 
and polymerisation at 60°C for 48 h. The coverslips were removed from the resin 
blocks by plunging briefly into liquid nitrogen. The cells of interest were identified by 
correlating the grid and cell pattern on the surface of the block with previously 
acquired confocal images. The area of interest was cut from the block and further 
trimmed by hand using a single edged razor blade to form a small trapezoid block face 
for serial ultrathin sectioning. Using a diamond knife, serial ultrathin sections of 70 nm 
thicknesses were cut through the entire extent of the cells of interest and collected on 
1.5% formvar-coated single slot grids. The sections were counterstained with lead 
citrate to further enhance contrast prior to viewing in the electron microscope (FEI 
Tecnai G2 Spirit BioTWIN with Gatan Ultrascan CCD camera). EM grade FA and GA 
were used. 
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2.7.2 Segmentation of ultrastructure 
Serial micrographs were stacked and aligned using Amira (Visage Imaging, Berlin).The 
pixels of NE, ER, centrioles and vesicles were manually traced based on their 
morphological features. The NE is a smooth double lipid bilayer and the nuclear pores 
appear to be a diaphragm-like structure on a cross section. The ER is either tubular or 
cisternal, and it can be distinguished from the NE by its attached ribosomes. The 
centrioles appear to be cylindrical when cut longitudinally whereas it appears to be a 
ring of 9 triplet microtubules on a transverse section. Vesicles are small spherical 
structures enclosed by a lipid bilayer, and they have circular cross sections on the 
micrograph. 
 
 Electron Tomography 2.8
For electron tomography, samples were prepared as detailed above but 200 nm-thick 
serial sections were collected through the entire extent of the cells of interest. 
Tomograms were acquired from the 200 nm sections at targeted regions in the 
reforming nuclear envelope – either at specific gaps, or where collections of vesicles 
were evident in close proximity to the reforming envelope. Images were collected at 1- 
degree intervals across a maximal tilt range of ±70 degrees, at a resolution of 2,048 x 
2,048 pixels, with a per pixel resolution of 0.79 nm (FEI Tecnai G2 Spirit BioTWIN with 
Gatan Ultrascan CCD camera). Tomograms were processed with IMOD (an open-
source, cross-platform image processing software) (Kremer et al., 1996), using patch 
tracking for alignment, and simultaneous iterative reconstruction technique (SIRT) for 
volume reconstruction. The reconstructed volume was exported as a series of 2D tiff 
images, and the NE and adjacent membranous structures, including vesicles, were 
manually segmented and reconstructed using Amira (Visage Imaging, Berlin). Movies 
were created from the 2D tiff stacks using Quicktime Player 7 Pro, and compressed 
using Stomp (Shinywhitebox Ltd). 
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 MiniSOG photo-oxidation 2.9
For miniSOG photo-oxidation experiment, the samples were fixed and stained 
differently. However, the dehydration, embedding, serial sectioning and imaging steps 
followed the conventional CLEM protocol as described above.  
 
Cells were transfected with 250-500 ng miniSOG-conjugated construct for 16 h and let 
to recover in 2 ml antibiotic-free medium for 24 h. The medium was discarded and the 
cells were fixed with 2.5% GA (v/v) in 0.1 M cacodylate buffer (pH 7.4) on ice for 30 
min. The cells were washed 5 times with cacodylate buffer and incubated in blocking 
buffer on ice for another 30 min. The blocking buffer was replaced with 2.5 mM DAB 
solution before photo-oxidation.  
 
A Zeiss LSM Invert 510 confocal microscope was used as a photo-oxidation platform. 
Samples were loaded on a customised cooling chamber built by Christopher Applebee, 
engineer at Cell Biophysics Lab. The chamber has a cooling jacket in which cold water 
was circulated by a peristaltic pump (BioScience Tools) so that the samples were 
maintained at ~4°C. The lid of the chamber was connected to oxygen supply at a rate of 
2.5 l/min to ensure samples were in an oxygenated environment. Figure of the setup is 
shown in Chapter 6. 
 
Photo-oxidation was done by illuminating samples in the chamber with a 150 W 
mercury lamp through a FITC filterset. A photo-oxidised cell gives a dark brown 
colour that originated from the DAB reaction product. Typical exposure time of a 
photo-oxidation reaction was 30 min. After photo-oxidation, cells were washed 5 times 
with cacodylate buffer. The cells were re-fixed in 2% FA/1.5% GA (v/v) in cacodylate 
buffer on ice for 30 min and were washed once with cacodylate buffer. After that, cells 
were incubated with 0.2% (v/v) osmium tetroxide in cacodylate buffer on ice for 30 
min, followed by three washes. The sample was kept in 1% FA/0.1M cacodylate buffer 
at 4°C before embedding.  
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 Serial block-face scanning electron microscopy (SBF SEM) 2.10
Serial block-face scanning electron microscopy (SBF SEM) data was collected using a 
3View2XP (Gatan, Pleasanton, CA) attached to a Sigma VP SEM (Zeiss, Cambridge). 
Cells were grown on gridded MatTek dishes and fixed as previously described at a 
specific stage of the cell cycle. In preparation for SBF SEM, the fixed cells were 
processed following the method of the National Centre for Microscopy and Imaging 
Research (Deerinck et al., 2010), which impregnates the sample with high 
concentrations of heavy metals to introduce maximal contrast and conductivity when 
viewed in the SEM. The cell of interest was identified by correlation of grid reference 
with previously acquired confocal images; this area was trimmed to a small trapezoid, 
excised from the resin block, and attached to a SBF SEM specimen holder using 
conductive epoxy resin (Circuitworks CW2400). Prior to commencement of a SBF SEM 
imaging run, the sample was coated with a 2 nm layer of platinum to further enhance 
conductivity. 
 
To relocate the cell of interest in the SEM, an overview was first acquired at 5 kV, 
sufficient to penetrate the platinum coating and generate an image of the underlying 
sample. Inverted backscattered electron images were then acquired through the entire 
extent of the cell of interest at a resolution of 8,192 x 8,192 pixels (horizontal frame 
width of 36.74 µm; pixel size of 4.5 nm) using a 2 µs dwell time and 50 nm slice 
thickness. The SEM was operated in variable pressure mode at 5 to 10 Pa, with high 
current mode active, at an indicated magnification of 7,000. The 20 µm aperture was 
used, at an accelerating voltage of 2 kV. Typically, between 300 and 400 slices were 
necessary for an entire cell, representing a total volume of approximately 400,000 µm3. 
 
As data was collected in variable pressure mode, only minor adjustments in image 
alignment were needed, particularly where the field of view was altered in order to 
track the cell of interest. Movies of each series were generated using Amira (Visage 
Imaging, Berlin), Quicktime Player 7 Pro, and Stomp (Shinywhitebox Ltd.). 
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 Isolation of nuclei and its DAG composition analysis by lipid mass 2.11
spectrometry 
Nuclei were purified following the (Andersen et al., 2005) protocol. ~1.5 x 108 HeLa 
cells were collected by adding Trypsin/versene EDTA solution to the culture dish. 
Collected cells were pelleted by centrifugation at 250xg, 4°C for 5 min and washed 3 
times with ice cold PBS before resuspending into Nuclei Buffer A. 5 µl aliquot of the 
resuspension was examined under a benchtop light microscope. The cell suspension is 
ready for nitrogen gas cavitation when 90% of the cells are swollen. 
 
Nitrogen gas cavitation was performed in a cell disruption bomb (Parr Instrument 
Company, USA). The cells were lysed at 200 psi and equilibrated on ice for 10 min 
before pressure release. The percentage of lysed cells was promptly checked using a 
benchtop light microscope. The lysate was washed in Nuclei Buffer A once, 
resuspended in Nuclei Buffer S1 (0.25 M sucrose content) and layered over Nuclei 
Buffer S2 (0.35 M sucrose content). The lysate were then centrifuged through the 
sucrose layers and resuspended in Nuclei Buffer S2. A small aliquot of pure nuclei (the 
final suspension) was reserved for confocal microscopy and the rest was submitted to 
phospholipids extraction and DAG analysis was performed on a LC/MS/MS system 
(Prominence HPLC, Shimadzu), as described in Jethwa (2014). 
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 Isolation of fusogenic vesicles from somatic Chapter 3
mammalian cells 
 Introduction 3.1
One of the best ways to investigate and manipulate cellular mechanism is to develop a 
cell-free assay. The advantage of a cell-free assay relies on its simplicity so that 
investigators are able to identify key roles of biomolecules. However, to develop a cell-
free assay is not a trivial task. Scientists have spent a long time constructing cell-free 
systems derived from Xenopus (Newport, 1987), Drosophila (Ulitzur and Gruenbaum, 
1989) and sea urchins (Cameron and Poccia, 1994) in order to understand NE assembly. 
 
In an in vitro NE assembly assay based on male pronucleus (MPN) formation in 
echinoderms, a membrane vesicle population known as MV1 has been isolated and 
demonstrated to be essential for forming a complete NE (Collas and Poccia, 1996). MV1 
has been well characterised. It is enriched in PLCγ and its substrate PtdIns(4,5)P2 and 
other phosphoinositides. The hydrolysis of PtdIns(4,5)P2 to diacylglycerol (DAG) 
renders it a fusogenic compartment (Byrne et al., 2007) (more details in introduction). 
Isolation of fusogenic MVs is well established in model organisms such as echinoderms 
and Xenopus whereas no comparable assay is available in somatic cells of higher 
organisms (see references above).  
 
The cell-free assay derived from echinoderms has several advantages. Firstly, the sea 
urchins provide large amount of raw material for protein and lipid purification. 
Moreover, fertilised sea urchin eggs progress through their initial mitotic cycles with a 
high degree of synchrony allowing extraction of cellular components at various stages 
of the cell cycle. Despite the above facts, there is still a necessity to develop a cell-free 
assay based on mammalian cells, to provide a closer model to humans. 
 
One major objective of this study is to isolate a fusogenic component analogous to MV1 
or MV1-like vesicles in mammalian cells (see Chapter 6) so that the ultimate goal is to 
develop a mammalian NE assembly cell-free assay. Such an in vitro assay would 
provide information regarding the protein and lipid composition, fusogenic properties 
of MV1-like vesicles to other membrane compartments and also it would inform about 
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its binding property to chromosomes, all of which will contribute to understanding the 
fusion mechanism during NE assembly. 
 
Mammalian tissue culture cells provided the raw material in this study. Although 
tissue culture cells are relatively straight forward to obtain and maintain, they may be 
more difficult than tissues to fractionate due to differences in cytoskeleton organisation 
(Howell et al., 1989). This chapter describes the optimisation of cell homogenisation 
and several gradient fractionation methods applied to isolate MV1-like vesicles from 
mammalian cells. 
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 Isolation of MV1-like vesicles from interphase cell homogenate 3.2
The key concept in developing a cell-free assay depends on isolating the right cellular 
components. It would have been preferable to obtain cell homogenate from 
synchronised cells, since MV1-like vesicles may have an enhanced population and/or 
execute its fusogenic function at a specific mitotic stage. However, it had been 
demonstrated that several conventional cell synchronisation protocols only recover a 
scarce population of synchronised cells. For instance, the “shake off” protocol was 
shown to yield only 3% mitotic cells. Large amounts of isolated cellular components 
are required for lipid-protein characterisation thus any large-scale sacrifice of material 
is impractical. Alternatively, starvation was suggested to force cells to arrest at G0 
phase so that cells may re-enter G1 phase in a more synchronous manner. However, it 
was shown that starvation did not result in any enrichment of the G1 phase cells 
(Hobday, 2012).  
 
A common protocol used to synchronise cells is nocodazole treatment. Nocodazole is a 
drug that interferes with the polymerisation of microtubules and is often used in cell 
biology experiments to arrest cells at prometaphase (Amon, 2002). The synchronisation 
is even more efficient in a thymidine/nocodazole double block condition. It was 
reported that cells have depolymerised microtubules after release from nocodazole 
(Zieve et al., 1980). Such an outcome is undesirable because biomolecules like 
PtdIns(4,5)P2 and PLCγ, enriched in MV1 may mislocalise due to depolymerised 
microtubules. Furthermore, nocodazole was shown to inhibit NE assembly in a 
mammalian cell-free assay (Vaillant and Paulin-Levasseur, 2008). Therefore, 
considering the above drawbacks, an interphase cell homogenate was used as starting 
material to isolate MV1-like vesicles. 
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 Optimisation of cell homogenisation 3.3
MV1 are characterised as low-density fractions enriched in PLCγ and free of Golgi and 
ER markers; MV1-like vesicles are expected to have similar characteristics. There are 
two critical steps to obtain subcellular fractions: 1) homogenisation of cells/tissues, 2) 
fractionation of homogenates. Initially we optimised the homogenisation step. 
 
The MV1 isolation protocol was established for fertilised sea urchin eggs. The living 
environment of marine organisms is different from terrestrial organisms thus the 
homogenisation buffer (HB) used in this study was modified based on some related 
mammalian cell-free assays. A metaphase homogenate of CHO cells was shown to 
support NE assembly around mitotic chromosomes in vitro (Burke and Gerace, 1986) 
and a postnuclear supernatant (PNS) of CHO cell homogenate was used to reconstitute 
endocytic vesicle fusion in a cell-free assay (Gruenberg and Howell, 1989). Unless 
otherwise stated, the HB used in this study refers to the modified HB based on 
Gruenberg and Howell’s work in 1989. Table 3.1 shows the composition of the original 
and modified HB. Multiple protease inhibitors were replaced by a protease inhibitor 
cocktail tablet and the serine protease inhibitor PMSF was replaced by a more stable 
substitute AEBSF.  
 
Table 3.1 Recipe of homogenisation buffers 
 Chemicals  Gruenberg & Howell, 1989 This study 
250 mM sucrose    
10 mM Tris   
1 mM iodoacetamide  - 
1 mg/ml antipain   - 
10 µg/ml aprotinin  - 
17 µg/ml benzamidine   
1 µg/ml pepstatin  - 
1 tablet of EDTA-free 
Complete mini protease inhibitors  
-  
1 mM PMSF  - 
1 mM AEBSF -  
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Optimisation of cell homogenisation was initially performed using CHO cells because 
it is the cell line used in the original study. HeLa cells were also used in 
homogenisation because a corresponding human genome database is available. This is 
useful for protein identification once MV1-like vesicles are isolated. Since MV1-like 
vesicles may be very low in quantity, approximately 1.5 x 108 cells were used in each 
homogenisation, corresponding to the number of cells used to isolate secretory 
granules or vesicles from the Golgi (Tooze, 2006). 
 
The homogenisation steps in the MV1 isolation protocol (Byrne et al., 2008) and 
Gruenberg and Howell’s protocol were compared. The major differences between the 
two were the homogeniser and the centrifugation speed to produce PNS. Figure 3.1-A 
illustrates the key steps in these two homogenisations. In the former protocol cells 
were homogenised by passing through a 22G syringe needle whereas in the latter 
protocol cells were homogenised by a metal ball bearing; the centrifugation force to 
produce PNS were 10,000xg and 1,000xg respectively. The PNS was subsequently 
ultracentrifugated to produce the total membrane fraction, which was afterwards 
fractionated by MV1-separating gradients (Figure 3.1-B). 
 
Figure 3.2 shows images of cell homogenates obtained using the two established 
protocols. Both protocols were able to produce membrane fragments (yellow arrows). 
Homogenised cells were indicated by reduced volume of the cytoplasm. However, 
some cells did not seem to be homogenised (red arrows). The ball bearing homogeniser 
visually generated more membrane fragments compared to a 22G syringe needle. This 
was indicated by enhanced observation of “clean nuclei” with the least nuclear 
membrane (white arrows). Fragmentation might be improved by increasing the 
number of passages through the homogeniser or reducing the volume of the solution 
that passes into the homogeniser, but over-homogenised cells may yield chromosome 
fragments that interact with and pull down MV1-like vesicle. The images of cell 
homogenates indicated the proportion of homogenised cells. To confirm the isolation 
of MV1-like vesicles, gradient separated-fractions were analysed by protein markers of 
various cellular organelles (see section below).   
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Figure 3.1 Fractionation flow chart of the MV1-separating gradient (different homogenisation 
protocols) 
*Membrane wash buffer (MWB) = 1:4 HB:PBS  
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Figure 3.2 Cell homogenates obtained using two established protocols 
HeLa cells were homogenised by a 22G syringe needle or a metal ball bearing. 200 µl of whole cells 
or homogenates were loaded and settled on a glass bottom cell culture dish. The cells or 
homogenates were stained with DiOC6 (green channel) and Hoechst 33342 (red channel) and 
imaged by confocal microscopy. Red arrows indicate unhomogenised cells, yellow arrows indicate 
membrane fragments and white arrows indicate “clean nuclei” with the least nuclear membrane. 
Scale bar, 20 µm. 
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 Isolation of MV1-like vesicles by density gradients 3.4
There are many devices to prepare a gradient but usually what matters most is the 
linearity of the gradient. By weighing the collected fractions, it was shown that the 
MV1-separating gradient and the Optiprep gradient were linear. The velocity gradient, 
however fitted into a sigmoid regression instead because the separation was not based 
on the cellular components reaching their density equilibrium (Figure 3.3). The 
regression lines allowed the fraction density to be determined. The range of density of 
the applied gradients is shown in Table 3.2. 
 
Density gradients may only partially separate MV1-like vesicles from the rest of the 
cellular organelles because different cellular components may have a similar density. 
To determine the purity of separated membrane fractions, they were analysed for 
detection of a number of protein markers. As mentioned before, PLCγ being enriched 
in MV1 it is therefore a marker for potential fusogenic vesicles. The presence of Ran is 
an indicator of a functional NE, since this GTPase was detected in fully formed NE in a 
cell-free assay (Byrne et al., 2005) and has been suggested to play a role in NE assembly 
(Hetzer et al., 2002). Also, there was a two-fold enrichment of Ran in MV1 compared to 
MV2 (Byrne 2007, unpublished data). Protein markers of some membrane 
compartments were included to see if any of these cellular compartments were co-
fractionated, details in Table 3.3. 
 
Table 3.2 Range of density in the applied gradients 
Fractionating gradient Range of density (g/ml) 
MV1-separating gradient 1.02 – 1.24 
PtdIns synthesising-organelle-separating gradient 
(Optiprep gradient) 
1.05 – 1.12 
TGN-separating gradient (velocity gradient) 1.02 – 1.14 
 
Table 3.3 Protein markers used for characterisation of separated fractions  
Marker Enriched in/specific to Molecular Weight kDa 
PLCγ enriched in MV1 135 
Ran detected in functional NE 25 
Calreticulin ER marker  63 
BiP ER marker 78 
Rab5 early endosome marker 24 
Rab7 late endosome marker 23 
Golgin-97 trans Golgi marker 97 
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Figure 3.3 All gradients used in this study 
Gradients were prepared according to their standard protocols. These gradients were chosen to 
separate different cellular components as indicated in the brackets. The gradients were aliquoted in 
0.5 ml fractions from the low density end and weighed by an analytical balance.  
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3.4.1 CHO and HeLa cell homogenates separated by the MV1-separating gradient 
It was predicted that MV1-like vesicles could be isolated by using well established 
protocols from previous studies. Strikingly, initial experiments indicated that 
modification of homogenisation was necessary. Figure 3.4 shows representative 
immunoblots of membrane fractions obtained using the two protocols described above. 
Using the MV1 isolation protocol, PLCγ, ER and Golgi markers were detected in few 
medium density fractions, but the signals of these markers were very weak. The ER 
marker was expected to distribute over a wide range of densities because the ER has 
rough and smooth subcompartments and comprises tubules and cisternae.  
 
 
 
Figure 3.4 Separated membranes from CHO cell homogenates obtained using two established 
protocols  
1.5 x 108 CHO cells were homogenised by the MV1 isolation or Gruenberg & Howell protocol (Figure 
3.1-A). The PNS was fractioned into soluble proteins and total membrane fraction. The total 
membrane fraction was fractionated by the MV1-separating gradient into membrane fractions of 
different densities and analysed by immunoblotting. Sample loading in SDS-PAGE: CHO cell 
homogenate (5 µg); fractionated membranes (2% of the total membrane fraction). Individual 
immunoblots are indicated by a vertical black line. Immunoblots were exposed for 10 min and same 
exposure time was used for immunoblots using the same protein markers. Data are representative 
of 3 independent experiments. 
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In contrast, no signal for the markers were detected in the membranes prepared using 
the Gruenberg and Howell protocol. Possibly the PNS was diluted before 
ultracentrifugation and the total membrane fraction was not fully resuspended without 
ultrasonication (Figure 3.1-A). Therefore, recovery of the total membrane fraction was 
decreased. Hence, the two homogenisation protocols were combined and modified 
(Figure 3.5). Cells were homogenised by a metal ball bearing and centrifuged at 
10,000xg to produce a PNS. The PNS was not diluted before ultracentrifugation and the 
total membrane fraction was ultrasonicated for a longer duration. An improvement of 
signal intensity was expected when using this combined protocol. 
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Figure 3.5 Fractionation flow chart of the MV1-separating gradient (combined homogenisation 
protocol) 
*Membrane wash buffer (MWB) = 1:4 HB:PBS  
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Figure 3.6 shows representative immunoblots of membrane fractions obtained using 
the combined protocol. Stronger signals were detected from all selected markers. In 
general, endosomal markers Rab5 and Rab7 were detected in lower density fractions 
compared to the ER marker. Similar results were observed in another density gradient 
in which Rab11 (an endosomal marker) was separated from the ER and detected in 
lower density fractions (Woods et al., 2002). Subcellular fractions of the Golgi were 
shown to have a lower density than those obtained from the ER in several density 
gradients (Balch et al., 1984, Yang et al., 1997b, Plonne et al., 1999). However, in some 
membrane fractions, both BiP (ER) and Golgin-97 (Golgi) were detected.  
 
In CHO cell membrane fractions, PLCγ and Ran were concentrated in fractions 8 to 11 
(density 1.08 – 1.12 g/ml), with the endosomal markers following almost identical 
distributions (Figure 3.6-A). PLCγ and Ran are soluble proteins but only a very low 
signal was detected in the soluble protein fraction of CHO cells, most likely because the 
loaded fraction was not concentrated enough. A more concentrated soluble protein 
fraction was loaded in HeLa cell experiments. 
 
In HeLa cell membrane fractions, the protein markers were slightly shifted to denser 
fractions (Figure 3.6-B). Another noticeable difference was that weak signals were also 
detected from each marker in the denser fractions. PLCγ and Ran were concentrated in 
fractions 10 to 14 (density 1.11 – 1.15 g/ml), along with the ER and Golgi markers. 
Again, the endosomal markers co-fractionated with almost all the PLCγ/Ran-positive 
fractions. Although CHO cell membranes resolved better than HeLa cell membranes, 
more PLCγ/Ran-positive and ER/Golgi-negative fractions were isolated from HeLa 
cells (Figure 3.6-B: fractions 5 – 7). Only one fraction showed the same property in 
CHO cell membranes (Figure 3.6-A: fraction 7). Interestingly, fraction 1 (density 1.02 
g/ml) isolated from HeLa cells was only PLCγ/Ran-positive. However, this low density 
PLCγ/Ran-positive fraction was detected in 1 out of 3 experiments.  
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Figure 3.6 Separated membranes from A) CHO and B) HeLa cells obtained using the combined 
protocol 
1.5 x 108 CHO/HeLa cells were homogenised using the combined protocol (Figure 3.5). The PNS was 
fractioned into soluble proteins and total membrane fraction. The total membrane fraction was 
fractionated by the MV1-separating gradient into membrane fractions of different densities and 
analysed by immunoblotting. Sample loading in SDS-PAGE: CHO/HeLa cell homogenate (5 µg); total 
membrane fraction (2.5% of PNS); soluble proteins (0.3% of PNS for CHO cell experiments and 1.5% 
of PNS for HeLa cell experiments); fractionated membranes (2% of the total membrane fraction). 
Individual immunoblots are indicated by a vertical black line. Immunoblots were exposed for 5 min 
and same exposure time was used for immunoblots using the same protein markers. Data are 
representative of 3 independent experiments. 
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3.4.2 CHO and HeLa cell homogenates separated by the PtdIns synthesising (PIS)-
organelle-separating gradient (Optiprep gradient) 
Given the limited separation of MV1-separating gradient, other density gradients were 
tried in parallel. Recently, membrane fractions enriched in phosphatidylinositol 
synthase activity were separated from the ER by an Optiprep based density gradient 
(Kim et al., 2011). Optiprep (or iodixanol) is an iso-osmolar medium and is usually used 
as a sucrose alternative in subcellular fractionation. In this study, PIS signals were 
always associated with ER signals but their intensities were enhanced in low density 
fractions whereas ER signals were the strongest at high density fractions. More 
importantly, PIS activity was maximised at a single fraction. 
 
PtdIns is phosphorylated to polyphosphoinositides such as PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3 by various kinases and the PIS-organelle was shown to be very mobile 
and was frequently associated with other membranes (Kim et al., 2011). Similar to the 
PIS-organelle, MV1-like vesicles may associate to other membranes where MV1-like 
vesicles are likely to have increased levels of phosphoinositides, the downstream 
products of PtdIns. Therefore, the PIS-organelle-separating gradient was tested to 
isolate MV1-like vesicles. Figure 3.7-A shows the workflow of this fractionation. A 25G 
syringe needle was used to homogenise cells in the PIS-organelle-separating protocol 
and Figure 3.8 shows an image of the cell homogenate, compared to the cell 
homogenate obtained by using a 22G syringe needle. Reduced volume of cytoplasm 
was observed in both homogenates. However, there were visually less membrane 
fragments or “clean nuclei” in the cell homogenate obtained using a 25G syringe 
needle. 
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Figure 3.9 reveals that PLCγ/Ran-positive fractions were co-fractionated with the ER 
(BiP), Golgi (Golgin-97) and endosomes (Rab5 and Rab7) in both CHO and HeLa cell 
membranes separated by the Optiprep gradient. Golgi signals were enriched in denser 
fractions relative to ER and endosomes signals. Using the same Optiprep gradient but 
another ER marker, Kim et al. (2011) had shown that fraction 16 to 21 are the ER 
fractions. However, we detected BiP, an ER marker, mainly in fraction 9 to 12. Ran was 
detected in all fractions with the first four fractions purely Ran-positive, this result was 
consistent in both CHO and HeLa cell membranes. The PLCγ/Ran-positive fractions, 
which were present in medium densities, could not be separated from the ER and the 
Golgi in this gradient.   
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Figure 3.7 Fractionation flow chart of the PIS-organelle-separating gradient and TGN-separating 
gradient 
Recipe of TGN-HB see Materials and Methods; TGN-membrane wash buffer (TGN-MWB) = 1:4 TGN-
HB:TBS. 
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Figure 3.8 Cell homogenates obtained using 22G and 25G syringe needle 
HeLa cells were homogenised by a 22G or 25G syringe needle. 200 µl of whole cells or homogenates 
were loaded and settled on a glass bottom cell culture dish. The cells or homogenates were stained 
with DiOC6 (green channel) and Hoechst 33342 (red channel) and imaged with a confocal light 
microscope. Red arrows indicate unhomogenised cells, yellow arrows indicate membrane fragments 
and white arrows indicate “clean nuclei” with the least nuclear membrane. Scale bar, 20 µm. 
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Figure 3.9 Separated membranes of A) CHO and B) HeLa cells fractionated by the PIS-organelle-
separating gradient 
1.5 x 108 CHO/HeLa cells were homogenised by a 25G syringe needle (Figure 3.7-A). The PNS was 
fractioned by the PIS-organelle-separating gradient into membrane fractions of different densities 
and analysed by immunoblotting. Sample loading in SDS-PAGE: fractionated membranes (1% of 
PNS). Individual immunoblots are indicated by a vertical black line. Immunoblots were exposed for 5 
min and same exposure time was used for immunoblots using the same protein markers. Data are 
representative of 2 independent experiments. 
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3.4.3 HeLa cell homogenate separated by the TGN-separating gradient (velocity 
gradient) 
Both the MV1-separating gradient and the Optiprep gradient provided limited 
separation of fractions analogous to MV1 from other organelles. Hence, a TGN-
separating gradient was tested to separate MV1-like vesicles from the Golgi. Figure 3.7-
B shows the flow chart of this fractionation procedure. This is an established sucrose-
based gradient to separate cellular organelles based on size rather than density (Tooze, 
2006). Larger components migrate faster than smaller ones thus this gradient is also 
known as velocity gradient. The velocity gradient was applied routinely to separate 
secretory granules/vesicles from the trans-Golgi. The separated fractions are affiliated 
to soluble proteins (fraction 1 – 3), immature secretory granules and constitutive 
secretory vesicles (fraction 4 – 11), mature secretory granules (fraction 12 – 19) and the 
trans-Golgi (fraction 20 onwards) (Figure 3.10, fraction affiliations).  
 
HeLa cell homogenates were separated by the velocity gradient. Most of the markers 
were found in the soluble fractions (Figure 3.10). As expected, Golgin-97 was detected 
in the trans-Golgi fraction (Figure 3.10: fraction 24), indicating that the gradient 
functioned properly. An interesting remark here is that apart from the soluble 
fractions, fraction 5 was the only PLCγ-positive fraction. This fraction was only co-
fractionated with Rab5. Its signal intensity was weak and only detected in one out of 
two experiments. Together, the above result demonstrated that a pure PLCγ or 
PLCγ/Ran-positive fraction is difficult to obtain and a successful isolation of such 
fractions may vary from batch to batch.  
 
In summary, several biochemical gradients were applied to separate MV1-like vesicles. 
Although pure PLCγ/Ran-positive fractions were isolated in some gradients, the 
separations either lacked reproducibility or lacked resolution in these gradients. Also, 
fractionation from interphase cell homogenates was challenging, the input of cells used 
may not have been sufficient to reproduce a pure separation of MV1-like vesicles. 
Therefore, given the above limitations, a complementary cell biology approach was 
adopted.  
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Figure 3.10 Subcellular fractions of HeLa cells fractionated by the TGN-separating gradient 
1.5 x 108 HeLa cells were homogenised by a 22G syringe needle (Figure 3.7-B). The PNS was 
fractioned by the TGN-separating gradient into subcellular fractions of different sizes and analysed 
by immunoblotting. Sample loading in SDS-PAGE: separated fractions (1% of PNS). Individual 
immunoblots are indicated by a vertical black line. Immunoblots were exposed for 5 min and same 
exposure time was used for immunoblots using the same protein markers. Data are representative 
of 2 independent experiments. 
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 Discussion 3.5
3.5.1 Performance of the different fractionating gradients 
Subcellular fractionation is a laborious procedure with multiple steps. Imperfection is 
common in subcellular fractionation because most of the time enrichment of derived 
components rather than homogeneity is achieved. Several gradients were applied to 
isolate MV1-like vesicles on the basis of density or size of the organelles. At the 
moment PLCγ and Ran enrichments were considered the criteria for MV1-like vesicles 
because MV1 is enriched in both PLCγ and Ran (Byrne et al., 2007) (also Byrne 2007, 
unpublished data). We aimed at isolating MV1-like vesicles in mammalian cells so that 
we could characterise their lipid and protein composition by lipid mass-spectrometry 
and proteomics analysis respectively, in order to provide further details about the 
potential proteins or lipids involved in somatic cell NE assembly.  
 
Isolation of MV1 is well established and the typical density of MV1 is around 1.02 g/ml 
(Collas and Poccia, 1996). On an MV1-separating gradient, a PLCγ/Ran-positive 
fraction was isolated in the first fraction, corresponding to the density of MV1 (Figure 
3.6-B: fraction 1). On a velocity gradient which separates cellular components by their 
size, the PLCγ signal was mainly found in low density fractions, within the range of 
1.02 g/ml to 1.04 g/ml (Figure 3.10). Nevertheless, these fractions were isolated 
inconsistently thus further investigation was difficult. If MV1-like vesicles have an 
identical density to MV1, it would mean the population of MV1-like vesicles is 
extremely scarce and a fractionation method with higher recovery would be required. 
 
It is also possible that MV1-like vesicles in mammalian somatic cells have a density 
different from sea urchin MV1. PLCγ/Ran-positive fractions were separated from the 
ER and the Golgi on an MV1-separating gradient, in a density between 1.06 g/ml and 
1.08 g/ml (Figure 3.6: fractions 5 – 7). Again, the yield of these fractions was low. The 
Optiprep gradient could not separate any PLCγ/Ran-positive cellular components 
from other organelles, probably because the gradient has a narrower range of density. 
Also, cells were visually less homogenised when using a 25G syringe needle (Figure 
3.8). The velocity gradient gave a clue regarding the size of MV1-like vesicle. Since the 
PLCγ-positive signal was detected in the immature secretory granules (ISGs) region of 
Chapter 3 
102 
 
the gradient (Figure 3.10: fraction 5), it is expected that MV1-like vesicles would have 
comparable sizes. ISGs have a mean diameter of 80 nm measured by morphometric 
analysis and more precisely the ISGs fraction contains vesicles with diameters ranged 
from 40 nm to 140 nm (Tooze et al., 1991). Thus, MV1-like vesicles may have similar 
diameters.  
 
In all of the gradients used, PLCγ/Ran-positive signals were rarely separated from the 
early and late endosomes. It would mean that MV1-like vesicles have similar density 
and size as the endosomes. Alternatively, growth factor stimulation could cause 
accumulation of PLCγ in endosomes (Grimes et al., 1996). Therefore, it is also possible 
that an endosomal population with recruited PLCγ was isolated and detected instead 
of MV1-like vesicles, or in those fractions a mixture of both could co-exist. To test this 
idea, the fractionation of serum-starved cells could be envisioned. 
 
3.5.2 Possible improvements in isolating of MV1-like vesicles and alternatives  
Density gradient separation is limited by the physical property of cellular 
compartments and the mixing of membranes after homogenisation. The purity of 
separated fractions depends on many factors such as the homogenisation conditions, 
the cell line and its culture conditions. MV1-like vesicles can be mitosis-specific 
components and in this case their abundance can be maximised by cell 
synchronisation. Although nocodazole was shown to inhibit NE assembly in vitro 
(Vaillant and Paulin-Levasseur, 2008), other synchronisation agents with an alternative 
mechanism of action may not have such drawback. For instance, hydroxyurea blocks 
cells at G1/S phase by inhibiting ribonucleotide reductase (Rosner et al., 2013). 
Extended incubation with hydroxyurea followed by washing may improve the yield of 
mitotic cells. In parallel, maturating-promoting factor (MPF) that promotes mitosis 
could be added to the G1/S blocked cells to guarantee the cells enter mitosis 
simultaneously (Lohka et al., 1988).  
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Although MV1 is isolated from the fertilised eggs of echinoderms without strict 
inhibition of protein phosphorylation/dephosphorlation, MV1-like vesicles may be 
subjected to these protein modifications. Hence, prevention of these may assure MV1-
like vesicles to be in their native stage. Addition of kinase and phosphatase inhibitors 
may increase the chance to obtain MV1-like vesicles. Similarly, addition of redox 
inhibitors would serve the same purpose. Furthermore, MV1-like vesicles may have 
the ability to fuse with membrane components such as the exocytotic vesicles. 
Therefore, addition of membrane fusion inhibitors such as TAT-NSF (a polypeptide 
that inhibits the N-ethylmaleimide-sensitive fusion proteins) and other similar 
inhibitors may improve the isolation of MV1-like vesicles (Morrell et al., 2005).  
 
In terms of gradient analysis, a comprehensive proteomic analysis of MV1 would 
provide information regarding “better” markers so that more references could be 
available for isolation and characterisation of MV1 analogous components. Indeed, an 
ideal subcellular fractionation is usually coupled with immunoisolation. An affinity 
column would aid the isolation of PLC-enriched fractions. In humans, there are 15 PLC 
isozymes divided into six subgroups (Vines, 2012). Fusogenic vesicles may be enriched 
in PLC activity but we do not know which isozyme(s) corresponds to the NE fusion 
mechanism in somatic cells. Nevertheless, for PLCγ there are only two isoforms and 
those can be the initial candidates to be studied. 
 
Subcellular fractionation involves tedious work. A complementary approach would be 
to verify the presence of fusogenic vesicles by morphological and compositional 
analysis in vivo. Morphological analysis can be combined with the use of 
immunochemistry or engineered molecular tags to identify the cellular structures with 
lipid-protein profile similar to MV1 or other vesicles involved in NE assembly. 
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3.5.3 The characteristics of mammalian fusogenic vesicles – another perspective 
A non-ER, non-Golgi, low density fraction with PLCγ and Ran enrichment was the 
target of our isolation. From the results of the density gradient fractionations, however, 
PLCγ and Ran were mainly detected in medium density fractions (from 1.06 g/ml to 
1.12 g/ml in the MV1-separating gradient, and from 1.06 g/ml to 1.08 g/ml in the 
Optriprep gradient). The intense PLCγ and Ran signals were always associated with 
the signals of ER, Golgi, early and late endosomes. Therefore, it is possible that PLCγ 
would be more evenly distributed in mammalian cells than in sea urchin eggs. 
 
The above observation may actually reflect the true identity of fusogenic vesicles in 
mammalian cells. In MV1 isolation, a population of vesicles known as MV2 has a 
density from 1.04 g/ml to 1.08 g/ml (Collas and Poccia, 1996). MV2 can be further 
separated into MV2α or MV2β, in which MV2α is enriched in a Golgi enzyme and 
MV2β is enriched in an ER enzyme (Collas and Poccia, 1996). Moreover, MV2α 
exhibited a comparable binding profile as MV1 to the chromatin and is required for 
fusion of MV1 to MV2β to form the NE. Since the PLCγ enrichment in mammalian 
cells shared more similarities to MV2 vesicles, it is reasonable to infer that fusogenic 
vesicles in mammalian cells are enriched in PLCγ and Ran and have similar densities 
as MV2. These fusogenic vesicles may also contain protein markers enriched in MV2. 
 
 Summary 3.6
Several biochemical gradients were applied to isolate MV1-like vesicles from 
mammalian cells. Although some isolated fractions shared properties with MV1, they 
were only sporadically isolated and their yield was low. In parallel, enrichment of 
PLCγ was mainly found in medium density fractions, suggesting that fusogenic 
vesicles in somatic mammalian cells may have distinct features compared to MV1 and 
possibly share some properties with MV2. By gradient analysis only we were not able 
to conclude that our isolated fractions were MV1-like vesicles, therefore a 
complementary cell biology approach was adopted. The following chapter will 
describe the localisation of phosphoinositides enriched in MV1. By probing these lipids 
in mammalian cells, we expect to identify cellular compartments where fusogenic 
vesicles reside. 
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 Localisation of PtdIns(3,4,5)P3 in mammalian cells Chapter 4
 Introduction 4.1
Phosphoinositides are mostly trace molecules in cells. Nevertheless, phosphoinositides 
are biologically important because many of them function as secondary messengers in 
cell signalling pathways. For instance, PtdIns(3,4,5)P3 is required for AKT activation 
(Alessi and Cohen, 1998) and PtdIns(4,5)P2 is required for GTPase activity of the 
trafficking protein Arf (Randazzo and Kahn, 1994). Phosphoinositides are unique 
phospholipids because their inositol headgroup can be reversibly phosphorylated on 
three positions, such capacity results in a diverse population of signalling molecules 
recognised by various protein effectors. Moreover, phosphoinositide-modifying 
enzymes play a regulatory role in membrane fusion events. For instance, PI3 kinase 
activity is required for the fusion of the endosomes (De Camilli et al., 1996, Li et al., 
1995). 
 
The structural role of phosphoinositides in the membrane has usually been overlooked. 
The size difference between the fatty acid tails and the headgroup of phosphoinositides 
gives rise to the various spontaneous curvatures. The localisation of phospholipids in a 
membrane compartment and their asymmetric distribution across a membrane bilayer 
will determine local membrane curvature which in turn influences the organelle shape 
and related function (Larijani and Poccia, 2012, Larijani et al., 2014). In vitro data 
suggests a role for phosphoinositides in NE assembly. The fusogenic vesicles that 
initiate NE assembly (MV1) are enriched in the phosphoinositides PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3 (Byrne et al., 2007). PtdIns(4,5)P2 can be hydrolysed to DAG which is 
necessary for membrane fusion. The role of DAG in mammalian NE assembly will be 
discussed in Chapter 5. This chapter investigates the localisation of PtdIns(3,4,5)P3 in 
mammalian cells.  
 
While MV1 has been shown as a compartment in echinoderms (Byrne et al., 2007, Byrne 
et al., 2014), the existence of similar vesicular NE precursors in mammalian cells has yet 
to be demonstrated. We predict MV1-like vesicles exist and function as NE precursors 
in mammalian NE assembly. MV1-like vesicles will have a similar lipid-protein profile 
as MV1, and therefore will likewise be enriched in PtdIns(4,5)P2 and PtdIns(3,4,5)P3.  
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To investigate the presence of endomembrane-PtdIns(3,4,5)P3 in mammalian cells, we 
used the PtdIns(3,4,5)P3-binding PH domain of GRP1 (GRP1PH). GRP1PH was fused to 
miniSOG, a novel tag that allows EM visualisation, in order to identify PtdIns(3,4,5)P3-
enriched vesicles at high resolution.  
 
 Investigating phosphoinositides localisation by imaging  4.2
The localisation of phosphoinositides to subcellular compartments has typically been 
determined by lipid-binding domains fused to fluorescent proteins. Recently quantum 
dot-tagged lipid-binding domains have been used to visualise intracellular 
phosphoinositides (Irino et al., 2012). Although such imaging approaches are not 
quantitative, and phosphoinositides detection is limited by the specificity of the tools 
available, it allows the validation of phosphoinositides localisation by co-labelling cells 
with organelle markers. As such this was the initial approach tested in this study. 
 
4.2.1 The choice of PtdIns(3,4,5)P3-binding domains 
While phosphoinositide synthesis has been shown to occur specifically at the 
cytoplasmic leaflet of the ER and to a lesser extent at the Golgi (Fagone and Jackowski, 
2009, Vidugiriene and Menon, 1993), the localisation of PtdIns(3,4,5)P3 to 
endomembranes has been rarely reported. Table 4.1 lists the cellular localisation of 
several commonly used PtdIns(3,4,5)P3 reporters. A recombinant probe was used by 
Lindsay et al. to detect PtdIns(3,4,5)P3 whereas the rest of the studies used transient 
transfection to detect PtdIns(3,4,5)P3. Apart from the GRP1PH domain, all other PH 
domains merely localised at the plasma membrane (see Table 4.1). 
 
The choice of lipid-binding domain, as a transfection probe, is very important. It is 
acknowledged that PH domains with a strong binding affinity can affect lipid turnover 
and therefore result in the sequestering of the target lipid in an exclusive compartment 
This is known as the “masking” effect (Balla et al., 2000). When the binding affinity of a 
lipid probe is too strong, the target lipid cannot dissociate from the probe easily. The 
cell will sense a lack of lipids in the required compartment and may draw the target 
lipid from other compartments, resulting in an exclusive localisation of the probe. 
Table 4.2 shows the binding affinity of some commonly used PtdIns(3,4,5)P3-binding 
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PH domains. Among them GRP1PH has a relatively low binding affinity and this may 
explain why GRP1PH can detect PtdIns(3,4,5)P3 in endomembranes whereas other PH 
domains mainly localise at the plasma membrane. Moreover, endomembrane-
PtdIns(3,4,5)P3 was detected by Lindsay et al. (2006) at the EM level using a GST-
GRP1PH recombinant probe and immunogold labelling, although no corresponding 
light microscopy images were shown.  
 
In addition to its reported endomembrane localisation, GRP1PH has a high selectivity 
for PtdIns(3,4,5)P3. GRP1PH binds to PtdIns(3,4,5)P3 with a 650-fold higher affinity 
relative to PtdIns(4,5)P2 (Klarlund et al., 2000). Therefore, even though it has a relatively 
low binding affinity compared to other PH domains it is still a useful tool to target 
PtdIns(3,4,5)P3. We constructed several GRP1PH probes to target endomembrane-
PtdIns(3,4,5)P3. These probes were fused with various tags necessary for different 
detection methods (Table 4.3). 
 
Table 4.1 PH domains used for detecting PtdIns(3,4,5)P3 in live or fixed cells 
Domain Localisation References 
AKTPH Plasma membrane (Watton and Downward, 1999) 
ARNOPH Plasma membrane (Venkateswarlu et al., 1998b) 
BTKPH Plasma membrane (Varnai et al., 1999) 
GRP1PH 
Plasma membrane, ER, NE, 
inner mitochondrial membrane 
(Lindsay et al., 2006, Venkateswarlu et al., 1998a) 
PDK1PH Plasma membrane (Komander et al., 2004) 
 
Table 4.2 PtdIns(3,4,5)P3-binding affinity of different PH domains 
Domain KD (nM) 
Relative 
affinity 
References 
AKTPH 0.4 – 6.4 High (Rong et al., 2001) 
ARNOPH 70 Low (Venkateswarlu et al., 1998b) 
BTKPH 40 – 100 Low (Saito et al., 2001, Baraldi et al., 1999) 
GRP1PH 50 – 140 Low (Klarlund et al., 2000, Corbin et al., 2004) 
PDK1PH 0.2 – 4 High (Komander et al., 2004, Currie et al., 1999, Ziemba et al., 2013) 
 
 
Table 4.3 GRP1PH probes used in this study 
Probe (N’ – C’) GRP1PH genotype Detection method Resolution 
GFP-GRP1PH WT Transfection LM 
GFP-GRP1PH.K273A Non-binding mutant Transfection LM 
GST-GRP1PH WT Recombinant probe LM 
GST-GFP-GRP1PH-tSOG WT Transfection, recombinant probe LM & EM 
GST-GFP-GRP1PH.K273A-tSOG Non-binding mutant Transfection, recombinant probe LM & EM 
GST-GFP-GRP1PH.R284A-tSOG Non-binding mutant Transfection, recombinant probe LM & EM 
GST-GFP-GRP1PH.K273A/R284A-tSOG Non-binding mutant Transfection, recombinant probe LM & EM 
 
tSOG = tandem miniSOG domains; LM = light microscopy; EM = electron microscopy  
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 Detecting PtdIns(3,4,5)P3 by transient transfection  4.3
As described above, transfection probes with a strong binding affinity may sequester 
target lipid in an exclusive compartment. Despite this limitation, endomembrane-
PtdIns(3,4,5)P3 has been visualised in PC12 and NIH3T3 cells using GRP1PH 
transfection probes (Gray et al., 1999, Venkateswarlu et al., 1998a). Hence, we tested the 
usefulness of chimeric GRP1PH in detecting PtdIns(3,4,5)P3 in our cell lines.  
 
GRP1PH and its non-PtdIns(3,4,5)P3-binding mutant were conjugated to GFP in order to 
detect endomembrane-PtdIns(3,4,5)P3 (Figure 4.1-A). Figure 4.1-B indicates that the 
GFP-tagged GRP1PH correctly expressed in mammalian cells without GFP cleavage. 
Figure 4.1-C shows the localisation of GFP-GRP1PH in live HeLa and COS7 cells under 
basal conditions. GFP-GRP1PH localised at the plasma membrane (white arrows) and 
also to endomembranes of high expressing cells (green arrows). On the other hand, 
GFP-GRP1PH.K273A, a non-PtdIns(3,4,5)P3-binding mutant, did not localise at the 
plasma membrane except in some very high expressing cells. An obvious nuclear 
localisation of GRP1PH transfection probe was observed. This had been reported 
previously by Venkateswarlu et al. who had suggested that its nuclear localisation was 
due to free entry of the probe because of its small molecular size. However, such 
observation might also suggest some unknown nuclear protein-binding sites of 
GRP1PH.  
 
GFP-GRP1PH has been shown translocated to the plasma membrane upon NGF and 
EGF stimulation in PC12 cells (Venkateswarlu et al., 1998a). When stimulated with 
EGF, GFP-GRP1PH displayed an explicit plasma membrane localisation (white arrows) 
in HeLa cells and also translocated to endomembranes (green arrows) that resemble 
the ER (Figure 4.2, upper panels). The translocation of GRP1PH was time-dependent, 
being the strongest after 30 min of EGF treatment and weaker at earlier time-points. In 
contrast, the K273A mutant did not translocate to the plasma membrane and 
endomembranes except after 30 min of EGF treatment (Figure 4.2, lower panels). In 
summary, the GRP1PH transfection probe is PtdIns(3,4,5)P3-specific and able to target 
endomembrane-PtdIns(3,4,5)P3 in both basal and stimulated mammalian cells.  
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Figure 4.1 GFP-GRP1PH is localised to the plasma membrane and endomembranes of cells 
under basal conditions 
(A) Schematics of GRP1PH constructs tagged with GFP; length of the domains is in scale with the 
number of base pairs. GRP1PH.K273A is an established non-PtdIns(3,4,5)P3-binding point mutation 
(Klarlund et al., 2000). (B) HeLa cells were transfected with 250 ng WT or mutant GRP1PH probe. 
Lysates of the transfected cells were subjected to Western blot analysis. The GRP1PH probes were 
correctly expressed in the transfected cells, as indicated by the bands of the predicted size (45 kDa). 
There was no cleavage of GFP from the constructs, indicated by the absence of a corresponding 
band at 25 kDa. (C) Live confocal images of HeLa and COS7 cells transfected with 250 ng GFP-
GRP1PH or GRP1PH.K273A for 16 h. Plasma membrane localisation (white arrows) of GFP-GRP1PH 
was detected in both high and low expressing cells. GFP-GRP1PH also displayed an ER-like 
localisation (green arrows) in high expressing cells. GRP1PH.K273A did not localise at the plasma 
membrane except in some high expressing cells, of which an increased intracellular fluorescence 
was also observed. Nuclear fluorescence of GFP-GRP1PH was observed in all transfected cells, with 
uncharacterised mechanism. Scale bar, 10 µm. 
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Figure 4.2 Translocation of GFP-GRP1PH to the plasma membrane in response to EGF 
stimulation 
HeLa cells were transfected with 250 ng GFP-GRP1PH or GFP-GRP1PH.K273A for 16 h and stimulated 
with 100 ng/ml EGF for 2, 15 and 30 mins. Stimulated cells were fixed with 4% PFA and imaged by 
confocal microscopy. WT and mutant GRP1PH transfected cells responded differently to EGF 
stimulation. An explicit plasma membrane (white arrows) and endomembranes (green arrows) 
translocation were observed in GFP-GRP1PH transfected cells in all time-courses, and stimulated 
cells showed the strongest cytoplasmic fluorescence after 30 min of EGF treatment. The 
translocation of GFP-GRP1PH.K273A to the plasma membrane was not observed except after 30 min 
of EGF treatment, suggesting that the non-binding property of K273A mutation is not absolute in 
vivo. Scale bar, 10 µm. 
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 Detecting PtdIns(3,4,5)P3 with a recombinant probe  4.4
GRP1PH transfection probe localised at the plasma membrane and endomembranes in 
the above experiments. However, we could not rule out the possibility that the 
expression of the probe may affect phospholipid dynamics through signalling 
pathways. Hence, the localisation of a transfection probe might not necessarily 
represent the genuine distribution of the targeted phosphoinositide. For instance, we 
had demonstrated that PtdIns(4,5)P2 was sequestered at the plasma membrane when 
transfected with the high affinity probe PLCδ1PH whereas endomembrane-PtdIns(4,5)P2 
could only be detected by a PLCδ1PH recombinant probe (Hobday, 2012). Therefore, to 
determine the in situ PtdIns(3,4,5)P3 localisation, we took a complementary approach 
and developed a GST-GRP1PH recombinant probe.  
 
For a recombinant probe to enter a fixed cell, detergent is required to permeabilise the 
plasma membrane. Depending on their physical properties such as the critical micelle 
concentration and charge, detergents may extract the lipids of interest from 
membranes or affect the performance of lipid-binding dyes (Chapter 2 commentary). 
Saponin is a mild detergent commonly used in phospholipid studies (Goldenthal et al., 
1985). It forms complexes with cholesterol thus creating pores in the plasma 
membrane, allowing the entry of macromolecules (Francis et al., 2002). However, the 
impact of saponin on membrane ultrastructure is usually neglected.  
 
Figure 4.3 illustrates the dose-dependent effect of saponin on the ultrastructure of 
endomembranes. In both 0.1% and 0.5% saponin-treated cells, the matrices of the 
mitochondria displayed a “hollow” phenotype, indicated by the lack of electron 
density in those regions (red arrows). The outer membranes of the mitochondria were 
deformed showing a ruffle phenotype (red brackets). The deformations were more 
severe in the 0.5% saponin-treated cell. Although mitochondria were disrupted by 
saponin, the NE and other endomembranes remained intact in saponin-treated cells 
compared to the control cell. Despite the use of detergent is an inevitable step in the 
application of recombinant probes, the recombinant GST-GRP1PH should give us the 
most reliable information about PtdIns(3,4,5)P3 localisation in endomembrane 
compartments.  
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Figure 4.3 Saponin has a dose-dependent effect on membrane ultrastructure 
HeLa cells were fixed with 4% PFA, permeabilised with 0.1% (A) or 0.5% (B) saponin, and prepared 
for electron microscopy. Cells were stained with 1% osmium tetraoxide, embedded in resin, serial 
sectioned and imaged by TEM. In both 0.1% and 0.5% saponin-treated cells, the matrix of some 
mitochondria was extracted and displayed a “hollow” phenotype (red arrows). Moreover, the outer 
membranes of some mitochondria were disrupted and ruffled in saponin-treated cells (red brackets) 
whereas in the control cell the outer membranes of mitochondria were smooth. The deformation of 
mitochondria was more severe in 0.5% saponin-treated cells than 0.1% saponin-treated cells. 
However, the NE (yellow arrows) and other endomembranes were intact in all saponin-treated cells 
compared to the control cell. Scale bar, 1 µm. 
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The GST-GRP1PH recombinant probe was expressed and purified from bacteria using 
glutathione−sepharose beads (Figure 4.4-A). The PtdIns(3,4,5)P3-binding specificity of 
purified GST-GRP1PH was tested using a “lipid strip”, a hydrophobic membrane that 
had been spotted with different lipids. Figure 4.4-B shows that GST-GRP1PH only 
bound to PtdIns(3,4,5)P3 on the strip. When GST-GRP1PH was pre-incubated with 
Ins(1,3,4,5)P4 (the soluble headgroup of PtdIns(3,4,5)P3,) for an hour, the binding of 
GST-GRP1PH to PtdIns(3,4,5)P3 decreased. This indicates that our recombinant probe is 
PtdIns(3,4,5)P3-specific.  
 
 
 
 
Figure 4.4 The GST-GRP1PH recombinant probe is PtdIns(3,4,5)P3-specific 
(A) Schematic of the GST-GRP1PH recombinant probe; length of the domains is in scale with the 
number of base pairs. GST-GRP1PH was expressed and purified from E. coli DH5α, as described in 
Chapter 2. (B) The specificity of GST-GRP1PH recombinant probe was analysed using a “lipid strip”, a 
hydrophobic membrane spotted with different lipids. The lipid strip was blocked with 3% fatty acid-
free BSA and incubated with either 0.5 µg/µl recombinant probe, or recombinant probe pre-
incubated for 1 h with a 10x molar excess of Ins(1,3,4,5)P4. This strip was subsequently incubated 
with an anti-GST antibody followed by a HRP-conjugated anti-mouse secondary antibody, treated with 
ECL and exposed to photographic film. GST-GRP1PH binding to PtdIns(3,4,5)P3 was diminished in the 
presence of Ins(1,3,4,5)P4. GST-GRP1PH was obtained from Nick Leslie’s group (University of 
Dundee) and the membrane strip experiment was performed by Marta Gutierrez (Unidad de 
Biofisica). 
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When applied to fixed and permeabilised cells, the recombinant GST-GRP1PH localised 
at the plasma membrane and endomembranes; the major fluorescent signal was 
detected in the endomembranes and to a lesser extent in the plasma membrane (Figure 
4.5). PtdIns(3,4,5)P3 was detected in the perinuclear region that resembles the ER (green 
arrow) and Golgi (red arrow), consistent with the phosphoinositide synthesis in these 
compartments. Interestingly, there was also a clear NE localisation of GST-GRP1PH, 
which had not been shown in any previous studies. When the cells were probed with 
GST-GRP1PH pre-incubated with Ins(1,3,4,5)P4, the organelles referred to above were 
not labelled. Instead a punctate fluorescent signals was observed.  
 
 
Figure 4.5 GST-GRP1PH is localised to endomembranes that resemble the NE, ER and Golgi 
COS7 cells were fixed with 4% PFA, permeabilised with 0.5% saponin and incubated with GST-
GRP1PH or GST-GRP1PH pre-incubated with Ins(1,3,4,5)P4 for 1 h at room temperature. The cells were 
subsequently incubated with a DY650-conjugated anti-GST antibody before confocal imaging. GST-
GRP1PH localised to endomembranes that resemble the NE (yellow arrow), ER network (green arrow) 
and Golgi (red arrow). The probe also localised at the plasma membrane to a lesser extent. 
Ins(1,3,4,5)P4 pre-incubated GST-GRP1PH displayed a diminished punctate fluorescent signal 
throughout the cell. Scale bar, 10 µm.   
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To confirm the localisation of GST-GRP1PH, and therefore of PtdIns(3,4,5)P3 to specific 
organelles, immunofluorescence experiments were performed on cells labelled with 
GST-GRP1PH, in addition to markers of the ER and NE (Figure 4.6). The global 
Pearson's correlation coefficient (PCC) suggested that localisation of GST-GRP1PH had a 
low positive correlation with the tested endomembrane markers. Although a perfect 
colocalisation between PtdIns(3,4,5)P3 and the tested markers was not observed, the 
fact that GST-GRP1PH , MAb414 and calreticulin had similar NE localisation suggested 
an association or presence of PtdIns(3,4,5)P3 at the NE (Figure 4.6-A &B, yellow 
arrows). Due to time constraints, co-localisation experiments between GST-GRP1PH and 
Golgi-specific markers were not performed. 
 
 
 
Figure 4.6 GST-GRP1PH partially co-localises with ER and NE markers 
COS7 cells were probed with GST-GRP1PH (green) as described in Figure 4.5. In parallel, the cells 
were probed with either a marker for (A) the NE (MAb414) or (B) ER (calreticulin), imaged using an 
Alexa 488-conjugated secondary antibody (magenta). Both the localisation of MAb414 and GST-
GRP1PH displayed a circular fluorescence around the nucleus (yellow arrows). Similarly, localisation 
of GST-GRP1PH resembled that of calreticulin at the NE (yellow arrows) but to a lesser extent at the 
ER network (white arrow). The degree of colocalisation between GST-GRP1PH and the 
endomembrane markers was analysed by the image analysis software Volocity 6.3 (PerkinElmer). 
The global Pearson's correlation coefficient (PCC) of GST-GRP1PH localisation relative to that of 
MAb414 and calreticulin are 0.38 ± 0.05 and 0.52 ± 0.03 respectively, averaged from n = 5 region 
of interest. Scale bar, 10 µm.  
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 Identification of the PtdIns(3,4,5)P3-generating enzyme in the 4.5
endomembranes 
Class I PI3 kinases are soluble proteins which exclusively produce PtdIns(3,4,5)P3, 
upon cell stimulation. Class IA PI3 kinases (PI3KCA) are thought to function mainly at 
the plasma membrane but they have also been reported associated with the NE and 
with vesicles (Katso et al., 2001, Rameh and Cantley, 1999). This observation is 
reminiscent of the localisation of PtdIns(3,4,5)P3 targeted by GRP1PH. Moreover, it has 
been shown that the plasma membrane translocation of GRP1PH requires PI3 kinase 
activity, since the translocation is inhibited by LY294002 and by deletion of the p85 
regulatory domain of PI3 kinases (Venkateswarlu et al., 1998a). The presence of 
PI3KCA on endomembranes would strongly support the data above, demonstrating 
the presence of an endomembrane-PtdIns(3,4,5)P3 pool. Therefore, we analysed the 
localisation of PI3KCA using immunofluorescence.  
 
Figure 4.7-B – E shows the localisation of the regulatory p85α and catalytic p110α and 
p110β subunits of PI3KCA in basal HeLa and COS7 cells, detected by indirect 
immunofluorescence. p85α displayed a NE- (yellow arrows), Golgi- and ER- like 
localisation, plus a vesicular localisation throughout the cytoplasm of most cells. In 
some cells, a perceived absence of Golgi localisation (red arrows) was observed. 
Moreover, there was no observable plasma membrane localisation of p85 under basal 
conditions. The catalytic subunits, p110α and p110β displayed a Golgi-like localisation 
(green arrows) as well as a vesicular localisation throughout the cytoplasm.  
 
The p85 subunit has been found associated with clathrin-coated vesicles upon NGF 
(nerve growth factor) stimulation (Howe et al., 2001). In our experiments, both the p85 
regulatory subunit and the two catalytic subunits displayed vesicular fluorescence in 
cells in addition to their endomembrane localisation under basal conditions. Whether 
these membrane-associated PI3KCA are active under these conditions will require 
further investigation. However, this indicates a potential production of PtdIns(3,4,5)P3 
in vesicles and/or endomembranes.  
  
Chapter 4 
117 
 
In the echinoderm NE assembly assay, fusogenic vesicles MV1 are enriched in 
PtdIns(3,4,5)P3. To verify the presence of similar PtdIns(3,4,5)P3-enriched vesicles in 
mammalian cells, a probe that allows high resolution imaging is required.  
 
 
 
(Cont’d) 
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Figure 4.7 Class IA PI3 kinases is localised to endomembranes of mammalian cells 
(A) Schematic representation of PI3KCA, which generates PtdIns(3,4,5)P3. PI3KCA localisation was 
detected by indirect-immunofluorescence, using antibodies against different domains of the enzyme. 
Mammalian cells were fixed with PFA, permeabilised with 0.5% saponin, incubated with the specified 
primary antibody followed by a fluorescently conjugated secondary antibody before confocal image 
acquisition (for details see Chapter 2). (B) In both COS7 and HeLa cells, p85 was localised to 
endomembranes that resemble the NE (yellow arrows), ER and Golgi. Vesicular fluorescence was 
detected throughout the cytoplasm. In some cells, a perceived absence of Golgi localisation (red 
arrows) was also noticed. (C – D) p110α and (E) p110β localised to endomembranes that resemble 
the Golgi (green arrows) in both cell lines. Similar to the p85 regulatory domain, both p110α and 
110β showed a vesicular fluorescence throughout the cytoplasm. Scale bar, 10 µm.   
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 Development of a PtdIns(3,4,5)P3-specific probe for high resolution 4.6
imaging 
The previous sections demonstrated that both PtdIns(3,4,5)P3 and PI3 kinase subunits 
were localised to vesicle-like structures in the cell cytoplasm. Thus, it is possible that 
these vesicles may represent an equivalent to MV1 in mammalian cells. To confirm 
this, vesicles would need to be imaged at high resolution. In order to image 
PtdIns(3,4,5)P3-containing, putative MV1-like vesicles at the EM level, GRP1PH was 
fused to a novel tag called miniSOG. The mechanism of how miniSOG generates EM 
contrast and its optimisation will be discussed in Chapter 6.  
 
Figure 4.8-A illustrates the miniSOG-GRP1PH probe GFP-GRP1PH-tSOG. Although 
miniSOG is a fluorescent tag, its fluorescent signal is weak and rapidly bleached. Thus, 
GFP was added to the constructs. A GST tag was also cloned at the N-terminus of the 
construct so that the probe could be compatible for recombinant protein production. 
Since recombinant protein purification is a laborious and time consuming process, 
transient transfection with GFP-GRP1PH-tSOG was used initially to target 
endomembrane-PtdIns(3,4,5)P3. Western blot analysis indicated no cleavage of GFP 
from the constructs (data not shown). MiniSOG might affect the localisation of the 
PtdIns(3,4,5)P3-binding domain. Before using the miniSOG-tagged probe for high 
resolution imaging, its correct localisation was analysed by confocal microscopy.  
 
Under basal conditions, GFP-GRP1PH-tSOG revealed a distinctive endomembrane 
localisation compared to GFP-GRP1PH in cells (Figure 4.8-B). Since the nuclear 
localisation was absent, we hypothesised that it was due to the increase in molecular 
size of the probe. The molecular size of miniSOG-GRP1PH (98 kDa) surpasses the 
threshold (~45-60 kDa) for passive diffusion of small molecules through the NPC 
(Lyman et al., 2002). The endomembrane localisation of GFP-GRP1PH-tSOG resembled 
that of GFP-GRP1PH; a slightly enhanced fluorescence was also noticed in the peri-
Golgi region of the cells. Interestingly, GFP-GRP1PH-tSOG showed a NE localisation 
which resembled that revealed by the GST-GRP1PH recombinant probe. 
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Figure 4.8 GFP-GRP1PH-tSOG displays a distinctive localisation compared to GFP-GRP1PH 
(A) Schematics of GFP-GRP1PH, GFP-GRP1PH-tSOG transfected probes, and the GRP1PH recombinant 
probe; length of the domains is in scale with the number of base pairs. GFP-GRP1PH-tSOG also 
contains a GST proximal to the GFP (not shown). (B) PtdIns(3,4,5)P3 in basal mammalian cells was 
labelled by transient transfection or recombinant protein probing. HeLa and COS7 cells were 
transfected with 500 ng GFP-GRP1PH or GFP-GRP1PH-tSOG for 16 h and imaged live. Alternatively, the 
cells were fixed with 4% PFA, permeabilised with 0.5% saponin and probed by GST-GRP1PH as 
described in Figure 4.5. GFP-GRP1PH-tSOG displayed both plasma membrane (white arrows) and 
endomembrane localisation. The plasma membrane localisation of GFP-GRP1PH-tSOG resembled 
that of GFP-GRP1PH and GST-GRP1PH; the endomembrane localisation resembled that of GFP-
GRP1PH. In addition, GFP-GRP1PH-tSOG localised at the NE (yellow arrows) like the GST-GRP1PH 
recombinant probe. Scale bar, 10 µm. 
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To test whether the GFP-GRP1PH-tSOG probe responded to growth factor stimulation 
(an indication of PtdIns(3,4,5)P3-targeting), cells were stimulated with EGF. Upon EGF 
stimulation, translocation of GFP-GRP1PH-tSOG to the plasma membrane and NE was 
observed (Figure 4.9). However, the increase in fluorescence at these compartments 
was not obvious. Further quantification will be required. In general, the NE (yellow 
arrows), ER (green arrows) and Golgi (red arrows) localisation of GFP-GRP1PH-tSOG 
was more prominent in COS7 cells.  
 
To confirm that GFP-GRP1PH-tSOG co-localised with the organelles specified above, the 
cells were transfected with the GFP-GRP1PH-tSOG probe, and subsequently labelled 
with specific markers for the NE, ER and Golgi (Figure 4.10). Calreiculin was used as a 
marker for the NE and ER. Both GFP-GRP1PH-tSOG and calreticulin displayed a very 
similar NE localisation, a circle of fluorescence around the nucleus. GFP-GRP1PH-tSOG 
also appeared in the proximity of the ER network labelled with calreticulin. The 
fluorescent signal of Golgi 97, a trans-Golgi marker, was detected in the trans- side of 
the Golgi-like localisation of GFP-GRP1PH-tSOG. Together, these data suggested the 
presence of PtdIns(3,4,5)P3 in the NE and trans-Golgi network. 
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Figure 4.9 GFP-GRP1PH-tSOG translocates to the plasma membrane and endomembranes upon 
EGF stimulation 
HeLa and COS7 cells were transfected with GFP-GRP1PH-tSOG for 16 h. The cells were either 
stimulated with EGF for 2 min or left without treatment prior to PFA fixation. The fixed cells were 
imaged by confocal microscopy. Under basal conditions, GFP-GRP1PH-tSOG localised at the plasma 
membrane (white arrows) and endomembranes as shown in Figure 4.8. The endomembrane 
localisation resembled the NE (yellow arrows), ER (green arrows) and Golgi (red arrows) and was 
better visualised in COS7 cells. Upon EGF treatment, the plasma membrane and endomembrane 
localisation of GFP-GRP1PH-tSOG appeared to have stronger signal but further quantification is 
required to confirm this. Scale bar, 10 µm. 
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Figure 4.10 GFP-GRP1PH-tSOG partially co-localises with specific organelle markers 
COS7 cells were transfected with GFP-GRP1PH-tSOG (green) for 16 h. The transfected cells were 
either stimulated with EGF for 2 min or untreated prior to PFA fixation. Fixed cells were 
permeabilised with 0.5% saponin for immunofluorescence. Permeabilised cells were incubated with 
primary antibodies against different organelles for 1 h followed by Alexa 594-conjugated secondary 
antibodies (magenta) for another hour before confocal image acquisition. (A) GFP-GRP1PH-tSOG 
partially co-localisated with calereticulin at the visual level. In both basal and EGF stimulated cells, 
NE localisation of GFP-GRP1PH-tSOG was similar to that of calreticulin (NE/ER marker), both of which 
displayed a circular fluorescence around the nucleus (yellow arrows). This indicates miniSOG-GRP1PH 
targeted PtdIns(3,4,5)P3 is present in the NE. However, the ER localisation of GFP-GRP1PH-tSOG 
resembled that of calreticulin to a lesser extent. White arrows indicate the absence of calreticulin 
localisation to the Golgi of the cells. (B) Fluorescent signals of Golgin-97 (trans-Golgi marker) were 
detected within the Golgi-like localisation of GFP-GRP1PH-tSOG in both basal and EGF simulated cells. 
This indicates the presence of PtdIns(3,4,5)P3 in the trans-Golgi. Scale bar, 10 µm.  
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The specificity of miniSOG-GRP1PH was tested in EGF stimulated cells. However, both 
GFP-GRP1PH-tSOG and the non-PtdIns(3,4,5)P3-binding K273A mutant (Figure 4.11-A) 
showed similar localisation at the plasma membrane and endomembranes (Figure 4.11-
B). This observation was unexpected as in section 4.3 we demonstrated that the K273A 
mutant translocated to membranes only after 30 min of EGF stimulation. We suspected 
that the K273A mutation might not have abolished the PtdIns(3,4,5)P3-binding 
completely, therefore we made the R284A mutant in the miniSOG-GRP1PH probe 
known to almost completely abolish PtdIns(3,4,5)P3-binding in vitro (Cronin et al., 2004, 
Lumb and Sansom, 2012). A double mutant (K273A/R284A) was also constructed. 
Unfortunately, R284A and K273A/R284A mutants localised at the plasma membrane 
and endomembranes in both basal and stimulated cells, similar to the WT miniSOG-
GRP1PH, (Figure 4.11-C). 
 
In summary, GFP-GRP1PH-tSOG resembled GFP-GRP1PH in terms of its plasma 
membrane and endomembrane localisation but it also localised at the NE like the GST-
GRP1PH recombinant probe. Further investigation of miniSOG-GRP1PH is required in 
order to determine if the PtdIns(3,4,5)P3 selectivity of the probes is disrupted during 
transient transfection.  
  
Chapter 4 
125 
 
 
Figure 4.11 Non-PtdIns(3,4,5)P3-binding miniSOG-GRP1PH mutants localise similarly as the WT 
(A) Schematic summary of miniSOG-GRP1PH probes; length of the domains is in scale with the 
number of base pairs. Both GRP1PH.K273A and GRP1PH.R284A are non-PtdIns(3,4,5)P3-binding 
mutants; GRP1PH.K273A/R284A is a double non-binding mutant. The GST tag before the GFP in 
each probe is not shown in order to simplify the figure. (B) HeLa cells were transfected with WT or 
K273A miniSOG-GRP1PH for 16 h. Transfected cells were stimulated with EGF for 2 min, fixed with 
4% PFA and imaged by confocal microscopy. Both WT and K273A miniSOG-GRP1PH localised at the 
plasma membrane (white arrows) and endomembranes. Yellow arrows indicate the NE localisation of 
the miniSOG-GRP1PH. (C) Similarly, COS7 cells were transfected with WT and mutant miniSOG-
GRP1PH for 16 h, stimulated with EGF and fixed for confocal imaging. R284A and the double mutant 
localised in the plasma membrane (white arrows), NE (yellow arrows), ER (green arrows) and Golgi 
(red arrows) as did the WT miniSOG-GRP1PH. Similar results were observed in basal COS7 cells 
(insets). Scale bar, 10 µm. 
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 Discussion 4.7
4.7.1 Presence of PtdIns(3,4,5)P3 in endomembranes 
We hypothesised that MV1-like vesicles had a similar lipid profile as MV1, therefore 
enriched in PtdIns(4,5)P2 and PtdIns(3,4,5)P3. PtdIns(3,4,5)P3 is a critical signalling 
molecule for various downstream targets (Wymann and Schneiter, 2008) and inhibition 
of PtdIns(3,4,5)P3 production has been shown to prevent NE assembly in vitro (Larijani 
et al. (2001) and personal communication). Since MV1-like vesicles may be derived 
from endomembranes in mammals, we were particularly interested in demonstrating 
the presence of endomembrane-PtdIns(3,4,5)P3. Endomembrane-PtdIns(3,4,5)P3 is 
rarely reported because of the use of overexpressed reporters which affect the lipid 
dynamics after transfection. However, a reporter with lower binding affinity may solve 
this problem. Hence, GRP1PH was conjugated with various tags to detect 
PtdIns(3,4,5)P3.  
 
We tried to detect endomembrane-PtdIns(3,4,5)P3 in mammalian cells by both 
transfection and recombinant probes. GFP-GRP1PH localised to endomembranes and at 
the plasma membrane of basal COS7 and HeLa cells (Figure 4.1). The K273A mutant of 
GRP1PH demonstrated that the localisation was specific to PtdIns(3,4,5)P3 (Figure 4.2). 
GRP1PH has a relatively low binding affinity (high KD) towards PtdIns(3,4,5)P3 
compared to other PtdIns(3,4,5)P3 reporters such as AKT1PH and PDK1PH. Therefore, 
this could mean that it has a relatively high dissociation constant (Koff), which results in 
faster exchange of molecules. The success in probing endomembrane-PtdIns(3,4,5)P3 by 
GRP1PH suggested that this PH domain was able to bind PtdIns(3,4,5)P3 but also had 
sufficient mobility not to be sequestered in an exclusive compartment, in contrast to 
other commonly used reporters.  
 
PH domains from different proteins may localise differently. Human GFP-GRP1PH 
expressed homogenously in basal PC12 (rat) cells (Venkateswarlu et al., 1998a) whereas 
murine GRP1PH-GFP displayed distinctive endomembrane localisation in basal NIH3T3 
(mouse) cells (Gray et al., 1999). Interestingly, endomembrane-PtdIns(3,4,5)P3 was 
detected by a murine GFP1PH in Lindsay et al. (2006) as well as in our study. Although 
the difference in expression of GRP1PH may be due to the choice of cell lines, 
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investigators should also be aware of the potential differences in the binding affinity of 
orthologous proteins.  
 
As mentioned before, the major drawback in delivering lipid-binding domains by 
transient transfection is the alteration of the lipid dynamics (Poccia and Larijani, 2009). 
Cells may compensate for the perceived depletion of PH domain-targeted lipids and 
synthesise additional lipids that affect the visualisation. To determine the in situ 
PtdIns(3,4,5)P3 localisation, immunodetection is a better approach because it monitors a 
less disturbed lipid distribution. A monoclonal antibody was used to visualise 
PtdIns(3,4,5)P3 in mammalian cells, but endomembrane-PtdIns(3,4,5)P3 was not 
detected in basal cells (Chen et al., 2002). Since GRP1PH has a 650-fold selectivity for 
PtdIns(3,4,5)P3 relative to PtdIns(4,5)P2 (Klarlund et al., 2000) whereas the anti-
PtdIns(3,4,5)P3 antibody has only a 100-fold selectivity for PtdIns(3,4,5)P3 relative to 
other phosphoinositides, the recombinant GRP1PH was eventually a better probe to use. 
 
Cells need to be permeabilised to allow recombinant probes in; recombinant probes 
can also enter the cells by microinjection. However, microinjection in somatic cells is 
not a straight forward process. Therefore, we initially applied GST-GRP1PH in 
permeabilised cells and determined the presence of PtdIns(3,4,5)P3 in endomembranes. 
Despite the deformation of mitochondria caused by saponin the major 
endomembranes (the NE, ER and Golgi) were normal after permeabilisation (Figure 
4.3). 
 
GST-GRP1PH localised to endomembranes which resemble the ER, NE and Golgi 
(Figure 4.5). This recombinant probe was shown to be PtdIns(3,4,5)P3-specific as 
indicated by the lipid strip experiment, and the competition assay with the 
PtdIns(3,4,5)P3 soluble headgroup Ins(1,3,4,5)P4 (Figure 4.4 & Figure 4.5). GST-GRP1PH 
partially co-localised with the two tested organelle markers (Figure 4.6). A perfect co-
localisation between GST-GRP1PH and MAb414 was not expected since MAb414 targets 
the nuclear pore complex and is known for its discontinuous localisation at the NE 
(Davis and Blobel, 1986). However, GST-GRP1PH and MAb414 displayed a highly 
similar fluorescence around the nucleus, suggesting that they are very close and likely 
to co-exist in the same compartment.  
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Similarly, both GST-GRP1PH and calreticulin localised at the NE, indicated by their 
similar localisation pattern. The partial overlapping between GST-GRP1PH and 
calreticulin in the ER network may be due to the presence of PtdIns(3,4,5)P3-
microdomain in the ER. To further verify the localisation of GST-GRP1PH in the ER, an 
ER membrane marker such as calnexin could be used.  
 
This is the first study to localise PtdIns(3,4,5)P3 in the NE. The NE is a subdomain of 
the ER thus PtdIns(3,4,5)P3 localisation in the NE may be a result of these two 
interconnected compartments. Furthermore, plasma membrane localisation is not the 
major readout revealed by the recombinant probe, this is contrary to most of the 
findings in the literature suggesting that PtdIns(3,4,5)P3 is mainly localised to the 
plasma membrane. 
 
The presence of PtdIns(3,4,5)P3 in endomembranes is also indirectly supported by 
immunodetection of PI3KCA subunits. The p85 regulatory domain was localised to 
endomembranes that resemble the NE, ER and Golgi and the class I catalytic domains 
(p110α, p110β) displayed a Golgi-like localisation. All of the tested domains showed a 
vesicular fluorescence throughout the cytoplasm. The presence of PI3KCA subunits 
and their substrate PtdIns(4,5)P2 (Hobday, 2012) at the endomembranes suggests the 
potential production of PtdIns(3,4,5)P3 in these compartments. Although the activity of 
the PI3KCA subunits is unknown, their vesicular distribution suggests the possibility 
of PtdIns(3,4,5)P3-enriched vesicles in the cytoplasm.  
 
In some cells, the p85 regulatory subunit displayed an absence of Golgi localisation, in 
contrast to the Golgi localisation of p110α subunit. Segregation of p85 and p110α was 
observed in L6 skeletal muscle cells and was suggested to be PtdIns(3,4,5)P3-dependent 
(Patel et al., 2003); GRP1PH and p110α were detected within the insulin-induced actin 
mesh structure, in which they potentially resided on vesicles entrapped by the actin 
mesh. To ascertain whether the localisation of PI3KCA subunits detected by antibodies 
is specific and responsible for PtdIns(3,4,5)P3 production, the experiments could be 
repeated in GFP-GRP1PH transfected cell or stable cell lines, targeted by p85 and 
p110α/β siRNA. Or alternatively, cells targeted by p85 and p110α/β siRNA could be 
probed by recombinant GRP1PH in parallel. A loss of GFP1PH, and thus PtdIns(3,4,5)P3 
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and/or PI3KCA signals is expected when p85 or p110α/β are depleted. Similarly, PI3 
kinase inhibitor studies can determine the specificity of the above PI3KCA antibodies.  
 
Furthermore, using an intramolecular FRET (Förster resonance energy transfer) lipid 
sensor (Sato et al., 2003), investigators demonstrated that PtdIns(3,4,5)P3 observed in 
endomembranes was produced in situ and the production was activated by receptor 
endocytosis. This evidence and our results support the presence of endomembrane-
PtdIns(3,4,5)P3 and PtdIns(3,4,5)P3-enriched vesicles in mammalian cells.  
 
4.7.2 GRP1PH-miniSOG probes require further optimisation 
The typical resolution of light microscopy is about 200 nm (Moravec, 1999) thus 
confocal microscopy does not have the resolution to visualise small membrane vesicles 
with a diameter less than 200 nm. Therefore GRP1PH was fused to the miniSOG CLEM 
tag in order to visualise PtdIns(3,4,5)P3-enriched vesicles at EM resolution. GFP-
GRP1PH-tSOG and GFP-GRP1PH localised similarly at the plasma membrane and 
endomembranes (Figure 4.9). The increase in fluorescent signal of GFP-GRP1PH-tSOG 
in these compartments was likely due to the fluorescence of the SOG domains.  
 
Unlike GFP-GRP1PH, GFP-GRP1PH-tSOG localised at the NE (Figure 4.9 & Figure 4.10), 
as indicated by a partial co-localisation with the NE/ER marker. The NE localisation 
might be because of a higher PtdIns(3,4,5)P3 dissociation constant (Koff) of GFP-GRP1PH-
tSOG compared to GFP-GRP1PH so that the miniSOG probe is more mobile to bind to 
the NE. To test this, the difference of binding affinity between GFP-GRP1PH-tSOG and 
GFP-GRP1PH could be determined by fluorescence loss in photobleaching (FLIP) in 
vivo. 
 
Moreover, the specificity of the miniSOG-GRP1PH requires further investigation since 
the K273A, R284A and double K273A/R284A mutants localised very similarly 
compared to the WT construct in both basal and stimulated cells (Figure 4.11). All 
GRP1PH mutants lost their PtdIns(3,4,5)P3 binding ability in vitro (Guillou et al., 2007, 
Knight et al., 2010). However, the mutant probe may have different binding affinity or 
non-specific binding in vivo. The binding affinity of WT GRP1PH has been shown to 
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increase 12-fold by the inclusion of PtdSer into model membranes (Corbin et al., 2004). 
Based on the same principle, the binding affinity of mutant GRP1PH may be increased 
to a level comparable to the WT GRP1PH in vivo. The similarity of localisation between 
WT and mutant miniSOG-GRP1PH may be also due to the effect of miniSOG tags. 
MiniSOG showed oligomerisation at concentration above ~20 µM (Martell et al., 2012). 
The local concentration of miniSOG-GRP1PH at the membrane may be high enough for 
minSOG to form dimers, allowing the GRP1PH mutants to localise similarly to the WT 
GRP1PH. WT GRP1PH should have a strong binding to the membranes compared to the 
GRP1PH mutants. Therefore, after FLIP at the membranes, a less fluent diffusional 
movement would be expected for WT GRP1PH. In contrast, mutant miniSOG-GRP1PH 
should diffuse more fluently.  
 
The specificity of miniSOG-GRP1PH can be also tested by preparing the corresponding 
recombinant probes and applying them on membrane lipid strip or permeabilised 
cells. In addition, the specificity of miniSOG-GRP1PH can be tested by addition of 
LY294002, a PI3 kinase inhibitor; loss of membrane localisation would be expected if 
the miniSOG-GRP1PH probe is PtdIns(3,4,5)P3-specific.  
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4.7.3 The ideal method to detect phosphoinositides 
Both transient transfection and recombinant probe imaging approaches have 
advantages and drawbacks. Transient transfection is advantageous due to its 
simplicity. However, expression of PH domains will disturb the phosphoinositide 
dynamics and their readout may diverge from the genuine lipid localisation (Poccia 
and Larijani, 2009). Although recombinant PH domains are preferable tools to detect 
the in situ localisation of target lipids, the inevitable permeabilisation step causes 
deformation of membrane ultrastructure and limits the application of some general 
lipid-binding dyes. Considering the above, an ideal approach to target 
phosphoinositides would be microinjection of the correct concentration of recombinant 
PH domains. In this way, membrane ultrastructure of the cells would be preserved and 
injected recombinant probe fused to fluorescent protein could reveal the in situ 
localisation of lipids of interest with minimal effect on its dynamics. Alternatively, 
stable cell line with knock-in acute inducible lipid reporter could be a feasible tool to 
detect phospholipids. This system would allow the expression of the lipid reporter to 
be titred more accurately than conventional transfection.  
 
 Summary 4.8
Using transfection and recombinant GRP1PH probes, PtdIns(3,4,5)P3 was detected at the 
NE, ER, Golgi and at the plasma membrane. In addition, localisation of PI3KCA 
subunits suggested a potential PtdIns(3,4,5)P3 production in endomembranes and also 
its presence in PtdIns(3,4,5)P3-enriched vesicles. To visualise these vesicles at EM 
resolution, GRP1PH was fused to the CLEM tag miniSOG. Although the miniSOG-
GRP1PH was able to target endomembrane-PtdIns(3,4,5)P3, its specificity against 
PtdIns(3,4,5)P3 will require further investigation before its application at the EM level. 
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 The role of DAG in mammalian NE assembly Chapter 5
 Introduction 5.1
Many studies have emphasised the role of proteins rather than lipids in changes in 
membrane curvature, organelle shaping and membrane fusion, reviewed in 
Zimmerberg and Kozlov (2006) and Graham and Kozlov (2010). Such emphasis is due 
to lack of in vivo data regarding the role of lipids in membrane morphology. In fact, 
membrane morphology is very sensitive to changes in lipid composition. Several 
model membrane studies have shown that the change of lipid composition results in 
different structures. For instance, enrichment of certain lipids within a membrane 
converts the membrane from lamellar phase to non-lamellar phase. (Chen and Cheng, 
1990, Epand et al., 1992, Han and Gross, 1992).  
 
The role of DAG in membrane fusion was suggested decades ago (Das and Rand, 
1984). Using fluorescence anisotropy, investigators demonstrated that DAG facilitates 
fusion in model membranes (Basanez et al., 1996, Allan et al., 1978). In the vesicle fusion 
model, localised DAG production is essential for the polarised fusion of MV1 to MV2, 
generating a complete NE (Dumas et al., 2010, Barona et al., 2005). Moreover, solid-state 
NMR analysis of the membrane composition of fusogenic vesicles (MV1) showed that 
the presence of DAG and phosphoinositides destabilises membranes and promotes 
fusion (Zhendre et al., 2011). However, the role of DAG in altering membrane 
morphology was not demonstrated in mammalian cells.  
 
Our goal was to locally deplete DAG in the NE and determine its impact on 
mammalian NE assembly. A DAG reporter was constructed to monitor the presence of 
DAG in mammalian cells during mitosis. A chemical inducible device was used to 
target a DAG metabolising enzyme to the NE, and the morphology of cells lacking 
DAG at the ER and NE was examined by correlative light and electron microscopy 
(CLEM).  
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 Localisation of DAG in mammalian cells  5.2
The C1 domains of PKC are established DAG reporters (Hurley and Grobler, 1997, 
Oancea et al., 1998) and the localisation of various PKC C1 domains in mammalian cells 
has been investigated extensively (Hobday, 2012). GFP-PKCεC1aC1b (hereafter 
referred to as GFP-C1aC1b) transfected probe was used to detect DAG in mammalian 
cells. PKCεC1aC1b was used because it has the highest affinity for DAG compared to 
other C1 domains from various PKC isoforms (Hobday, 2012). 
 
Figure 5.1-A shows the localisation of GFP-C1aC1b in interphase cells. In both HeLa 
and COS-7 cells, strong signals were detected at the NE (yellow arrow), ER (green 
arrows) and Golgi (white arrows). Live cells transfected with GFP-C1aC1b or labelled 
with NDB-DAG SUVs had identical NE, ER and Golgi localisation Figure 5.1-B). GFP-
C1aC1b was co-localised to the ER network labelled with calreticulin antibodies 
(Figure 5.1, insets) whereas the non-DAG-binding mutant GFP-C1aC1b.W264G only 
displayed a minor fluorescence at the Golgi. This shows that our reporter is DAG 
specific (Figure 5.1-C).  
 
Having established the specificity of GFP-C1aC1b interphase cells, we next examined 
the DAG localisation in mitotic cells. GFP-C1aC1b probed DAG in the reforming NE 
and ER of HeLa and COS-7 cells at telophase (Figure 5.1-E & F). The localisation of 
DAG in the reforming NE and ER was supported by the consistent distribution of 
DiOC6 (general membrane marker), ER tracker and GFP-POM121 (nuclear pore 
marker) (Figure 5.1-G – I). In addition, the presence of DAG was stronger and more 
observable in the reforming NE as the cells progressed from early to late telophase. 
Having demonstrated DAG was present in the NE of both interphase and mitotic cells, 
the next step was to target DAG metabolism specifically at the NE in order to show 
that DAG has a functional role in NE reassembly. 
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(Cont’d) 
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Figure 5.1 DAG is localised to the NE, ER and Golgi in mammalian cells 
(A) HeLa and COS-7 cells were transfected with GFP-C1aC1b, fixed, stained with Hoechst 33342 and 
imaged by confocal microscopy. (B) HeLa cells were transfected with GFP-C1aC1b (left) or labelled by 
addition of PtdCho/NBD-DAG (60:40 mole%) SUVs (right) before live confocal imaging. (C) GFP-
C1aC1b co-localised with the indirect immunofluorescence of calreticulin (ER marker) at the ER 
(insets of the upper panels); chromosomes were stained with Hoechst 33342. In contrast, DAG 
localisation were absent from the NE and ER (insets of the lower panels) and reduced at the Golgi 
when the cells were transfected with GFP-C1aC1b.W264G (non-DAG-binding mutant). In interphase 
cells (A–C), DAG localised at the NE (yellow arrows), ER (green arrows) and Golgi (white arrows). HeLa 
(E) and COS-7 (F) cells were transfected with GFP-C1aC1b and followed though mitosis by live 
confocal microscopy. Localisation of GFP-C1aC1b followed similar distribution as DiOC6 (G), ER 
tracker (H) and GFP-POM121 (I). Yellow arrows and green arrows in (E–I) indicate the NE and ER 
reassembly respectively. Scale bar, 10 µm. Confocal imaging experiments were performed by Marie-
Charlotte Domart (Cell Biophysics and EM unit, London Research Institute).  
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 Determining the role of DAG in mammalian NE assembly 5.3
5.3.1 DAG species in the NE 
Early studies using two-dimensional thin-layer chromatography and gas 
chromatography revealed that there are only traces of DAG in the mammalian NE 
(Kleinig, 1970, Keenan et al., 1972). However, little is known about the DAG species 
and their structural details such as the length and saturation of their fatty acid chains. 
The chain length and saturation of lipid define its elasticity thus affecting the 
membrane property and protein aggregation on the membrane (Lee, 2004, Rawicz et 
al., 2000). Hence, an accurate quantification of DAG species will provide insight to 
understand their biological function in NE assembly and conduct follow-up functional 
or structural studies.  
 
We isolated mammalian nuclei and analysed their DAG composition by lipid mass-
spectrometry. ER and NE-enriched mammalian nuclei were isolated using nitrogen 
cavitation. Figure 5.2-A shows the morphology of isolated nuclei. After cavitation, the 
isolated nuclei retained only the NE and ER, and the proportion of clean nuclei with 
minimal ER attachment ranged from 42 to 64% (white arrows). Lipid mass-
spectrometry analysis indicated that the ER and NE are enriched in unsaturated 
species of DAG (Figure 5.2-B) thus we targeted the unsaturated DAG species with a 
chemically-induced dimerisation device. 
  
Chapter 5 
137 
 
 
Figure 5.2 Enrichment of polyunsaturated DAG in purified mammalian ER/NE 
(A) Nuclei were purified from HeLa cells. Nitrogen cavitation was performed in a pressure chamber at 
200 psi (for details see Chapter 2). Whole cells and isolated nuclei were labelled with DiOC6 (green) 
and Hoechst 33342 (red). White arrows indicate pure nuclei with minimal ER attachment. Scale 
bars, 10 µm. (B) Lipids were extracted from whole cells or isolated nuclei obtained in (A) and 
subjected to lipid mass-spectrometry analysis. The data was divided into saturated and unsaturated 
DAG species. Black bars, whole cell; grey bars, isolated nuclei. Quantitative analysis of DAG was a 
collaborative study with Michael Wakelam (Babraham Institute, Cambridge). Adapted from Domart et 
al. (2012).  
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5.3.2 Rapalogue dimerisation device 
We developed a rapalogue-induced dimerisation device to modulate DAG. In contrast 
to chemical or peptide inhibitors that globally target DAG, the dimerisation tool 
executes a localised intervention in cellular process upon addition of a dimeriser (Fili et 
al., 2006). In other words, we can modulate DAG in a spatial-temporal-specific manner. 
Figure 5.3-A explains the principle of the rapalogue dimerisation tool. Upon addition 
of rapalogue (the inducer), RFP and FKBP (rapalogue-binding domains) will be 
brought together by forming a heterodimer. This allows delivery of protein effector to 
a specific compartment. 
 
To target the NE, the NE-targeting domain of lamin B receptor (LBR) was fused to 
FKBP. The NE-targeting and rapalogue-binding construct is referred to as GFP-2FKBP-
LBRΔTM2-8. It displayed similar NE and ER localisation compared to GFP-LBR and 
endogenous LBR (Figure 5.4). FRB-conjugated lipid-modifying enzymes can form 
heterodimer with GFP-2FKBP-LBRΔTM2-8 in the presence of rapalogue, resulting in 
the recruitment of these enzymes at the NE and ER (Peel et al., 2013).  
 
The lipid-modifying enzymes were conjugated with FRB. There are two approaches to 
deplete DAG in the NE: 1) direct modification of DAG 2) restriction of the upstream 
precursor of DAG, PtdIns(4,5)P2 (Figure 5.3-B). DGKεK was selected as the enzyme to 
phosphorylate DAG to PtdOH because this protein domain targets unsaturated DAG 
species (Pettitt and Wakelam, 1999), which are the major DAG species in the NE and 
ER according to our mass-spectrometry analysis (see section above). Alternatively, 
SKIP was used to dephosphorylate PtdIns(4,5)P2 to PtdIns(4)P in order to deplete the 
DAG precursor (Schmid et al., 2004). 
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Figure 5.3 Principle of the rapalogue dimersiation device and the pathways to target DAG 
(A) Acute intervention of lipid target. A membrane-targeting marker and a lipid-modifying enzyme are 
fused to the FKBP (FK506-binding protein) and FRB (FKBP12-rapamycin associated protein 1) 
domain respectively. FKBP and FRB are immunophilins that able to bind to the same 
immunosuppressants ligand rapamycin in order to form a heterodimer. In our dimerisation device, a 
rapamycin analog (hereafter referred to as rapalogue) functions as the heterodimeriser (yellow) to 
recruit the lipid-modifying enzyme to the targeted membrane through an immunophilins-
heterodimeriser interaction. GFP and RFP are the fluorescent reporters of the membrane-targeting 
marker and lipid-modifying enzyme, respectively. (B) DAG can be depleted by phosphorylation to 
PtdOH using DGKεK or by converting its upstream precursor PtdIns(4,5)P2 to PtdIns4P through SKIP.  
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Figure 5.4 GFP-2FKBP-LBRΔTM2-8 correctly localises to the NE and ER 
Left panel: Localisation of endogenous LBR in HeLa cells, detected by indirect immunofluorescence. 
Middle panel: HeLa cells transfected with GFP-LBR. Right panel: HeLa cells transfected with the 
rapalogue-binding GFP-2FKBP-LBRΔTM2-8 construct. All probes above displayed similar NE and ER 
localisation. Scale bar, 10 µm. Adapted from Domart et al. (2012). 
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5.3.3 Acute modification of DAG in the mammalian NE 
GFP-2FKBP-LBRΔTM2-8 (LBR) successfully recruited the lipid-modifying enzymes 
(DGKεK and SKIP) to the NE upon treatment with rapalogue (Figure 5.5-B & Figure 
5.6-B). In addition to being the targeting portion of the rapalogue dimerisation device, 
LBR was used as a tool to monitor the reassembly of the NE. Previous studies have 
shown that during mitosis, LBR localisation is redistributed to the ER and 
subsequently recruited back to the NE (Haraguchi et al., 2000, Smith and Blobel, 1993). 
Hence, we expected to see a LBR localisation in the reforming NE of unperturbed cells.  
 
Upon addition of rapalogue, DGKεK was predicted to recruit to the NE and 
phosphorylate DAG to PtdOH. This resulted in a fragmented NE in both HeLa and 
COS-7 cells, as determined by the LBR distribution (Figure 5.5-C–D). In contrast, when 
the cells were transfected with a non-catalytic DGKεK (Figure 5.5-G) or untransfected 
with DGKεK (Figure 5.5-F), a LBR localisation, indicative of a complete NE, was 
detected in telophase cells. The DGKεK.D434N mutant also demonstrated that the 
fragmentation phenotype is due to catalytic effect of DGKεK. The NE of the cells co-
expressing LBR and DGKεK was intact in the absence of rapalogue (Figure 5.5-E).  
 
DGKεK phosphorylated DAG at the NE/ER to PtdOH, and PtdOH is also a 
biomolecule with a negative membrane curvature (see Introduction). To ensure the 
disruption of NE was not due to the accumulation of PtdOH but rather the depletion of 
DAG, we removed the DAG precursor PtdIns(4,5)P2 by recruiting SKIP to the NE. 
When the cells co-expressing LBR and SKIP were treated with rapalogue, the NE was 
fragmented (Figure 5.6-C). However, in the absence of rapalogue (Figure 5.6-D), or 
when a catalytically inactive SKIP was used (Figure 5.6-E), or both (Figure 5.6-F), cells 
underwent normal NE reassembly. In general, there were some cytoplasmic 
fluorescent patches in the LBR transfected cells and the fluorescence of these patches 
was possibly enriched when lipid modifying enzymes were recruited to the NE/ER in 
the presence of rapalogue.  
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While the above experiments allowed us to monitor NE reassembly, they did not allow 
us to visualise the expected changes in DAG. To directly observe the modulation of 
DAG, cells were triple transfected with a “dark” version of GFP-LBR, SKIP and GFP-
C1aC1b. A minimal detection of DAG was expected under this condition. When 
treated with rapalogue, there was no detection of DAG around the chromosomes. 
However, vesicular fluorescence and some intense fluorescent patches of GFP-C1aC1b 
were detected in the cytoplasm, indicating DAG could be detected in these cells (Figure 
5.7-A). In the absence of rapalogue, DAG was localised to the reforming NE (yellow 
arrow) and ER (green arrow) (Figure 5.7-B). Since C1aC1b will compete with DGKεK 
for DAG, we could not monitor the DAG localisation when DGKεK was used as the 
lipid-modifying enzyme.  
 
In summary, DAG depletion in the NE by both direct and indirect approaches led to 
impaired NE assembly and possibly some impacts on other endomembranes. 
However, we lack ultrastructural information regarding the completeness of the NE 
and the identity of the cytoplasmic fluorescence at the light microscopy level. 
Therefore correlative light and electron microscopy was utilised to answer these 
questions.  
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Figure 5.5 Acute depletion of DAG to PtdOH results in incomplete NE 
(A) Diagram of rapalogue dimerisation device. Upon addition of rapalogue, RFP-Flag-FRB-DGKεK 
(DGKεK) will be recruited to GFP-2FKBP-LBRΔTM2-8 (LBR), and DAG will be phosphorylated to 
PtdOH. (B) Confocal images of live interphase cells double transfected with LBR (green) and DGKεK 
(red). 45 min after addition of 500 nM rapalogue, DGKεK was recruited to the NE and ER. HeLa (C) 
and COS-7 (D) cells co-expressing LBR and DGKεK underwent impaired NE reassembly when treated 
by rapalogue. HeLa cells in the absence of rapalogue (E) or expressing LBR alone (F) underwent 
normal NE reassembly. When DGKεK was replaced by its non-catalytic mutant (D434N) the NE 
reassembly was normal (G). Yellow arrows indicate LBR localisation in the reforming NE. Images 
representative of n = 10 experiments. Scale bar, 10 µm. Adapted from Domart et al. (2012).  
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Figure 5.6 Acute depletion of PtdIns(4,5)P2 results in an incomplete NE 
(A) Diagram of rapalogue dimerisation device. Upon addition of rapalogue, RFP-Flag-FRB-SKIP (SKIP) 
is recruited to GFP-2FKBP-LBRΔTM2-8 (LBR), and PtdIns(4,5)P2 is dephosphorylated into PtdIns4P. 
(B) Confocal images of live interphase cells double transfected with LBR (green) and SKIP (red). 45 
min after addition of 500 nM rapalogue, SKIP was recruited to the NE and ER. (C) HeLa cells co-
expressing LBR and SKIP underwent impaired NE reassembly when treated by rapalogue. HeLa cells 
in the absence of rapalogue (D) or expressing a non-catalytic SKIP (E), or both conditions (F) 
underwent normal NE reassembly (yellow arrows). Images representative of n = 3 experiments. Scale 
bar, 10 µm. Adapted from Domart et al. (2012). 
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Figure 5.7 DAG is not accumulated in the NE when its precursor was removed 
HeLa cells were triple transfected with a dark LBR, RFP-Flag-FRB-SKIP and GFP-C1aC1b. (A) When 
treated with rapalogue, the NE was not formed. (B) In the absence of rapalogue, DAG localisation 
was detected in the reforming NE (yellow arrows) and ER (green arrows). Scale bar, 10 µm. Adapted 
from Domart et al. (2012) 
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 Correlative light and electron microscopy (CLEM) analysis of DAG-5.4
depleted mammalian NE and ER 
Since light microscopy does not have the resolution to determine the presence of gaps 
in the reforming NE, CLEM was used to reveal the ultrastructure of fragmented NE 
and to assess DAG depleted phenotype of the ER. Figure 5.8 illustrates the work flow 
of CLEM. Live HeLa cells were imaged using confocal microscopy, fixed at the mitotic 
stage of interest, and embedded for TEM. The embedded cells were serial sectioned, 
imaged in order, aligned and manually segmented for 3D model reconstruction. 
Segmentation is a laborious and skill-demanding process because precision and 
experience are required to manually trace the morphology features of the NE and ER. 
Serial sectioning generated ~80 to 140 ultrathin sections (70 nm) through a cell of 
interest and for each cell it took at least four weeks to generate a 3D model from the 
initial confocal imaging. Therefore, CLEM experiments were performed once per 
condition. It took two months to manually segment the four cells described below.  
 
Control cells (without modulation of DAG) labelled with DiOC6 were fixed at 
anaphase (Figure 5.9-A) or telophase (Figure 5.9-B). At anaphase, the NE was 
incomplete with gaps of ~4 to 5 µm whereas at telophase the NE was almost complete 
with gaps of ~50 nm (Figure 5.9-A & B, purple arrows). Segmentations (Figure 5.9-A & 
B) and 3D models (Video 5.1) reveal a mainly tubular ER at early anaphase and a 
combination of ER sheets and tubules at telophase. 
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Figure 5.9-C & D reveal a fragmented NE with large gaps (purple arrows) in DAG 
depleted cells (modulated by DGKεK) fixed at early telophase and cytokinesis 
respectively. The gaps in the rapalogue treated telophase cell were about 5 µm in 
diameter and resembled the gaps in the control anaphase cell. In the rapalogue treated 
cytokinesis cell, large gaps (> 5 µm) were found in the NE facing the mitotic pole and 
the NE failed to form on the side facing the mid-body. The location of the gaps in DAG 
depleted cells was consistent with the lack of LBR localisation shown in the 
corresponding confocal images. The fragmented NE phenotype was more severe in the 
DGKεK high-expressing cell (cytokinesis) than in the low-expressing cell (telophase). 
Moreover, depletion of DAG resulted in a multi-lamellar phenotype of the ER (Figure 
5.9-D, inset green arrows and Video 5.1). The multi-lamellar ER appeared to have some 
contact with the fragmented NE by a few tubules (Figure 5.9-D, inset yellow arrow) 
and such an aberrant phenotype corresponded to the intense cytoplasmic fluorescence 
of LBR shown in the confocal images (also see section above). Together these data 
demonstrate that depletion of DAG leads to failure of NE reassembly and abnormal 
phenotype of the ER.  
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Figure 5.8 Correlative light and electron microscopy work flow 
(A) Cells were cultured on gridded glass coverslips and transfected with the rapalogue dimerisation 
device. The cell of interest was identified and fixed at the required mitotic stage. The corresponding 
position was mapped on the grid using bright-field microscopy. Fixed cells were stained, dehydrated 
and embedded in resin. Scale bars, 10 µm. (B) Resin-embedded cells were relocated with respect to 
the imprinted grid and underwent serial sectioning. Approximately 80 to 140 sections with a 
thickness of 70 nm were collected through a single cell. The sections were imaged in order and the 
images acquired were aligned using Amira software. (C) The NE and ER were manually traced based 
on their morphological features (segmentation), and the segmentation was used to construct a 3D 
model. NE (red), ER (blue), centriole (yellow). 3D model in the figure represents the NE of a telophase 
cell.  
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Figure 5.9 Large gaps were observed in the reforming NE of DAG-depleted cells 
HeLa cells labelled with DiOC6 were followed through mitosis by confocal microscopy and fixed at 
early anaphase (A) and telophase (B). The cells were prepared for EM imaging and the NE (red), ER 
(blue) and centriole (yellow arrow) were manually segmented based on their morphological features. 
The dashed white line in the anaphase cells indicates the dividing cell’s symmetry axis. Purple 
arrows indicate gaps in the reforming NE. Cells co-expressing GFP-2FKBP-LBRΔTM2-8 and RFP-Flag-
FRB-DGKεK were treated with rapalogue, followed through mitosis, and fixed at early telophase (C) 
and cytokinesis (D). These DAG depleted cells were analysed by CLEM and segmented as described 
above. Large gaps (~ 5 µm) were observed at the reforming NE in both early telophase and 
cytokinesis cells (purple arrows). DAG depleted ER consisted multi-lamellar sheets (inset green 
arrows) and the multi-lamellar ER had a minimal contact with the reforming NE (inset yellow arrow). 
Scale bar: fluorescence 10 µm; EM: as shown in the electron micrograph. Segmentations from serial 
sections were constructed into 3D models of controls (E) and DAG-depleted (F) cells for a better 
visual comparison. Confocal imaging experiments were performed by Marie-Charlotte Domart (Cell 
Biophysics and EM unit, London Research Institute) (Domart et al., 2012). 
 
Video 5.1 3D models of control and DAG-depleted cells 
Segmentations of NE (red), ER (blue) and centriole (yellow) from serial sections were constructed 
into 3D models. NE in DAG depleted cells were highly fragmented. Control anaphase (top left); 
control telophase (top right); DAG depleted telophase (bottom left); DAG depleted cytokinesis 
(bottom right). The models were rotated 360° at a speed of 12 frames per second. 
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 Exogenous DAG addition rescues fragmented NE  5.5
The depletion of DAG showed an impact on the NE and ER during mitosis, and we 
speculated that the fragmented NE can be rescued by addition of exogenous DAG. 
Ideally, it would be preferable to monitor the DAG level in a rapalogue-treated, 
LBR/DGKεK co-expressing cell during the rescue. However, the DAG level cannot be 
efficiently probed with the C1aC1b domain, because it completes with DGKεK for the 
same substrate. Nevertheless, we can supply the cells with small unilamellar vesicles 
(SUVs < 50 nm diameter) containing known amounts of DAG.  
 
SUVs composed of BIODIPY-PtdCho and unsaturated 18:0/24:4 1,2-DAG (80:20 mole%) 
were added to untransfected mammalian cells (Figure 5.10-A). Every cell was 
incorporated with SUVs 1 min post addition, indicated by the intracellular fluorescent 
of BIODIPY-PtdCho. 1,2-DAG-containing SUVs were added to rapalogue-treated, 
LBR/DGKεK co-expressing cells at metaphase and followed till telophase and 
cytokinesis. Localisation of LBR was detected in the reforming NE at both telophase 
and cytokinesis (Figure 5.10-B). Electron micrographs revealed that the reformed NE 
was virtually complete (Figure 5.10-C), and nuclear pores were found in the NE 
(yellow arrow). 3D models illustrate the fragmented NE of a rapalogue-treated cell and 
the NE recovery of a rapalogue-treated cell after addition of 1,2-DAG-containing SUVs 
(Figure 5.11). The ER retained its multi-lamellar phenotype after addition of the 1,2-
DAG-containing SUVs (Figure 5.10-C, green arrows). Furthermore, the daughter cells 
of rapalogue-treated, LBR/DGKεK co-expressing cell did not go through a second 
mitotic division and died, but the daughter cells under the same condition which were 
rescued with 1,2-DAG-containing SUVs survived and underwent subsequent mitotic 
division (Video 5.2).  
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1,2-DAG is a second messenger for C1 domain-containing proteins and it is possible 
that the rescued phenotype was due to the activator of these proteins. To verify this, 
the rescue experiment was repeated using SUVs containing 1,3-DAG, which does not 
bind C1 domains (Sanchez-Pinera et al., 1999). Figure 5.12 shows the structural 
formulae of 1,2-DAG and 1,3-DAG. SUVs containing 18:1/18:1 1,3 DAG were added to 
rapalogue-treated, LBR/DGKεK co-expressing cells at metaphase. Incorporation of the 
SUVs is indicated by white arrows (Figure 5.13-A). A fragmented NE was rescued by 
SUVs composed of PtdCho and unsaturated 1,3-DAG (80:20 mole%). The rescued NE 
was close to completion and nuclear pores were detected on the reformed NE (Figure 
5.13-B & C). When a rapalogue-treated cell was rescued by 60:40 mole% PtdCho/1,3-
DAG SUVs, a complete NE with nuclear pores was formed. Compared to the cell 
rescued by SUVs containing 20 mole% 1,3-DAG, the cell rescued by SUVs containing 
40 mole% 1,3-DAG appeared to have less multi-lamellar ER sheets. Moreover, the 
fluorescence of 1,3-DAG-containing SUVs localised to the rescued NE (Figure 5.14).  
 
Table 5.1 summarise the quantification of NE phenotype under different experimental 
conditions. In 11 single cell experiments, DAG-containing SUVs were able to rescue 
fragmented NE, with a reproducibility of 100% for 1,2-DAG-containing SUVs and 
almost 90% for 1,3-DAG-containing SUVs. Together, the novel findings in this chapter 
indicate both a signalling and structural role of DAG in NE assembly. 
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Figure 5.10 1,2-DAG rescues fragmented NE caused by DAG depletion 
(A) Confocal image of metaphase HeLa cells 1 min post-addition of SUVs containing 18:0/20:4 1,2-
DAG. The SUVs are made up of BODIPY-PtdCho and unsaturated 18:0/20:4 1,2-DAG (80:20 mole% 
respectively). Incorporation of SUVs was marked by the intracellular fluorescence of BODIPY (white 
arrows). (B) NE localisation of LBR during mitosis in rapalogue-treated, LBR and DGKεK co-
expressing HeLa cells after addition of 1,2-DAG SUVs, imaged by confocal microscopy (C) 
Ultrastructure of DAG-depleted, 1,2-DAG SUVs rescued cell fixed at cytokinesis, imaged by CLEM. 
LBR (green), DGKεK (red). Yellow arrow indicates a nuclear pore in the complete NE. Scale bar, 
confocal: 10 µm, EM: as indicated on the images. Images representative of n = 11 experiments. 
Rescue experiment performed by Marie-Charlotte Domart (Cell Biophysics and EM unit, London 
Research Institute). 
 
Video 5.2 1,2-DAG rescues fragmented NE caused by DAG depletion 
CLEM images of aligned serial ultrathin sections of LBR/DGKεK co-expressing cell, treated with 
rapalogue and rescued with SUVs composed of Egg-PtdCho and 18:0/20:4 1,2 DAG (80:20 mole%). 
The rescued NE resembled that of a control interphase cell. The video is played at a speed of 1 
frame per second. 
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Figure 5.11 3D models of DAG-depleted and DAG-containing SUVs-rescued cells 
Comparison of 3D models constructed from serial sections of a DAG-depleted cell (left) and a DAG-
depleted but 1,2-DAG-containing SUV-rescued cell (right). The NE of the DAG-depleted cell was 
fragmented. In contrast, the NE of the 1,2-DAG-containing SUV-rescued cell was close to completion. 
NE (red), centriole (yellow).  
 
 
 
Figure 5.12 Structural formula of DAG isomers 
The fatty acid chains attach to the sn-1 and sn-2 carbon position in 1,2-DAG whereas the fatty acid 
chains attach to the sn-1 and sn-3 carbon position in 1,3-DAG. 
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Figure 5.13 1,3-DAG rescues fragmented NE caused by DAG depletion 
(A) Confocal image of metaphase HeLa cells 1 min post-addition of SUVs which consisted of BODIPY-
PtdCho and unsaturated 18:1/18:1 1,3-DAG (80:20 mole%). Incorporation of SUVs was marked by 
the intracellular fluorescence of BODIPY (white arrows). (B) NE localisation of LBR during mitosis in 
rapalogue-treated, LBR and DGKεK co-expressing HeLa cells after addition of 1,3-DAG-containing 
SUVs, imaged by confocal microscopy (C) Ultrastructure of DAG-depleted, 1,3-DAG-containing SUVs-
rescued cell fixed at cytokinesis, imaged by CLEM. LBR (green), DGKεK (red). The yellow arrow 
indicates a nuclear pore in the almost complete NE. Scale bar, confocal: 10 µm, EM: as indicated on 
the images. Images representative of n = 11 experiments. Rescue experiment done by Marie-
Charlotte Domart (Cell Biophysics and EM unit, London Research Institute). 
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Figure 5.14 SUVs with higher proportion of 1,3-DAG completely rescue fragmented NE 
A HeLa cell co-expressing dark LBR/DGKεK (red) was treated with rapalogue and rescued by SUVs 
(green) composed of PtdCho and 1,3-DAG (60:40 mole%). EM images show a complete NE with 
nuclear pores (yellow arrows) after rescue. Incorporation of 1,3-DAG-containing SUVs localised to the 
rescued NE. Scale bar, confocal: 10 µm; EM: as indicated on the images. Rescue experiment done 
by Marie-Charlotte Domart (Cell Biophysics and EM unit, London Research Institute). 
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 Discussion 5.6
5.6.1 The requirement of DAG at the reforming NE 
In order for membrane compartments to have the required topology the membranes 
must exhibit curvature of the required relative amount. There are considerable studies 
suggesting the role of proteins in altering membrane curvature and organelle shaping 
(Voeltz et al., 2006, Shibata et al., 2009, Kozlov et al., 2014). On the other hand, an 
asymmetric distribution of lipids or enrichment of lipid molecules in one of the lipid 
bilayer leaflets contributes to membrane curvature (Farsad and De Camilli, 2003, Farge 
and Devaux, 1992). To achieve a highly curved lipid bilayer, lipid with a conical shape 
such as DAG is required. DAG has a reduced head-to-tail ratio (negative spontaneous 
curvature) thus it facilitates the bending of membrane towards the head group. 
Localised DAG production is essential for NE formation in a cell-free assay (Dumas et 
al., 2010, Barona et al., 2005) and the fusogenic property of DAG has been demonstrated 
(Zhendre et al., 2011, Barona et al., 2005). Although the involvement of lipids have been 
understated in organelle shaping (Shibata et al., 2009), we have shown by modulating 
specific lipid species required for generating membrane curvature, such as DAG, that 
they have an essential role in organelle shaping as well as membrane fusion.  
 
The DAG reporter GFP-C1aC1b showed that DAG is present in the reforming NE 
during telophase in both HeLa and COS-7 cells and lipid mass-spectrometry confirmed 
the presence of unsaturated DAG species in the NE and ER. When DAG in the NE/ER 
was depleted using the rapalogue dimerisation tool, the NE was fragmented, and DAG 
was not detected in the NE. In addition, we demonstrated that the fragmented NE was 
due to a direct depletion of DAG rather than accumulation of PtdOH, by limiting the 
DAG precursor PtdIns(4,5)P2 through SKIP. Similar result has also been shown in 
echinoderm cells (Byrne et al., 2005, Domart et al., 2012). A catalytically inactive lipid-
modifying enzyme supported this argument as well. Furthermore, the severity of an 
aberrant NE phenotype corresponded to the expression level of DGKεK. The above 
findings suggest that DAG is essential for NE assembly.  
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CLEM analysis revealed large gaps in the reforming NE in the DAG-depleted cells. 
Our 3D model shows that the NE of a DAG-depleted early telophase cell resembled the 
NE of a control anaphase cell. Progression of mitosis did not allow the DAG-depleted 
cells to recover from its disrupted phenotype, indicated by the cell death in DAG-
depleted cells. DAG had a role in ER shaping, as the source of the intense fluorescence 
was identified as multi-lamellar ER sheet by CLEM. Such phenotype might be due to 
the loss of negative membrane curvature provided by DAG, in which the ER was not 
able to form tubular structures without DAG. 
 
Compared to protein knock-down or inhibitor treatment, our rapalogue dimerisation 
tool acutely modified membrane lipid components only at the NE and ER. Single cell 
experiments were performed and we achieved 76 to 95 % reproducibility (Table 5.1). In 
parallel to the DAG modulation in mammalian cells, similar findings were observed in 
unfertilised or fertilised egg membranes (Wang et al., 2013). Microinjection of DGK and 
Synaptojanin 1 (a 5-phosphatase using PtdIns(4,5)P2 as substrate) to sea urchin eggs 
resulted in an alteration of ER morphology and impaired NE assembly. Together, DAG 
depletion in mammalian cells and echinoderms by two different techniques concurred 
that DAG has a conserved role in NE assembly and ER structure modification. 
 
5.6.2 DAG has a structural role in NE assembly 
In mammals, the fragmented NE caused by DAG depletion was rescued by delivery of 
exogenous 1,2-DAG through SUVs. Incorporation of SUVs into the cells was rapid, 
indicated by the intracellular fluorescence of BODIPY-PtdCho 1 minute post addition. 
Rescued cells were able to form a complete NE with nuclear pores, and this indicates 
that the rescued NE is structurally and functionally complete. However, the ER of 
rescued cells retained the multi-lamellar phenotype. Such observation may be due to 
the fact the ER has a differential sensitivity to DAG depletion compared to the NE as 
well as the ER being a highly complex membrane compartment to reassemble. 
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Similarly, depletion of DAG in echinoderm embryos and oocytes affected nuclear 
membrane fusion as well as ER morphology but was rescued by the localised addition 
of DAG-containing SUV (Domart et al., 2012). In both mammalian and echinoderm 
rescue experiments, there might be a possibility that the restored phenotype of the NE 
and ER was a result of PtdCho addition. However, DAG-containing SUVs prevented 
abnormal ER morphology caused by DAG-depletion whereas SUVs composed of 100% 
PtdCho could not (Wang et al., 2013). Furthermore, SUVs containing PtdEtOH 
(phosphatidylethanolamine), a lipid estimated at half the degree of negative curvature 
as DAG, had intermediate rescuing abilities compared to DAG-containing SUVs (Wang 
et al., 2013, Larijani et al., 2014). Such observations suggest PtdCho has no effect in 
rescuing DAG-depletion.  
 
The non-C1-binding DAG isomer 1,3-DAG was able to rescue a fragmented NE in 
DAG-depleted cells. This non-signalling DAG isoform confirmed that DAG has a 
structural role in addition to a signalling role in NE assembly. Moreover, an increased 
dose of 1,3-DAG improved the rescue. Similarly, when introducing 1,3-DAG to DAG-
depleted eggs, normal NE and ER phenotypes were observed (Wang et al., 2013). The 
dual role of DAG has been suggested by several groups (Wickner and Schekman, 2008, 
Allan et al., 1978, Larijani and Poccia, 2009, Larijani et al., 2014) but we are the first 
group to demonstrate its structural role in the regulation of NE structure in mammals.  
 
DAG depletion alters the ability of membranes to form highly curved structures or 
undergo fusion. We propose that NE assembly or organelle shaping depends on both 
lipid and protein-dependent mechanisms. It was suggested that bent membranes may 
generate hydrophobic voids in its curved region, and to maintain an energetically 
favourable structure lipids with extreme spontaneous curvature are required to fill 
those voids (Kozlovsky and Kozlov, 2002). Since DAG exhibits an extreme spontaneous 
curvature and a rapid transbilayer movement (Bai and Pagano, 1997), it may serve as a 
good candidate to re-equilibrate across the bilayer in such a highly curved structure.  
  
Chapter 5 
161 
 
 Summary 5.7
Using a rapalogue dimerisation device, we depleted DAG in the NE and ER of 
mammalian cells and this led to fragmentation of the reforming NE and affected the ER 
morphology, wherein these abnormalities were rescued by exogenous DAG. By using 
different DAG isomers, we demonstrated that in addition to its signalling role DAG 
also has a structural role in NE reassembly and organelle morphology. The structural 
role of DAG in NE assembly and ER shaping is conserved through the deuterostome 
superphylum, supported by related studies in echinoderms. In conclusion, this is the 
first study to demonstrate the dual roles of DAG in altering membrane curvature. 
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 Characterisation of fusogenic vesicles in Chapter 6
mammalian cells 
 Introduction 6.1
Vesicles are small spherical organelles that consist of soluble cellular content enclosed 
by a lipid bilayer. Depending on their function, vesicles may have distinctive protein 
and/or lipid profiles. They are commonly involved in a variety of cellular activities 
such as exocytosis, endocytosis, intracellular transportation, and intercellular 
communication.  
 
Many cellular compartments produce vesicles (Sundaramoorthy et al., 2010, 
Christianson et al., 2014, Scott et al., 2014). Fusion events between vesicles and other 
membrane structures are widely reported and investigated (Woodbury and Hall, 1988, 
Brunger, 2001, Rizo and Rosenmund, 2008), and the production and fusion of vesicles 
plays an important role in maintenance of a functional cell. 
 
Fusogenic vesicles that are involved in or essential for NE assembly were isolated from 
cell-free systems of different model organisms (Chapter 3). Recently, it has been 
reported that the nuclear localisation sequence (NLS) of nucleoplasmin recruits NE 
precursor MVs via importin α/β interaction in Xenopus egg extracts (Lu et al., 2012). 
Vesicles may participate in different stages of NE assembly. In an echinoderm cell-free 
assay, MV1 initiates NE assembly by binding to chromatin (Collas and Poccia, 1996). 
Lu et al. (2012) suggested that vesicles derived from Xenopus egg extracts are involved 
in NE assembly at a later stage. However, the participation of vesicles in mammalian 
NE assembly has not been demonstrated in vivo. 
 
Because of the following difficulties, there is no study pertaining to the role of vesicles 
in NE assembly done in live cells. First, it is impossible to distinguish subpopulations 
of vesicles by their morphology. Second, to identify fusogenic vesicles, protein and 
lipid markers are required. There are many lipid-binding domains with various 
affinities for the same lipid and this may lead to different observations of the lipid 
localisation (Chapter 4). Each lipid-binding domain needs to be chosen carefully for 
use as a lipid probe. Lastly, conventional light microscopy does not have enough 
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resolution to identify vesicles even when they can theoretically be characterised by 
protein and lipid markers. Therefore, to identify MV1-like vesicles, a marker 
compatible with high resolution microscopy is required. 
 
This chapter describes our investigation of the presence of vesicles which may be 
involved in mammalian NE assembly by electron tomography, and the quantitative 
analysis of putative MV1-like vesicles. We also tested a novel engineered tag that 
allows correlation of light microscopy with electron microscopy, in order to 
characterise fusogenic vesicles. 
 
 Quantification of vesicular structure in the vicinity of NE gaps 6.2
The role of DAG in NE assembly was demonstrated in Chapter 5 but the involvement 
of MV1-like vesicles in mammalian NE assembly remains unknown. We postulated 
that MV1-like vesicles are required to seal the gaps in a reforming NE by membrane 
fusion, and that these vesicles are likely to be present in the vicinity of NE gaps at late 
mitotic stages. 
 
The ultrastructure of mitotic cells thus was examined by serial section TEM. Figure 6.1-
A shows a HeLa cell fixed at telophase. The cell was resinated and cut into serial 
sections for micrographs acquisition. Serial micrographs were aligned and the cellular 
structures such as the NE, ER and centriole were manually selected on the micrographs 
based on their morphological features (segmentation). Figure 6.1-B shows the 
unmodified and segmented electron micrographs of the telophase cell. The ER and NE 
were selected based on their enhanced electron density on the micrograph and were 
distinguished by the presence of ribosomes and NPC on the membranes respectively. 
The centriole was selected based on its characteristic feature, a pair of perpendicular 
cylindrical structures, and the presence of 9 pairs of microtubule triplet in its cross 
section. In parallel, the NE gaps and putative vesicles were also segmented. Any 
opening in the reforming NE that was greater than 75 nm (the average lateral length of 
a NPC in the telophase cell) was segmented as a NE gap; a straight line was drawn 
from one edge of the NE gap to the other. A circular brush was used to select vesicles 
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on the micrographs; any structure with a circular cross section and approximately 
equal diameter in xy- and z-direction was selected as a vesicle.  
 
The segmentations were reconstructed into a 3D model which indicates how the 
vesicles were orientated relative to the reforming NE (Figure 6.1-C). Approximately 
14,000 vesicles were selected throughout the cytoplasm of the cell. Some of which were 
very close to the NE gaps (Figure 6.1-B, white arrow) but some were further away. 
There was no obvious distribution pattern of these vesicles. Nevertheless, it is 
conceivable that among all marked vesicular structures, a subpopulation is MV1-like 
vesicles responsible for sealing the NE gaps. Vesicles involved in fusion events are 
more likely to be targeted to the gaps of the reforming NE. Hence, we focused on 
quantifying vesicles that were closer to the NE gaps, rather than those further away. 
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Figure 6.1 Numerous vesicles were found in the cytoplasm during mitosis 
(A) Low magnification electron micrograph of a section taken through a HeLa cell fixed at telophase 
and preserved in resin. The cell was cut into serial 70 nm-thick-sections and imaged using a TEM. (B) 
The serial sections were aligned and manually segmented. Top panel depicts an unmodified electron 
micrograph. Middle panel depicts the segmented electron micrographs, of which the cellular 
organelles were segmented in different colours: NE (red), ER (cyan), centriole (purple); the NE gaps 
and vesicles were shown in green and yellow respectively. Bottom panel shows a segmented 
electron micrograph at high magnification in which the white arrow indicates a population of vesicles 
in the vicinity of a NE gap. (C) Segmentation of cellular organelles, NE gaps and vesicles were 
reconstructed into 3D models. The middle panel shows a 3D model of the reforming NE and ER. The 
bottom panel shows a 3D model of the NE, centriole, NE gaps and vesicles. 
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A systematic quantification helps to understand the spatial distribution of the vesicles. 
We compared the distribution pattern of the vesicles at the NE gaps versus the regions 
without gap. In addition, we compared the pattern among NE gaps of different sizes. 
The sizes of a NE gap were classified according to their total area. Figure 6.2 illustrates 
the method to calculate the total area of a NE gap. The length of the gap per section 
was measured and was multiplied by the depth of the micrograph (70 nm) to obtain 
the area per section. The area of the NE gap per section was summed to obtain the total 
area. In the telophase cell, the length of the NE gaps ranged from 76 nm to 977 nm and 
there were 22 small, 46 medium and 8 large NE gaps. The sizes and quantities of the 
NE gaps are summarised in Table 6.1. Small, medium and large NE gaps differed in 
their area by an order of magnitude accordingly. 
 
 
 
Figure 6.2 The size of a NE gap is defined by its area 
To calculate the area of a NE gap, the length of the gap per section was measured and multiplied by 
70 nm, which is the depth of the micrograph. The area of the NE gap per section was summed up to 
obtain the total area. 
 
 
Table 6.1 The number and size of NE gaps in a telophase cell 
Size # of gaps Min. area (nm2) Max. area (nm2) Mean area (nm2) 
Small gaps 22 5800 9900 7600 ± 300 
Medium gaps 46 11000 82000 27000 ± 2700 
Large gaps 8 100000 350000 220000 ± 32000 
 
All values rounded to two significant digits.  
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Figure 6.3 depicts the method to determine the distribution pattern of the vesicles in 
the vicinity of the NE gaps and regions without gap. The vicinity referred to a circular 
sampling field with a radius of 1 µm; the radius was set at 1 µm so that the sampling 
field did not exceed the cell. The centre of the sampling field for a NE gap was one of 
its end points. The centre of the sampling field for a region without gap was a point 
chosen randomly by algorithm on the segmented NE, wherein the sampling field of a 
region without gap must not overlap with that of a NE gap. The number of vesicles in 
the sampling field and the distance of these vesicles from the centre of the sampling 
field were measured. The sampling field was divided into inner (radius = 0.5 µm) and 
outer (0.5 µm < radius < 1 µm) sections and the density of vesicles within these sections 
were calculated and summarised in Table 6.2.  
 
The highest number of vesicles was found in the vicinity of the large NE gaps. There 
were 6.5-fold and 8.5-fold more vesicles in the vicinity of the large NE gaps compared 
to that of the small gaps and regions without gaps respectively (Table 6.2). Moreover, 
the mean number of vesicles in the vicinity of the NE gaps decreased as the size of gap 
decreased. Similarly, the vesicle density (#/µm2) in the vicinity of the large NE gaps 
was the highest. In general, the vesicle density in the whole sampling field was 
approximately the same as the outer sampling field in all the NE gaps and regions 
without gap. For large and medium NE gaps, their inner sampling fields had higher 
vesicle density compared to the outer sampling fields. However, an opposite trend was 
observed in the small NE gaps and regions without gap. 
 
Figure 6.4 shows the vesicle density (#/µm2) in the inner and outer sampling fields of 
NE gaps and regions without gap. The vesicle density at the large NE gaps was 
significantly higher than that in the NE gaps of other sizes and regions without gap, in 
both inner and outer sampling fields. The vesicle density in the inner sampling field of 
the large NE gaps was 10 times higher than that of the small NE gaps and regions 
without gap. Such observation suggests a correlation between number of vesicles and 
the size of the NE gaps.  
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Figure 6.4 The vesicle density in the vicinity of large NE gaps is significantly higher than that in 
other regions 
The vesicle density in the inner and outer sampling field of NE gaps of various size and regions 
without gap was plotted into a bar chart. The data was analysed by one way-ANOVA. The vesicle 
density in the inner sampling field of large NE gaps was significantly higher than that of small, 
medium NE gaps and regions without gap. Asterisk scale: * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, 
**** P ≤ 0.0001. 
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The physical characteristics of the vesicles may provide useful information to target 
MV1-like vesicle, therefore the diameter of the vesicles in the inner sampling field of all 
NE gaps was measured. For each vesicle, its diameters in x- and y- direction were 
measured and averaged as its true diameter. The diameters of all measured vesicle 
were plotted into a histogram with an interval of 5 nm (Figure 6.5). The diameter of the 
vesicles ranged from 40 to 80 nm, and the average diameter was 57 nm. Among the 164 
measured vesicles, the average diameter was approximately 55 nm. The actual binding 
of these vesicles to the NE was not detected so that it is difficult to conclude that they 
are involved in fusion events. Thus, the identity of these vesicular structures will need 
further validation. 
 
 
Figure 6.5 Most vesicles have a diameter of about 55 nm 
The diameter of all vesicles in the inner sampling field of the NE gaps was measured. The diameter 
of a vesicle was averaged from its x- and y- diameter, and plotted into a histogram with a 5 nm 
interval. Among the 164 vesicles, their diameter ranged from 40 to 80 nm and most of the vesicles 
(n = 65) affiliated to the 55 nm-group.  
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 Presence of vesicles in the vicinity of the reforming NE 6.3
Electron tomography (ET) was also used to identify vesicles in telophase cells. This 
technique is usually used to acquire high resolution volume data (Baumeister et al., 
1999). Figure 6.6 illustrates the principle of ET. One major advantage of ET is that it has 
a virtual z-resolution several orders of magnitude higher than the z-resolution of serial 
section TEM. Virtual z-resolution of ET can reach 2.4 Å at the best performance (Scott et 
al., 2012) whereas the resolution of conventional TEM varies with different factors but 
is usually within the range of 20 to 40 Å (Milne et al., 2013). In serial section TEM, 
imperfect alignment of ultrathin sections could lead to inaccurate reconstruction of the 
3D architecture of cellular structure but this could be avoided using ET since a 
relatively thick section was cut for tomogram construction. Moreover, the cross section 
of vesicles and tubular structures is very similar, both of which appear to be a circle 
and may have similar lateral diameter, and this could lead to misidentification of 
cellular structures. With better virtual z-resolution, ET was used to distinguish vesicles 
from various membrane components encompassing cisternae, tubules and saddle. 
 
 
 
Figure 6.6 Principle of electron tomography  
(A) A section through a cell is imaged at different angles (±70° tilt range), resulting in a series of 1D 
projection images, from which the intensity peaks are derived. Broken arrows pointing towards the 
intensity peaks indicate selected projection rays from high contrast features of the section. The 
pattern of the intensity peaks changes depending on the angle at which the section is imaged. B) 
The 1D projection images are projected back into the virtual space of a tomogram, where the 
projected rays are indicated by broken arrows pointing towards the virtual space. The section of the 
cell is reconstructed computationally into a 3D volume, indicated by the cell shown in broken lines. 
Adapted from Matt Russell (EM unit, London Research Institute).  
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Figure 6.7 and Figure 6.8 are two independent electron tomography analyses showing 
the regions of gaps identified from early telophase cells. Serial sections were cut 
through the cells and a 200 nm-thick mid-section from each cell was cut for tomogram 
construction. At low magnification, the NE appeared complete but discontinuities of 
the reforming NE (yellow arrows) can be seen at higher magnification (Figure 6.7-A & 
Figure 6.8-A).  
 
Figure 6.7-B and Figure 6.8-B display the snapshots of the virtual z-sections from the 
tomograms. Top panels reveal the unmodified snapshots and bottom panels are the 
segmented snapshots. The NE (red) and its proximal vesicular structures (yellow) were 
segmented based on their enhanced electron density; the nucleus and the cytoplasm 
can be distinguished by their texture. A spherical object, such as a vesicle, will not 
extend more than its diameter in any direction (x-, y-, z-) in a space. A 55 nm vesicle 
can only be visualised within a small cubical volume (55 x 55 x 55 nm) when the visual 
field is progressing through any axes. In contrast, a tubular structure with the same 
diameter can be visualised throughout the 200 nm section when the visual field is 
progressing along its longitudinal axis. The membrane structures in close proximity to 
the NE gap were only observed within a small cubical virtual space (white arrows). 
Therefore, it is valid to conclude that these membrane structures were vesicles and not 
tubules. Multiple vesicles were found in close proximity to the NE gap of the early 
telophase cells. 
 
The segmented tomograms were constructed into 3D models. Figure 6.7-C & Figure 
6.8-C are snapshots of the 3D models at different angels, indicating the location of the 
vesicles relative to the reforming NE. Video 6.1 and Video 6.2 are videos showing the z-
direction progression of the tomograms and the full rotation of the reconstructed 3D 
models. In conclusion, electron tomography confirmed the presence of vesicles in the 
vicinity of NE gaps during NE assembly. However, without a phosphoinositide/DAG 
reporter, the identities of these vesicles are still unknown. Therefore, the vesicles were 
probed by phosphoinositide or DAG-binding domain conjugated to a novel tag that 
allows visualisation of ultrastructure at EM resolution. 
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Figure 6.7 Multiple vesicles are observed at the gap of a reforming NE #1 
(A) Electron micrographs from a 200 nm-thick section taken through a HeLa cell fixed at early 
telophase. A gap was identified (yellow arrow), and the section was analysed by ET to produce an 
electron tomogram and a corresponding video (Video 6.1-A). The tilt range of the tomogram is from -
68 to +60 degrees, with final pixel size of 0.79 nm in xy. The final tomogram was ~163 nm in 
thickness after trimming the top and bottom. (B) Snapshots of the unmodified electron tomogram 
(upper panels) and the corresponding segmented version (lower panels). The reforming NE was 
segmented in red, with vesicles shown in yellow. White arrows indicate virtual space occupied by the 
vesicles along the z-axis. N: nucleus, C: cytoplasm. (C) 3D model snapshots of the reforming NE and 
proximal vesicles at different angles. Scale bar, as indicated in the figure. 
 
Video 6.1 Multiple vesicles are observed at the gap of a reforming NE #1 
Electron tomogram and segmentations described in Figure 6.7 were made into videos. Video 6.1-A 
shows the z-progression of the unmodified tomogram. Emergence and disappearance of the vesicles 
were observed from 0:04 to 0:08 s as the visual field progressed. Video 6.1-B displays the 3D model 
of the segmented gap region at full rotation. Videos are played at a speed of 10 frames per second. 
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Figure 6.8 Multiple vesicles are observed at the gap of a reforming NE #2 
Electron micrographs from a 200 nm-thick section taken through the same HeLa cell (different 
region) fixed at early telophase. Figure description is identical to Figure 6.7.  
 
Video 6.2 Multiple vesicles are observed at the gap of a reforming NE #2 
Electron tomogram and segmentations of region #2 were made into videos. Video 6.2-A shows the z-
progression of the unmodified tomogram. Emergence and disappearance of the vesicles were 
observed throughout the visual field progression. Video 6.2-B displays the 3D model of the 
segmented gap region #2 at full rotation. Videos are played at a speed of 10 frames per second. 
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 MiniSOG – a novel tool to characterise fusogenic vesicles at EM 6.4
resolution 
Fluorescent protein-fused lipid-binding domains allow visualisation of fusogenic lipids 
using light microscopy (Chapters 4 and 5). However, as the presumed fusogenic 
vesicles are very small (55 nm in diameter), they fall below the resolution limit of light 
microscopy. Therefore, a tool is required to correlate the functional localisation of 
phospholipids or DAG using light microscopy with its structural context using EM. 
Several techniques have been developed to specifically target cellular components in 
EM such as immuno-labelling (Roussel and Nussbaum, 1982), quantum dots made of 
electron dense molecules (Roussel and Nussbaum, 1982) and engineered probes which 
are photo-convertible to produce EM detectable signals (Giepmans, 2008). Most of 
these methods are not trivial and require a long time to optimise. 
 
Immuno-labelling is a technique commonly used to probe a specific protein or lipid in 
cellular compartments. For instance, recombinant PH domains combined with anti-
GST immunogold had been used to detect PtdIns(3,4)P2 (Watt et al., 2004) and 
PtdIns(3,4,5)P3 (Lindsay et al., 2006). Typical immuno-labels are secondary antibodies 
conjugated to gold or other heavy metals, or to other molecules which generate 
electron density from DAB/HRP reactions. However, immuno-labelling has several 
limitations. First, immuno-labelling is restricted by the availability of suitable 
antibodies. High affinity and high specificity interaction between immuno-label and 
antigen is not always guaranteed. Moreover, during EM sample preparation chemical 
fixation may destroy or mask the antigen (D'Amico et al., 2009) and heavy metal 
staining may destroy reactivity of immuno-labels (Wright and Rine, 1989). Although 
pre- or post-embedding immuno-labelling could maximise the performance of 
immuno-labels, it requires thorough understanding of the structures of interest (De 
Paul et al., 2012). Lastly, most immuno-labels are large molecules. For them to enter a 
cell, permeabilisation by detergent is required. Detergents would extract the lipid(s) of 
interest or damage the native cellular structures (Chapter 4). Hence, an alternative tool 
is required. 
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MiniSOG is a genetically engineered tag derived from a flavoprotein domain which 
produces singlet oxygen molecules upon photo-excitation, and can be expressed as a 
fusion protein (Shu et al., 2011). The mechanism of photosensitised production of 
singlet oxygen and generation of EM contrast by miniSOG is shown in Figure 6.9.  
 
 
 
Figure 6.9 Photosensitised production of singlet oxygen by miniSOG to enhance EM contrast 
MiniSOG at ground state (S0) can be illuminated by a 450 – 490 nm light source to reach the excited 
singlet stage (S1). Energy released from S1 to S0 generates fluorescence emission at 500 – 530 nm. 
Energy can be transferred from S1 to a less excited stage T1 (triplet stage with 2 unpaired electrons). 
When energy is released passing from T1 to S0, ground stage oxygen (3O2) is excited to singlet oxygen 
(1O2) simultaneously. DAB will react with the singlet oxygen and precipitate as localised polymers, 
which can be stained with osmium tetroxide (OsO4) to generate EM contrast. ↑↓, paired electrons. ↑↑, 
unpaired electrons. Imaged adapted from Shu et al. (2011). 
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We developed several miniSOG fusion proteins as probes to target DAG and 
PtdIns(3,4,5)P3 in subcellular compartments. Three miniSOG constructs were offered 
by the Tsien’s group: the first contains a single miniSOG domain at the C terminus, the 
second contains tandem miniSOG domains at the N terminus, and the third contains 
tandem miniSOG domains at the C terminus. Herein the single and tandem miniSOG 
are referred as SOG and tSOG respectively. The localisation of miniSOG-fused GRP1PH 
domain (PtdIns(3,4,5)P3 marker) was covered in Chapter 4. This chapter will focus on 
the localisation of the miniSOG-fused DAG probe. A summary diagram of these 
constructs is shown in Figure 6.10-A. 
 
 
Figure 6.10 Fluorescence of miniSOG fusion proteins is weak 
(A) Schematics of PKCεC1aC1b domain fused to different tags; length of the domains is in scale with 
the number of base pairs. Localisation of (B) the established DAG probe GFP-C1aC1b and (C) 
different miniSOG-fused C1aC1b domains in HeLa cells. Cells were transiently transfected with 500 
ng DNA construct for 16 h and imaged live by confocal microscopy. NE (white arrow), ER and Golgi 
localisation were detected in cells transfected with GFP-C1aC1b. The NE and ER localisation were 
almost absent in the cells transfected with different miniSOG conjugated probes, only a minor 
fluorescence was retained in the peri-Golgi region of the cells transfected with the tSOG-conjugated 
probes. Scale bar, 5 µm.  
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 Localisation of miniSOG fusion proteins 6.5
The GFP-C1aC1b construct is an established DAG reporter and it localises to the NE, 
ER and Golgi (Domart et al., 2012). However, the fluorescence of miniSOG-fused 
C1aC1b photobleached rapidly, resulting in weak fluorescent signals (Figure 6.10-B). 
Thus, it was difficult to determine the DAG localisation using these probes. Although 
tSOG-fused C1aC1b domains had slightly improved fluorescence and photobleached 
less rapidly, stable fluorescent signals are required to trace localised production of 
DAG during mitosis. Martell et al. (2012) added a second fluorescent protein to 
miniSOG-fused domains in order to improve its fluorescent signals. Similarly, we 
added GFP to the miniSOG-fused C1aC1b constructs (Figure 6.11-A). 
 
Figure 6.11-B & C depict the localisation of C1aC1b tagged with both GFP and 
miniSOG. GFP-C1aC1b and GFP-C1aC1b-SOG expressed similarly in both HeLa and 
COS-7 cells, with a clear localisation to the NE (white arrows), ER (green arrows) and 
Golgi (yellow arrows). Localisation of GFP-C1aC1b-tSOG was comparable to that of 
GFP-C1aC1b but intense DAG patches, an over-expressed phenotype of C1aC1b, were 
also observed (red arrow). tSOG-GFP-C1aC1b displayed a punctate localisation to the 
ER but did not localise to the NE. These results suggest that localisation of miniSOG 
fusion protein can be affected by the orientation of miniSOG in the construct. 
Furthermore, a non-DAG-binding C1aC1b was also tagged with miniSOG. Figure 6.12 
shows that GFP-C1aC1b.W264G-SOG localised homogenously in the cytoplasm and 
nucleus of the cells but not to any membranes compared to the WT construct. This non-
DAG-binding construct served as the negative control in the photo-oxidation 
experiments.  
 
 
(Cont’d)  
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Figure 6.11 GFP tag improves fluorescence of miniSOG fusion proteins 
(A) Schematics of PKCεC1aC1b domain fused to both GFP and miniSOG tags; length of the domains is 
in scale with the number of base pairs. Localisation of these DAG probes in (B) HeLa and (C) COS-7 
cells. The cells were transiently transfected with 250 ng DNA construct for 16 h. Identical NE (white 
arrows), ER (green arrows) and Golgi (yellow arrows) localisation were observed in GFP-C1aC1b and 
GFP-C1aC1b-SOG transfected cells. The red arrow indicates a patch of intense DAG localisation in a 
GFP-C1aC1b-tSOG transfected cell. Confocal light microscopy images were acquired in live cells. 
Scale bar, 10 µm. 
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Figure 6.12 Mutant DAG probe shows no localisation to the NE, ER and Golgi 
HeLa and COS-7 cells were transiently transfected with 250 ng DNA construct for 16 h. In HeLa and 
COS-7 cells transfected with GFP-C1aC1b-SOG, DAG localised at the NE (white arrows), ER (green 
arrows) and Golgi (yellow arrow). When transfected with the non-DAG-binding mutant GFP-
C1aC1b.W264G-SOG, DAG localisation was absent from the NE, ER and Golgi in both HeLa and COS-
7 cells. Confocal images were acquired in live cells. Scale bar, 10 µm.  
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 Optimisation of miniSOG photo-oxidation and EM sample 6.6
preparation 
GFP-C1aC1b-SOG and GFP-C1aC1b expressed similarly (Figure 6.11-B & C) therefore 
GFP-C1aC1b-SOG was used as the probe in the photo-oxidation experiments. 
Photosensitised production of singlet oxygen requires a highly oxygenated 
environment for a good yield (Ruiz-Gonzalez et al., 2013). To prevent the heating of 
samples caused by high energy wavelengths of light, a cooling system is also 
necessary. Figure 6.13 shows the customised photo-oxidation setup used in the 
following experiments (constructed by Christopher Applebee, Cell Biophysics 
Laboratory, London Research Institute and Biophysics Institute Bilbao). Samples were 
constantly oxygenated in a Petri dish chamber and cooled by a steel water jacket 
during photo-oxidation. 
 
Table 6.3 lists the optimised procedure for photo-oxidation and EM sample 
preparations. Briefly, miniSOG fusion protein-transfected cells were fixed, photo-
oxidised and embedded in resin for serial sectioning before acquisition of EM images. 
Many steps in the procedure required optimisation, including fixative concentration, 
photo-oxidation duration, and the concentration and combination of heavy metal 
staining reagents. Given the long protocol, optimisation of photo-oxidation and EM 
sample preparation was performed in interphase cells instead of mitotic cells. During 
photo-oxidation, the singlet oxygen generated by miniSOG reacts with DAB to 
produce a brown precipitate. Figure 6.14 shows that the cells transfected with miniSOG 
fusion protein can be distinguished from untransfected cells by their colour after 20 
min photo-oxidation. 
 
In the untransfected cells, EM contrast in the membrane compartments was due to 
osmium tetroxide staining; in the transfected cells, EM contrast of DAG enriched 
membranes was due to both osmium tetroxide staining and the miniSOG reaction 
products. Enhanced EM contrast was observed in the peri-nuclear regions of GFP-
C1aC1b-SOG transfected cells, and within these regions some vesicles showed a 
slightly higher electron density (yellow arrows). Although the photo-oxidation reaction 
had worked, the structures of interest were not clearly distinguished from the rest of 
the cellular components with any degree of confidence.   
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In the initial experiments, photo-oxidised cells were stained with 1% osmium tetroxide 
and then stained en bloc with 2% uranyl acetate before serial sectioning. Both osmium 
tetroxide and uranyl acetate are heavy metal staining reagents that bind to proteins 
and lipids to allow EM visualisation. Osmium tetroxide is also a tertiary fixative for 
biological samples. We suspected that when the samples were stained by 1% osmium 
tetroxide, the background EM contrast might be too strong thus masked the EM 
contrast provided by the miniSOG reaction products. Therefore, a reduced background 
contrast might increase the chance to identify miniSOG reaction products from other 
cellular components. 
 
We refined the protocol by decreasing the concentration of osmium tetroxide to 0.2% in 
the primary staining step. In addition, in preference to en bloc staining, samples were 
incubated with 2% uranyl acetate after serial sectioning as this offered more control 
over the level of uranyl acetate staining (Table 6.3, steps 14 & 24).  
 
  
Chapter 6 
187 
 
 
Figure 6.13 Photo-oxidation setup for miniSOG probes 
Top: The customised setup for photo-oxidation comprised two major components. 1) An oxygen 
source controlled by a regulator and connected to the lid of the photo-oxidation chamber. 2) A 
cooling system to prevent the sample from overheating. Bottom: A close up of the photo-oxidation 
chamber. The chamber holds a 35 mm Petri dish; the dish is surrounded by a metal water jacket. 
Cooling water is circulated in the water jacket by the peristaltic pump. Setup was constructed by 
Christopher Applebee (Cell Biophysics Laboratory, London Research Institute and Biophysics 
Institute Bilbao). 
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Figure 6.14 Photo-oxidation indicated by brownish colour of DAB reaction product  
HeLa cells were transiently transfected with GFP-GRP1PH-tSOG and fixed in 2.5% glutaraldehyde. 
Cells were excited at 488 nm for 20 min, at 4°C in an oxygenated environment. Bright field images 
were taken before and after photo-oxidation. Scale bar, 20 µm. 
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Figure 6.15 MiniSOG reaction products cannot be distinguished when sample was processed with 
1% osmium tetroxide 
(A) Identification of photo-oxidised cells in bright field and electron microscopy. HeLa cells were 
transfected with 250 ng GFP-C1aC1b-SOG for 16 h. After 30 min of photo-oxidation, the transfected 
cells showed brownish colour (red box) whereas the untransfected cells appeared relatively 
transparent (white box) in the bright field. (B & C) Electron micrographs revealed ultrastructure of 
photo-oxidised cells, both GFP-C1aC1b-SOG transfected and untransfected. In untransfected cells, 
the NE, ER and other membranes were stained by osmium tetroxide and were distinguished by their 
morphological features. In transfected cells, enhanced EM contrast, corresponding to the DAB 
precipitate observed in bright field, was detected in the peri-nuclear region. Within the peri-nuclear 
region, some vesicles had slightly higher electron density (yellow arrows) than the surrounding 
structures. N: nucleus; C: cytoplasm. Scale bar, as indicated in the figure.  
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Figure 6.16 shows electron micrographs of a HeLa cell transfected with GFP-C1aC1b-
SOG, and photo-oxidised following the optimised protocol (Table 6.3). Decreased 
concentration of osmium reduced the background contrast in the micrographs and this 
allowed us to pick out the miniSOG reaction product at the vesicles. Compared to the 
result from the initial experiments, numerous vesicles with distinguishable EM 
contrast (Figure 6.16, yellow arrows) were found in the peri-nuclear region, some of 
which were 100 nm away from the NE (Figure 6.16, panel 2 & 4). Most of these vesicles 
have a larger diameter (65 – 70 nm) compared to those identified by serial section TEM; 
such observation was expected as these vesicles were surrounded by miniSOG reaction 
product (Figure 6.17). This findings suggest that DAG enriched vesicles are present in 
interphase cells, although the involvement of these vesicles in fusion events require 
further verification. We expected DAG localisation to the NE, ER and Golgi. However, 
we could not clearly identify miniSOG reaction product associated with these 
compartments.  
 
Overall, the photo-oxidation protocol requires further optimisation since miniSOG 
reaction products was absent from the NE, ER and Golgi. Due to time constraints, the 
vesicles in vicinity of the gaps of the reforming NE were not characterised. However, 
this will be the next goal to achieve. 
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Figure 6.16 DAG-enriched vesicles are identified at reduced background contrast 
Electron micrographs of an interphase HeLa cell transfected with 250 ng GFP-C1aC1b-SOG for 16 h. 
The cell was photo-oxidised for 30 min. Red boxes corresponding to the magnified area of the cells in 
the numbered panels. Samples were stained by 0.2% osmium tetroxide and incubated with 2% 
uranyl acetate after serial sectioning. In the magnified fields of view, numerous vesicles had 
enhanced electron density (yellow arrows) and were distinguished from the background EM contrast, 
some of which are very close to the NE. The electron density in the NE was punctate, and it was 
difficult to distinguish if miniSOG reaction products were associated with the NE. N: nucleus; C: 
cytoplasm. Scale bar, as indicated in the figure. 
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Figure 6.17 Quantification of miniSOG-labelled vesicles of an interphase cell 
The number and diameter of miniSOG-labelled vesicles in the proximity of the NE (within a radius of 
1 µm) were measured as described in Figure 6.5 and plotted into a histogram. The average diameter 
of these vesicles was 71 nm and most of the vesicles (n = 18) affiliated to the 65 and 70 nm-groups. 
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 Discussion  6.7
6.7.1 The presence of fusogenic vesicles during NE assembly 
Vesicles that promote NE assembly were isolated from several non-mammalian cell-
free assays decades ago (Ulitzur and Gruenbaum, 1989, Zhang and Zhai, 1995, Byrne et 
al., 2007). However, vesicles obtained in cell-free assays may be the result of 
homogenisation rather than the cellular components retaining their native structures. 
Although MV1 was shown to be a cellular compartment (Byrne et al., 2014, Byrne et al., 
2007), similar fusogenic vesicles have not been identified in mammalian cells.  
 
Using electron tomography, we obtained high resolution volume information of the 
reforming NE and multiple vesicles were found in close proximity to NE gaps. Further 
investigation is necessary to demonstrate that these vesicles are involved in NE 
assembly, but preliminary quantification revealed that more vesicles were found in the 
vicinity of NE gaps compared to regions without gap. These findings suggest that 
vesicles are required at the NE gaps and these vesicles may be involved in membrane 
fusion.  
 
To determine the distribution pattern of vesicles, their distance from the centre of the 
sampling field was measured (Figure 6.3). However, the measured distance is not 
necessarily the closest distance between the vesicles and the gap because a NE gap is 
three dimensional. Our quantification did not measure the 3D distance between the 
vesicles and the NE gaps as it requires complicated algorithms to achieve this task. 
Nevertheless, the simplified quantification was able to unveil the distribution pattern 
of putative fusogenic vesicles in two dimensions. 
 
The ER envelopment model suggests that reassembly of NE during mitosis relies on 
the binding and flattening of ER tubules around the nucleus to complete the NE, 
without any requirement for membrane vesicles or fusion (Anderson and Hetzer, 
2007). Conversely, our findings verified the presence of vesicles in close proximity to 
the reforming NE and these vesicles might play a significant role in completing a 
reforming NE. This is the first study to examine the role of vesicles in NE reassembly of 
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mammalian cells. The next step is to determine the lipid and protein composition, and 
therefore the fusogenic property of these vesicles. 
 
6.7.2 Characterisation of fusogenic vesicles 
MiniSOG is a very small molecule (12 kDa), and as such is less likely to affect the 
innate protein structure of lipid binding domains. It was also reported that 
incorporation of miniSOG does not perturb cellular functions such as calcium uptake 
(Martell et al., 2012). However, our results showed that the localisation of DAG reporter 
was influenced by the orientation of the GFP and miniSOG tags relative to the DAG-
binding domain. Hence, it is recommended to verify the localisation of a miniSOG- and 
GFP-fused protein using an established reporter. The GFP-C1aC1b-SOG reporter is 
DAG-specific as indicated by its non-DAG-binding mutant.  
 
Photo-oxidation was performed across the field of view rather than targeted to a 
specific organelle of the cell therefore both miniSOG fusion protein-transfected and 
untransfected cells were excited by the same amount of energy. MiniSOG fusion 
protein-transfected cells were successfully photo-oxidised after 20 to 30 minutes. When 
processing samples with 1% osmium tetroxide, all subcellular structures were highly 
contrasted such that miniSOG reaction product could not be easily distinguished from 
non-targeted cellular components. Processing samples with 0.2% osmium tetroxide 
reduced electron contrast sufficiently to allow visual separation of miniSOG reaction 
product from surrounding structures.  
 
Surprisingly, we were not able to identify similar miniSOG reaction product associated 
with the NE, ER and Golgi. Recently, imaging mass spectrometry has verified the 
specific binding of osmium tetroxide to different lipids (Belazi et al., 2009). It is possible 
that differences in the lipid composition of membranes may lead to differential staining 
patterns. Fusogenic vesicles are likely to have specialised lipid composition when 
compared to other major membranes, and this may explain why we were unable to 
identify miniSOG reaction product associated with the NE, ER and Golgi. To visualise 
DAG at the NE, ER and Golgi, improved signal of DAB reaction product would be 
required. DAB staining can be intensified by addition of nickel or cobalt ions during 
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sample preparation and this has been reported and widely applied (Adams, 1981, 
Deitch et al., 1990). Therefore, related optimisation could help us to detect all DAG-
enriched membranes.  
 
DAG-enriched vesicles were found in the peri-nuclear region of an interphase cell. This 
suggests that fusogenic vesicles are required by the cell throughout the cell cycle, in 
addition to sealing the gaps of the NE during mitosis. The next step in our studies will 
be to characterise the vesicles associated with NE gaps during mitosis using the 
miniSOG fusion protein. In addition to miniSOG, similar tools such as APEX (Martell 
et al., 2012) and the biarsenical-tetracysteine system (Giepmans, 2008) are tags that 
provide EM contrast. Each of these tools has its own advantages and drawbacks. 
However, they could be used as alternative tools to target MV1-like vesicles.  
 
 Summary 6.8
In this chapter we verified the presence of vesicles in the vicinity of NE gaps. 
Quantitative analysis showed that the vesicle density was the highest in the vicinity of 
the large NE gaps and this suggest a potential role of vesicles in NE assembly. A novel 
tag called miniSOG was developed and tested in order to specifically characterise 
MV1-like vesicles. Although this tool requires further optimisation, preliminary results 
indicated that there were many DAG-enriched vesicles in the interphase cells and that 
these DAG-enriched vesicles might be the MV1-like vesicles required for fusion events. 
Other genetically engineered CLEM probes are also available to specifically target 
cellular components. However, the optimisation process will depend on the structures 
of interest and the biological question to be answered.  
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 Acute modification of DAG at the Golgi and its Chapter 7
impact on nuclear envelope assembly 
 Introduction 7.1
By depleting DAG in the NE/ER, we demonstrated localised production of DAG is 
necessary for NE reassembly. A similar result to that was shown during NE assembly 
of the male pronucleus in echinoderm cell-free assays (Byrne et al., 2007). In addition to 
the ER, the Golgi is another DAG-containing compartment.  
 
DAG can be detected at the Golgi by using the GFP-C1aC1b probe (see Chapter 5). 
Also, the production of DAG at the Golgi is indirectly supported by the Golgi 
localisation of ceramide transfer protein (CERT), involved in the transfer of ceramide 
from the ER to the Golgi; sphingomyelin synthase (SMS) uses the transferred ceramide 
as substrate and simultaneously converts PtdCho to DAG (Perry and Ridgway, 2005). 
Golgi-DAG has been shown to recruit protein kinase D (PKD) leading to the formation 
of transport carriers to be delivered to the plasma membrane (Baron and Malhotra, 
2002, Maeda et al., 2001). Accumulation of DAG in the cytoplasmic leaflet of TGN 
membranes introduces negative curvature in its bilayer and promotes TGN 
vesiculation (Bard and Malhotra, 2006).  
 
The Golgi vesiculates during interphase and mitosis. Protein trafficking through the 
generation of vesicles from the Golgi has been well documented (Warren and 
Malhotra, 1998, Emr et al., 2009). Golgi vesiculation during mitosis has been extensively 
studied (Persico et al., 2009). These findings are reminiscent of the vesicles identified in 
the vicinity of the NE gaps in the previous chapter. Furthermore, Golgi-derived 
vesicles (MV2α) are involved in the formation of the NE of male pronucleus in 
echinoderm cell-free assays (Collas and Poccia, 1996). Together, these findings suggest 
that the Golgi is a possible source of fusogenic vesicles.  
 
Localised DAG production in Golgi vesicles may contribute to membrane fusion at the 
reforming NE. Therefore, we applied rapalogue-induced dimerisation tools that target 
DAG at the Golgi to determine the impact of Golgi-DAG depletion on NE reassembly 
during mitosis.  
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 Acute Golgi-DAG depletion by rapalogue dimerisation tools 7.2
To deplete DAG at the Golgi, the rapalogue dimerisation tool described in Chapter 5 
was used. The Golgi functions as a site for protein and polysaccharide modification. It 
contains three sub-compartments, which are classified as cis-, medial- and trans-Golgi 
according to their orientation relative to the ER and plasma membrane, and their 
biochemical profile. Numerous Golgi resident proteins are responsible for 
macromolecule modification and cargo trafficking, and many of them are transported 
to other cellular compartments. Therefore, many Golgi resident proteins are not 
desirable for use as organelle-specific markers. For instance, acute manipulation of 
phosphoinositides (PIs) in the Golgi was performed using a rapamycin-induced 
dimerisation tool conjugated to the TGN38 Golgi marker (Szentpetery et al., 2010). 
However, TGN38 cycles between the trans-Golgi network and the plasma membrane 
(Stanley and Howell, 1993). Therefore, to specifically recruit lipid-modifying enzymes 
to the Golgi, proteins with a restrictive Golgi localisation are required. We constructed 
three rapalogue dimerisation tools conjugated with different Golgi resident proteins 
and tested their ability to recruit lipid-modifying enzymes.  
 
7.2.1 GCNT1 (glucosaminyl (N-acetyl) transferase 1, core 2) 
GCNT1 is responsible for the biosynthesis of branched oligosaccharides, and has been 
shown to be confined to the cis- and medial-Golgi (Skrincosky et al., 1997). The cytosolic 
and transmembrane domains of GCNT1 are responsible for its Golgi localisation 
(Zerfaoui et al., 2002). We incorporated GCNT1 into the rapalogue dimerisation tool to 
target cis- and medial-Golgi. 
 
7.2.2 ST6GALNAC1 (ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-
acetylgalactosaminide alpha-2,6-sialyltransferase 1) 
ST6GALNAC1 is an enzyme that alters the O-glycan structures of polysaccharides by 
adding a sialic acid to GalNAc. It has a highly restricted localisation pattern in non-
cancer cells (Ikehara et al., 1999). Immunoelectron microscopy showed that 
ST6GALNAC1 is located throughout the Golgi (Sewell et al., 2006). Therefore, 
ST6GALNAC1 was used to target the whole Golgi. 
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7.2.3 GRASP65 (Golgi reassembly stacking protein 65) 
GRASP65 is a Golgi stacking protein that localises to the cis-Golgi (Barr et al., 1997). It 
participates in mitotic Golgi fragmentation (Sutterlin et al., 2005) and Golgi ribbon 
formation though the GRASP65-GM130 (Golgi matrix protein 130) complex 
(Puthenveedu et al., 2006). The amino acids 1-201 of GRASP65, also known as the 
GRASP domain, contain a myristoylated site which allows Golgi membrane targeting 
(Tang et al., 2010). Thus the GRASP domain was used as a cis-Golgi marker.  
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 Optimisation of rapalogue dimerisation tools targeting the Golgi 7.3
7.3.1 Oligosaccharide transferases 
Two oligosaccharide transferases targeting different Golgi subcompartments were 
cloned into the rapalogue dimerisation tool. Figure 7.1 shows the localisation of GFP-
2FKBP-GCNT1 and GFP-2FKBP-ST6GALNAC1 in HeLa cells. Both rapalogue 
constructs were correctly expressed at the Golgi, indicated by the similar expression of 
the same oligosaccharide transferase solely fused to a GFP. High expressing cells 
transfected with the rapalogue dimerisation tools showed increase in cytoplasmic 
fluorescence, but the major fluorescent signal was concentrated at the Golgi. 
 
However, lipid-modifying enzymes were not recruited to the Golgi using these 
oligosaccharide transferases rapalogue constructs. Figure 7.2-B shows the rapalogue-
treated HeLa cells co-expressing GFP-2FKBP-GCNT1 and RFP-Flag-FRB-DGKεK/SKIP. 
DGK and SKIP are lipid-modifying enzymes that deplete DAG in our targeted 
membrane. DGK phosphorylates DAG to PtdOH and SKIP dephosphorylate 
PtdIns(4,5)P2 to PtdIns(4)P limiting the DAG precursor (see Chapter 5). In the presence 
of rapalogue, DGKεK or SKIP was expected to be recruited to the Golgi within an hour 
but there was no recruitment after 3 h of rapalogue treatment. Although a slight 
increase in DGKεK or SKIP fluorescence was observed as time progressed, the 
fluorescence did not co-localise with that of GCNT1. Similarly, SKIP was not recruited 
to the Golgi using GFP-2FKBP-ST6GALNAC1. After 2 h of rapalogue treatment, there 
was no co-localisation between the ST6GALNAC1 and SKIP fluorescent signals (Figure 
7.3-B).  
 
A possible explanation for the failed recruitment may be that the interaction between 
the rapalogue and the FKBP domains was blocked. Figure 7.4-A illustrates the 
possibility that GFP may bind to the short cytosolic domain of the oligosaccharide 
transferase thus preventing rapalogue from binding to the 2FKBP. To verify this, the 
GFP could have been re-orientated on the lumenal side of the Golgi (Figure 7.4-B). 
However, due to time constraints, we focused on the optimisation of the rapalogue 
dimerisation tool using the GRASP Golgi marker.  
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Figure 7.1 Rapalogue dimerisation tools based on oligosaccharide transferases localise correctly 
to the Golgi 
(A) Schematics of oligosaccharide transferases fused to the rapalogue-binding 2FKBP domains and 
the fluorescent tag GFP; length of the domains is in scale with the number of base pairs. (B) Left 
panel: confocal image of HEK293T cells transduced with GCNT1-GFP (green) and probed by nuclear 
stain (blue), adapted from *Lo et al. (2013). Right panels: HeLa cells transfected with GFP-2FKBP-
GCNT1. Confocal images of live transfected cells with different expression levels were acquired. (C) 
Left panel: HeLa cells transfected with ST6GALNAC1-YFPvenus, adapted from *Hassinen et al. (2010). 
Right panels: HeLa cells transfected with GFP-2FKBP-ST6GALNAC1. Confocal images of live 
transfected cells with different expression levels were acquired. (B – C), GCNT1 and ST6GALNAC1 
rapalogue dimerisation tools localised to the Golgi (yellow arrows). Enhanced cytoplasmic 
fluorescence of the rapalogue dimerisation tools was observed in the high expressing cells. Scale 
bar, 10 µm.  
*These researches were originally published in the cited journals (see references) © the American 
Society for Biochemistry and Molecular Biology  
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Figure 7.2 Lipid-modifying enzymes are not recruited to GFP-2FKBP-GCNT1 in the presence of 
rapalogue 
(A) Diagram of GCNT1 rapalogue dimerisation tool. Upon addition of rapalogue, RFP-Flag-FRB-DGKεK 
(DGKεK) or RFP-Flag-FRB-SKIP (SKIP) is predicted to be recruited to GFP-2FKBP-GCNT1 (GCNT1) so 
that Golgi-DAG will be depleted by conversion to PtdOH, or by limitation of its precursor PtdIns(4,5)P2. 
(B) HeLa cells double transfected with GCNT1 (green) and DGKεK/SKIP (magenta) were imaged live 
by confocal microscopy and followed for 3 h after addition of rapalogue. Yellow arrows indicate the 
Golgi localisation of GCNT1. No obvious recruitment of DGKεK/SKIP to GCNT1 was observed in the 
presence of rapalogue. Scale bar, 10 µm. 
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Figure 7.3 SKIP is not recruited to GFP-2FKBP-ST6GALNAC1 in the presence of rapalogue 
(A) Diagram of ST6GALNAC1 rapalogue dimerisation tool. RFP-Flag-FRB-SKIP (SKIP) is predicted to 
be recruited to GFP-2FKBP-ST6GALNAC1 (ST6GALNAC1) in the presence of rapalogue so that Golgi-
DAG will be depleted through conversion of its precursor PtdIns(4,5)P2 to PtdIns4P. (B) HeLa cells 
double transfected with ST6GALNAC1 (green) and SKIP (magenta) were imaged live by confocal 
microscopy and followed for 2 h after addition of rapalogue. Yellow arrows indicate the Golgi 
localisation of ST6GALNAC1. No recruitment of SKIP to ST6GALNAC1 was observed in the presence 
of rapalogue. Scale bar, 10 µm.  
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Figure 7.4 Putative explanation for the failed recruitment by the oligosaccharide transferase 
rapalogue dimerisation tools 
(A) The typical structure of an oligosaccharide transferase contains three parts: a large lumenal 
domain, a transmembrane domain (TMD) and a short cytoplasmic domain. GFP may interact with the 
short cytosolic domain of the oligosaccharide transferases thus prohibiting rapalogue (yellow) from 
binding to the FKBP domains. (B) Construct with the GFP re-orientated to the Golgi lumen may recruit 
lipid-modifying enzymes to the Golgi. 
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7.3.2 GRASP65 
Figure 7.5-A shows how the GRASP domain of GRASP65 was cloned into the 
rapalogue dimerisation tool. A non-Golgi-binding mutant GRASP.G2A was also 
cloned into the tool as a negative control. Localisation of GRASP65 has been studied 
and well documented (Barr et al., 1997). COS7 and HeLa cells transfected with GRASP-
GFP displayed distinctive Golgi fluorescence (yellow arrows) and a minimal NE 
fluorescence (white arrows) in the high expressing cells (Figure 7.5-B). GRASP.G2A 
however did not localise to any membrane structures, and was instead distributed 
homogeneously in the cytosol and the nucleus. 
 
Initial GRASP rapalogue dimerisation tools mislocalised. COS7 cells transfected with 
2FKBP-GRASP-GFP displayed a strong nuclear and a reduced Golgi fluorescence 
compared to the given GFP-tagged constructs. A similar result was observed in cells 
transfected with 2FKBP-GRASP.G2A-GFP (Figure 7.5-C). Since the first few amino 
acids of GRASP are responsible for its Golgi localisation, we suspected that the 2FKBP 
domains hindered the binding of GRASP to the Golgi in the initial GRASP rapalogue 
dimerisation tools. Therefore, the 2FKBP domains were re-orientated to the C terminus 
of the construct (Figure 7.6-A). COS7 and HeLa cells transfected with the modified 
GRASP rapalogue construct exhibited an identical Golgi localisation compared to the 
cells transfected with the given constructs (Figure 7.6-B). Hence, the modified GRASP 
rapalogue dimerisation tool was used to recruit DGKεK to the Golgi.  
 
Live HeLa cells co-expressing GRASP-GFP-2FKBP and RFP-Flag-FRB-DGKεK were 
treated with rapalogue and followed for 3 h. In the presence of rapalogue, DGKεK was 
recruited to the Golgi after 1 h, supported by the co-localisation of DGKεK and 
GRASP-GFP-2FKBP (Figure 7.7-B, white arrows and merged images). Consistent and 
reproducible recruitment was observed in low and high expressing cells. Therefore, 
GRASP-GFP-2FKBP was used in the following experiments to deplete Golgi-DAG. 
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Figure 7.5 Mislocalisation of initial GRASP rapalogue dimerisation tools  
(A) Schematics of the original GRASP constructs and GRASP domains fused to the rapalogue 
dimerisation tool; length of the domains is in scale with the number of base pairs. GRASP.G2A is 
non-myristoylatable and thus is a non-Golgi-binding mutant. (B) COS7 and HeLa cells were 
transfected with the WT and mutant GRASP domain fused to GFP. Live confocal images of 
transfected cells with different expression levels were acquired. Yellow arrows indicate the Golgi 
localisation of GRASP and white arrows indicate the minimal NE localisation of GRASP in the high 
expressing cells. GRASP.G2A localised homogenously in the nucleus and the cytosol. (C) COS7 cells 
were transfected with 2FKBP-GRASP-GFP or its mutant. In the 2FKBP-GRASP-GFP transfected cells, a 
strong nuclear fluorescence and a reduced Golgi fluorescence were observed compared to the 
original construct. Similar localisation patterns were observed in the 2FKBP-GRASP.G2A-GFP 
transfected cells. Scale bar, 10 µm.  
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Figure 7.6 Modified GRASP rapalogue dimerisation tool correctly localise to the Golgi  
(A) Putative explanation for the mislocalisation of initial GRASP rapalogue dimerisation tools. The 
2FKBP domain may hinder the interaction between GRASP and the Golgi membranes thus resulting 
in the mislocalisation of 2FKBP-GRASP-GFP. A construct with 2FKBP re-orientated to the C terminus 
may restore the binding of GRASP to the Golgi. (B) COS7 and HeLa cells were transfected with 
GRASP-GFP-2FKBP. Live confocal images of transfected cells with different expression levels were 
acquired. Yellow arrows indicate the Golgi localisation of GRASP, identical to that of the original 
construct shown in Figure 7.5-B. Scale bar, 10 µm. 
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Figure 7.7 Modified GRASP rapalogue dimerisation tool recruits DGKεK to Golgi membranes 
(A) Diagram of the modified GRASP rapalogue dimerisation tool. Upon addition of rapalogue, RFP-
Flag-FRB-DGKεK (DGKεK) is expected to be recruited to GRASP-GFP-2FKBP (GRASP). DAG in the 
Golgi will be converted to PtdOH. (B) Live HeLa cells double transfected with GRASP (green) and 
DGKεK (magenta) were imaged by confocal microscopy and followed for 3 h after addition of 
rapalogue. Yellow arrows indicate the Golgi localisation of GRASP and white arrows indicate the 
recruitment of DGKεK to the Golgi. Scale bar, 10 µm. 
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 Golgi-DAG depletion in mammalian cells  7.4
The GRASP rapalogue dimersiation tool was optimised for Golgi-DAG depletion. The 
next step was to follow the transfected cells though mitosis, and determine the impact 
of Golgi-DAG depletion on NE reassembly. To ensure DAG is specifically modified at 
the Golgi, cells with an excessive expression of GRASP were not selected. High 
expression of DGKεK may also cause cell death. Therefore, only the cells with the 
following two criteria were selected. First, the initial fluorescence of GRASP should be 
restricted to the Golgi. Second, the initial fluorescence of DGKεK should be 
homogenously distributed in the cytosol and the intensity should be just slightly 
higher than the background. The positions of these cells were recorded and checked 
every 30 min after addition of rapalogue until a cell entered mitosis.  
 
Figure 7.8-A shows the recruitment of DGKεK or its catalytically inactive mutant 
DGKεK.D434N to the Golgi of HeLa cells. Before adding rapalogue, the cells were 
incubated with ER tracker. The ER tracker was used as an indicator for normal NE 
reassembly. Golgi-DAG-depleted cells were expected to have impaired NE reassembly 
whereas the unperturbed cells were expected to have a complete NE at cytokinesis. 
However, at the light microscopy level, we observed no difference in NE morphology 
between Golgi-DAG-depleted and unperturbed cells. In both conditions, signal from 
the ER tracker was detected at the reforming NE of the cells in every mid-section 
(Figure 7.8-B, white arrows). Since the resolution of light microscopy, approximately 
200 nm, does not allow us to observe ultrastructure of the NE to determine if there are 
any gaps or abnormal phenotype, the Golgi-DAG-depleted and unperturbed cells were 
analysed using CLEM.  
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Figure 7.8  Light microscopy does not have adequate resolution to distinguish the morphological 
differences between Golgi-DAG-depleted and unperturbed cells 
(A) RFP-Flag-FRB-DGKεK (DGKεK) or RFP-Flag-FRB-DGKεK.D434N (DGKεK.D434N) was recruited to 
GRASP-GFP-2FKBP (GRASP) in the presence of rapalogue. DGKεK (left panel) or DGKεK.D434N (right 
panel) co-localised with GRASP (yellow arrows) after 1 h of rapalogue treatment. GRASP, green; 
DGKεK or DGKεK.D434N, magenta. Scale bar, 20 µm. (B) Middle sections of DGKεK- & 
DGKεK.D434N-expressing cells shown in (A) were followed for 5 to 7 h till mitosis and fixed at 
cytokinesis (live images). Prior to the addition of rapalogue, cells were incubated with the ER tracker 
(grey) in order to determine a normal NE reassembly. In both Golgi-DAG-depleted (DGKεK-expressing) 
and unperturbed (DGKεK.D434N-expressing) cells, signals of the ER tracker were observed at the 
reforming NE (white arrows). No morphological differences were noted. The cytokinesis cells were 
fixed for subsequent CLEM analysis. Scale bar, 10 µm. 
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 Serial block-face scanning electron microscopy (SBF SEM) analysis of 7.5
Golgi-DAG-depleted mammalian cells 
In conventional CLEM, electron micrographs are acquired using serial section TEM. A 
typical CLEM workflow was illustrated in Chapter 5. Using this approach, it can take 
months to obtain high resolution images and corresponding 3D reconstructions of the 
ultrastructure of a cell because manual serial-sectioning is skill- and experience-
demanding. Moreover, although commercial algorithms are available to align 
micrographs automatically, the fine tuning of alignment is time consuming. Lost or 
broken sections, which are not uncommon during sample collection, result in missing 
information of volume data of the cells. To improve the speed of acquisition of high 
resolution images, SBF SEM was used to analyse the NE morphology of Golgi-DAG-
depleted cells. 
 
The principle of SBF SEM is illustrated in Figure 7.9. A heavily stained epoxy resin-
embedded sample (the trapezoid block) is mounted on an in-chamber ultramicrotome. 
A SEM image is taken of the surface of the resinated sample by detection of 
backscattered electrons. After that, a diamond knife cut off the top of the trapezoid 
block and a successive SEM image is taken after retraction of the diamond knife. One 
major advantage of SBF SEM is the automated generation of a large number of serial 
images within a relatively short time. Moreover, since the resin block is very stable in 
the sectioning chamber, the images are already approximately aligned at the point of 
acquisition. These advantages maximise the throughput of high resolution information 
of cells of interest.  
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Figure 7.9 Principle of SBF SEM 
An electron beam scans the surface of the resin-embedded sample (trapezoid) and the 
backscattered electron beams are collected by the detector to form SEM images. Then an ultrathin 
slice (50 nm in our experiments) is cut off the top of the trapezoid using a diamond knife associated 
with the automated ultramicrotome. This process repeats until the whole sample is cut through. 
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 The impact of Golgi-DAG depletion on NE assembly 7.6
We are interested in the impact of Golgi-DAG depletion on NE assembly at late mitotic 
stages and we expected Golgi-DAG depletion would not affect the NE morphology in 
interphase cells. Figure 7.10 shows the NE morphology of interphase cells co-
transfected with GRASP-GFP-2FKBP (GRASP) and RFP-Flag-FRB-DGKεK (DGKεK). In 
the presence of rapalogue, DGKεK was recruited to the Golgi (lower panel: + rapa). 
However, regardless of the absence or presence of rapalogue, the interphase cells 
appeared to have an intact NE in the electron micrographs, suggesting depletion of 
Golgi-DAG has no effect on NE morphology in interphase cells.  
 
Figure 7.11 reveals the NE morphology of a NE-DAG-depleted and a Golgi-DAG-
unperturbed cell at cytokinesis, which served as the positive and negative control for 
the Golgi-DAG depletion experiment respectively. When DGKεK was recruited to the 
NE/ER with LBR a fragmented NE was observed. This indicated our lipid-modifying 
enzyme DGKεK is catalytically active and able to cause the same phenotype as 
described in Chapter 5. As expected, when DGKεK was not recruited to the Golgi in 
the absence of rapalogue, the cytokinesis cell co-transfected with GRASP and DGKεK 
displayed a complete NE.  
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Figure 7.10 The NE is intact in interphase cells transfected with the Golgi rapalogue dimerisation 
tools 
HeLa cells were co-transfected with GRASP-GFP-2FKBP (GRASP; green) and RFP-Flag-FRB-DGKεK 
(DGKεK; magenta), and were imaged live by confocal microscopy before fixation for SBF SEM 
analysis. Right panels display a selected electron micrograph near the base of the interphase cells of 
interest. In both the absence (interphase cell 1) and presence (interphase cell 2) of rapalogue, the 
interphase cells appeared to have an intact NE, showed in the micrographs at high magnification. 
Scale bar, 10 µm (fluorescence and low magnification electron micrographs); 200 nm (high 
magnification electron micrographs).  
 
  
Chapter 7 
217 
 
 
Figure 7.11 The NE morphology of NE-DAG-depleted and Golgi-DAG-unperturbed cytokinesis cells 
HeLa cells under different treatments were followed through mitosis and imaged live by confocal 
microscopy. The cells of interest were fixed at cytokinesis and subjected to SBF SEM analysis. Top 
panel: In the presence of rapalogue, cells co-transfected with GFP-2FKBP-LBRΔTM2-8 (LBR; green) 
and RFP-Flag-FRB-DGKεK (DGKεK; magenta) showed a phenotype of fragmented NE, identical to the 
results showed in Chapter 5. Multiple NE gaps (red arrows) were observed and some of them have a 
length of over 5 µm (big red arrow). Bottom panel: In the absence of rapalogue, cells co-transfected 
with GRASP-GFP-2FKBP (GRASP; green) and DGKεK appeared to have an intact NE. Scale bar, 10 
µm.  
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Then we analysed the impact of Golgi-DAG depletion on NE completion at 
cytokinesis. Figure 7.12 shows the NE morphology of the cytokinesis cells in which 
DGKεK was recruited to the Golgi. It is difficult to control the expression levels of the 
rapalogue dimerisation tools in these cells. Hence, we “qualified” the recruitment 
instead. For a robust recruitment, the fluorescent intensity of DGKεK should be equal 
or stronger than that of GRASP in most of the z-sections. Conversely in a weaker 
recruitment, the fluorescent intensity of DGKεK is weaker than that of GRASP in most 
of the z-sections. A detailed quantification of recruitment is in progress but is not 
included here due to time constraints. Out of five experiments, cell 1a & b (robust 
recruitment) displayed a fragmented NE phenotype (Video 7.1.1) whereas the other 
cells (weaker recruitment) showed an intact NE. Moreover, the fragmented NE 
phenotype in the Golgi-DAG-depleted cells appeared less severe compared to the NE-
DAG-depleted cells. However, further quantification of the fragmented NE phenotype 
is required. This result suggests that Golgi-DAG is involved in NE assembly during 
mitosis. 
 
Catalytically inactive DGKεK was recruited to the Golgi in the control experiments. We 
expected a complete NE in these cells. However, mixed NE phenotypes were observed 
(Figure 7.13). In both strong (cell 1a & b) and weaker (cell 4a &b) recruitments NE gaps 
were observed. These NE gaps appeared smaller compared to those in the Golgi-DAG-
depleted cell. We are conducting a thorough quantification for better comparison. The 
mixed phenotypes in these control experiments may be related to the progression of 
mitosis. Since the cells are not synchronous we cannot expect them all to be at exactly 
the same stage in mitosis. Therefore if gaps are still perceived with the inactive mutant 
of DGKεK it is not indicative of the malfunctioning of the inactive kinase.  
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Figure 7.12 Golgi-DAG-depleted cells show fragmented NE 
HeLa cells co-transfected with GRASP-GFP-2FKBP (GRASP; green) and RFP-Flag-FRB-DGKεK (DGKεK; 
magenta) were treated with rapalogue, followed through mitosis and fixed at cytokinesis for SBF 
SEM analysis. n = 5 experiments were performed and the results were grouped according to the 
robustness of enzyme recruitment to the Golgi. Cell 1a & b displayed a fragmented NE with multiple 
NE gaps (cell 1a, red arrows; also see Video 7.1.1) whereas other daughter cells (cell 2 – 5a & b) 
with weaker recruitment of DGKεK displayed an intact NE. Scale bar, 10 µm. 
 
Video 7.1 Golgi-DAG-depleted cells show fragmented NE 
Serial electron micrographs of daughter cells 1 – 5a & b were exported in .tiff format and converted 
into videos with QuickTime player. Video 7.1.1 – Video 7.1.5 represents the result of daughter cells 1 
– 5a & b respectively. Videos are played at a speed of 6 frames per second. 
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Figure 7.13 Mixed phenotypes are observed in cells with mutant DGKεK recruited to the Golgi 
HeLa cells co-transfected with GRASP-GFP-2FKBP (GRASP; green) and RFP-Flag-FRB-DGKεK.D434N 
(mtDGKεK; magenta), a catalytic inactive DGKεK, were treated with rapalogue, followed through 
mitosis and fixed at cytokinesis for SBF SEM analysis. n = 5 experiments were performed and the 
results were grouped according to the robustness of enzyme recruitment to the Golgi. Cells 1, 2, 3a 
& b had a robust recruitment of mtDGK to the Golgi. NE gaps were observed in cell 1a & b (cell 1a, 
red arrow; Video 7.2.1). However, cells 2a & b and 3a & b appeared to have an intact NE (Video 
7.2.2, Video 7.2.3). Cell 3 – 5a & b had a weaker recruitment of mtDGK to the Golgi. Cells 5a & b 
showed an intact NE but cells 4a & b displayed a fragmented NE with multiple NE gaps (cell 4a & b, 
red arrows; Video 7.2.4). Scale bar, 10 µm. 
 
Video 7.2 Mixed phenotypes are observed in cells with mutant DGKεK recruited to the Golgi 
Serial electron micrographs of daughter cells 1 – 5a & b described in Figure 7.13 were exported in 
.tiff format and converted into videos with QuickTime player. Video 7.2.1 – Video 7.2.5 represent the 
results of daughter cells 1 – 5a & b respectively. Videos are played at a speed of 6 frames per 
second. 
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To determine the correlation between completeness of the NE and progression of 
mitotic stage, we analysed the midbody of cytokinesis cells. As the cell progresses 
through cytokinesis, its midbody undergoes two obvious morphological changes. The 
midzone length of the midbody increases whereas the furrow diameter of the midbody 
decreases. Position of the cytokinesis furrow and its progression is a robust and highly 
regulated cellular process (Maddox et al., 2007). Moreover, the furrow diameter has 
been shown to be regulated by a motor protein KIF-4 at a specific time point during 
cytokinesis (Hu et al., 2011). Therefore, the furrow diameter of the midbody is a 
possible indication of the mitotic stage.  
 
The midbody is a cylindrical structure in three-dimensions and a precise measurement 
of the furrow diameter will require 3D model reconstruction. Due to time limitation, 
the mid-section furrow diameter was measured and approximated as the true furrow 
diameter of the midbody. Table 7.1 summarises the measurement of furrow diameter 
in the Golgi-DAG-depleted and unperturbed cells. In the control experiments where 
the Golgi was recruited with catalytically inactive DGKεK. Cell 1a & b, and cell 4a & b 
have larger furrow diameter than the rest of the cells except for cell 2a & b. This 
suggests that cell 1a & b, and cell 4a & b were in an earlier mitotic time point in which 
small NE gaps may still exist. 
 
 
Table 7.1 Mid-section furrow diameter in Golgi-DAG-depleted and unperturbed cells 
Rapalogue tools: 
(GRASP/DGKεK) 
Mid-section furrow 
diameter (µm) 
Rapalogue tools: 
(GRASP/DGKεK.D434N) 
Mid-section furrow 
diameter (µm) 
Cell 1a & b 2.79 Cell 1a & b 3.08 
Cell 2a & b 2.81 Cell 2a & b 5.72 
Cell 3a & b 2.80 Cell 3a & b 2.39 
Cell 4a & b 1.71 Cell 4a & b 3.36 
Cell 5a & b 5.12 Cell 5a & b 2.72 
 
GRASP/DGKεK: Golgi-DAG-depleted condition; GRASP/DGKεK.D434N: Golgi-DAG-unperturbed 
condition. Underlined cells displayed a fragmented NE phenotype. 
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 Discussion 7.7
7.7.1 Optimisation of Golgi marker-based rapalogue dimerisation tools 
Three markers were tested to recruit lipid-modifying enzymes to the Golgi. For the 
oligosaccharide transferases, although correctly localised to the Golgi, they failed to 
recruit the lipid-modifying enzymes. Interactions between the fluorescent protein and 
the cytosolic domain of the transferases may have obstructed the binding of rapalogue 
to the 2FKBP domains leading to such a result. Initially, the full length oligosaccharide 
transferases were fused to the rapalogue-binding domains. This was to avoid 
mislocalisation compared to fuse a domain that is never guaranteed to localise the 
same. However, Golgi N-glycosyltransferases such as ST6GALNAC1 have been shown 
able to form homo- and heterodimeric complexes (Hassinen et al., 2010). The dimer 
may bring the 2FKBP domains into very close proximity and hinder rapalogue 
binding. Interestingly, the cytosolic and TMD of oligosaccharide transferases have been 
shown to be sufficient for Golgi localisation (Colley, 1997). Therefore, rapalogue 
dimerisation tools that fuse solely with the Golgi-localising domain of oligosaccharide 
transferase may be a better tool for lipid-modifying enzyme recruitment.  
 
Initial GRASP rapalogue dimerisation tools mislocalised but the modified constructs 
were correctly localised to the Golgi, and were able to recruit lipid-modifying enzymes 
in the presence of rapalogue. These findings suggest that the construction of inducible 
dimerisation device is far from being a straightforward process and that the orientation 
of protein domains in the rapalogue dimerisation construct is critical. It is therefore 
necessary to understand the membrane binding mechanisms of the selected markers. 
 
 The impact of Golgi-DAG depletion on NE assembly 7.7.2
Similar to the experiments performed in Chapter 5, we modulated the DAG levels in 
the Golgi using the rapalogue dimerisation tools. A cis-Golgi targeting marker 
GRASP65 was used and depletion of Golgi-DAG resulted in NE gaps at cytokinesis. 
SBF SEM analysis indicated that the fragmented NE phenotype in the Golgi-DAG-
depleted cells was less severe compared to that in the NE-DAG-depleted cells. This 
observation suggests that localised DAG production from the Golgi may be mainly 
involved in NE gap closure. Such suggestion can be supported by the fact that DGKεK 
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recruitment does not affect the NE in interphase cell, and only cells with robust 
recruitment of DGKεK to the Golgi upon rapalogue treatment displayed a fragmented 
NE. 
 
To obtain a dividing cell with optimal expression levels of both the Golgi marker and 
lipid-modifying enzyme is not a trivial task. DGKεK is recruited to the Golgi (a GRASP 
vs DGKεK titration) in the presence of rapalogue, and as time progresses excessive 
DGKεK may accumulate in the cytoplasm. In many cases, prolonged recruitment of 
DGKεK to the Golgi led to cell death. In addition, highly expressed GRASP65 
mislocalised and those cells were not selected, limiting the number of cells we could 
study. Although synchronisation of cells is possible, addition of synchronising agents 
is not preferable in our case as they affect the NE reassembly as mentioned earlier.  
 
 Mixed phenotypes in Golgi-DAG-unperturbed cells  7.7.3
In Chapter 5, when DGKεK.D434N was recruited to the NE (n = 6 independent 
experiments), 1 out of 19 cells (5.3%) had a fragmented NE (Table 5.1). The fact that 
DGKεK.D434N did not give totally negative results suggests an incomplete penetrance 
of this catalytically inactive enzyme in vivo. Therefore, it is possible to see fragmented 
NE when DGKεK.D434N was recruited to the Golgi. The chance seeing fragmented NE 
appeared higher (2 out of 5 cells) when we modulated Golgi-DAG. However, without 
enough statistics, a definite conclusion could not be drawn. Alternative approaches to 
obtain statistically significant data will be discussed in the next chapter.  
 
There is also a possibility that the mixed phenotypes are associated with mitotic 
progression. The furrow diameter was used as an indicator for mitotic progression, 
and the preliminary results indicated that those cells with a fragmented NE were at an 
earlier mitotic progression (Table 7.1). Although an exception was noticed (cell 2, 
GRASP/DGKεK.D434N recruitment), the midbody of this cell appeared asymmetrical 
(Video 7.2.2). Hence, this cell may not be the best representative in the furrow diameter 
analysis. The fragmented NE phenotypes given by DGKεK.D434N were likely because 
of the penetrance of DGKεK.D434N, or an observation of mixed cell cycle population, 
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or both. A cell synchronisation protocol that does not affect NE reassembly could be a 
solution to verify such speculation.  
 
In addition, to confirm whether the fragmented NE phenotype in these DGKεK.D434N 
expressing cells is DAG-dependent, we could rescue the cells with DAG-containing 
SUVs; a non-rescuable result would indicate that the NE gaps are caused by other 
factors. Nevertheless, this experiment would need to be done on synchronised cells or 
cells labelled with a marker which indicates mitotic progression. Super-resolution 
would be required because confocal microscopy does not have sufficient resolution to 
determine the gaps at the NE. In conclusion, this is the first study showing the possible 
involvement of the Golgi, and associated DAG localisation, in NE assembly.  
 
 Summary 7.8
We tested several Golgi markers for their ability to recruit DGKεK to the Golgi. A 
rapalogue construct using the cis-Golgi marker GRASP65 was optimised. Depletion of 
cis-Golgi-DAG resulted in fragmentation of the NE, suggesting the involvement of the 
Golgi and its localised DAG production in NE assembly during mitosis. Although a 
totally negative result was not observed in the experiments using a catalytically 
inactive DGKεK, such observation was likely because of a mixed cell cycle population. 
Statistically significant data will be required to distinguish if the NE gaps are caused by 
Golgi-DAG depletion. 
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 General discussion Chapter 8
 Overview 8.1
The major objective of this thesis was to investigate the role of fusogenic vesicles in 
mammalian NE assembly. Our understanding of the mammalian NE assembly is 
dominated by the morphological observation of mitotic ER (quite often assumed by 
investigators as the only membrane compartment contributing to reforming the NE) 
and the localisation of NE proteins during mitosis. At least a single fusion event is 
required to fuse NE precursor membranes into a complete NE during an open mitosis. 
However, this critical fact is usually understated. Over the last thirty years, our group 
and collaborators focused on elucidating the NE fusion mechanism using the 
echinoderm cell-free assay and we demonstrated localised production of fusogenic 
lipid (DAG) as the critical molecular mechanism of NE assembly. Several key findings 
were discovered using the echinoderm model, including the requirement of MV1s to 
form a complete NE of the male pronucleus and where MV1s are compartments 
enriched in poly-phosphoinositides, PLCγ and a src kinase. Nevertheless, the NE 
fusion mechanism in mammalian cells remains uncharacterised. We hypothesised 
fusogenic vesicles similar to MV1 were conserved in mammalian cells and these MV1-
like vesicles would be responsible for sealing the gaps of a reforming NE during 
mitosis. 
 
8.1.1 The challenges and novel findings  
The major challenge in this study is the limited biochemical information regarding 
mammalian NE assembly. Earlier studies have observed the presence of vesicles in 
mammalian NE assembly assay but mammalian fusogenic vesicles have not been 
isolated. Also, whether the observed vesicles are formed due to homogenisation or 
whether they are vesicular compartments similar to MV1 is unknown. Moreover, 
although the enrichment of PtdIns(4,5)P2, PtdIns(3,4,5)P3 in MV1 serves as an index to 
identify fusogenic vesicles in mammalian cells, probing phosphoinositides and their 
derivatives is a challenging task because the visualisation of these biomolecules is 
dependent on their specific-binding domains that usually participate in cell signalling. 
Furthermore, vesicles are small targets therefore conventional light microscopy lacks 
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resolution to confirm the identity of candidate vesicles despite the fact that they can be 
labelled by phosphoinositide reporters. In addition, immuno-based EM is not the best 
method to label fusogenic vesicles since gold particles are relatively big compared to 
the vesicles and the use of detergent in permeabilisation will cause morphological 
changes in some cellular organelles. It is only recently that some alternative tools have 
become available to provide specific labelling of lipids/proteins and EM contrast 
simultaneously. 
 
Using biochemical and cell biology approaches, the novel findings of this thesis are as 
follows: 
 Membrane vesicles are found in the vicinity of the NE gaps during mitosis. 
 The density (number of vesicles per area) of membrane vesicles is significantly 
higher in regions of large NE gap than in regions without gap, indicating a potential 
role of membrane vesicles in sealing NE gaps. 
 Fusogenic vesicles in mammalian cells may have distinct features compared to MV1 
and may originate from the ER or the Golgi.  
 Localisation of PtdIns(3,4,5)P3 and class I PI3 kinase at the ER, Golgi and perinuclear 
region suggests a population of PtdIns(3,4,5)P3-enriched or MV1-like membrane 
vesicles in mammalian cells. 
 DAG-enriched membrane vesicles are observed in interphase cells at EM resolution, 
these vesicles may participate in house-keeping membrane fusion events.  
 Acute depletion of Golgi-DAG results in fragmented and incomplete NEs during 
mitosis, suggesting the involvement of Golgi in mammalian NE assembly. 
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 The mammalian fusogenic vesicles that are responsible for NE gap 8.2
closure 
Lipid profile analysis of isolated membrane fractions requires complicated lipid mass-
spectrometry protocols and large amounts of raw material. Hence, immunodetection of 
PLCγ, and Ran (MV1 features) was used as a relatively fast approach to determine 
membrane fractions analogous to MV1. Low density membrane fractions that are 
PLCγ- and Ran-positive were isolated from mammalian cells but these membrane 
fractions were very low in quantity and were not reproduced in all subcellular 
fractionations. At the same time, PLCγ and Ran were mainly enriched in medium 
density membrane fractions and were not separately from other endomembrane 
compartments. To confirm that these fractions were responsible for completing the NE, 
we tested if these fractions were also enriched in other fusion machineries.  
 
Recent study from our group have confirmed the protein SFK1, a src kinase, as one of 
the fusion machineries that drives NE fusion event in the echinoderm model (Byrne et 
al., 2014). However, a detailed protein profile of MV1 is missing. Protein profile 
analysis of MV1 may identify MV1-specific markers which help to isolate fusogenic 
vesicles in mammalian cells. Alternatively, since MV1 binds to demembranated sperm 
nuclei (Collas and Poccia, 1996), we can use this property as a tool to isolate MV1-like 
vesicles.  
 
Mammalian fusogenic vesicles responsible for NE gap closure may originate from the 
ER, Golgi or other endomembranes. One of the fundamental criteria of membrane 
fusion is the localised production of DAG and DAG has been observed at the NE, ER 
and Golgi (Domart et al., 2012, Peddie et al., 2014). All these membrane compartments 
have been reported to vesiculate. Therefore, it will be a difficult task to isolate our 
target vesicles through a biochemical approach.  
 
In the complementary cell biology approach, we confirmed the presence of MVs in the 
vicinity of the NE gaps using electron tomography. Quantitative analysis of these MVs 
indicated a putative consumption of them for NE gap closure but without further 
characterisation a precise conclusion cannot be drawn. Using the miniSOG constructs 
we detected DAG-enriched vesicles in interphase cells, the next step will be to 
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determine if the MVs in the vicinity of the NE gaps are enriched in DAG and other 
fusion machineries. In this respect, we are developing polyphosphoinositide reporters 
that conjugated with miniSOG, a fusion protein provides EM contrast through photo-
conversion. Some of our reporters could be used as recombinant probes for future 
works.  
 
Furthermore, we speculate that the fusogenic vesicles required for NE gap closure are 
enriched in NE proteins such as LBR in addition to fusogenic lipids. Hence, co-
localisation of these fusion machineries in the candidate vesicles will evidence our 
hypothesis. Co-localisation experiment at EM resolution has not been performed. 
However, the development of the next generation EM tags and their combination use 
will render possible the pursuit of this type of experiments (Chapter 6).  
 
 Visualisation of phosphoinositides and their derivatives 8.3
We demonstrated the presence of PtdIns(3,4,5)P3 in endomembranes by both 
transfection (GFP-GRP1PH) and recombinant (GST-GRP1PH) probes. Since our targets 
are small vesicles (with an average diameter of approximately 55 nm), a GST-GFP-
GRP1PH-tSOG construct is being optimised in order to target PtdIns(3,4,5)P3-enriched 
vesicles at cytokinesis at EM resolution. Apart from the PtdIns(3,4,5)P3 reporters, a 
recombinant DAG probe (GST-GFP-C1aC1b) was also constructed in this study and 
will be used to determine if there is a difference in localisation of DAG using different 
probing approaches. Our next goal is to minimise the effect of reporters on lipid 
dynamics in order to obtain more precise information regarding the in situ localisation 
and quantity of target lipids. Alternative lipid reporter delivery techniques such as 
microinjection and protein transfection (Oba and Tanaka, 2012) are some possible ways 
to achieve the above objectives.  
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 The duality of DAG 8.4
DAG has a well-documented second messenger role in various cellular functions 
(Toker, 2005) including the regulation of NE morphology (Larijani et al., 2014). By 
acutely depleting DAG in the NE/ER using the rapalogue dimerisation device, we 
identified the role of DAG in mammalian NE assembly. At the same time, the 
incomplete NE phenotype caused by acute DAG depletion was rescued by both 1,2-
DAG (second messenger) and 1,3-DAG (non-second messenger), indicating both the 
signalling and structural role of DAG in NE assembly. Lipid mass-spectrometry data 
indicated that the NE/ER contains mainly polyunsaturated DAG and early studies also 
support the fact that there is a variety of DAG species in mammalian cells (Hodgkin et 
al., 1998). There is more than one pathway to generate DAG (Becker and Hannun, 2005, 
Oude Weernink et al., 2007) in mammalian cells. For instance, hydrolysis of 
phosphatidylinositol by phospholipase C and phosphatidylcholine by phospholipase 
D and a phosphatase can generate DAG. It will be an interesting question to ask 
whether, as in the formation of the male pronucleus, a specific DAG species is enriched 
in the mammalian fusogenic vesicles required for NE gap closure. There may be 
different pools of DAG responsible for the spatial-temporal-specific fusion events, and 
these DAG pools may originate from different membrane compartments.  
 
 High throughput techniques to bridge light microscopy and electron 8.5
microscopy  
Confocal microscopy allows tracing of specific lipid by fusion protein but lacks 
resolution to observe vesicles and NE gaps; electron microscopy provides 
ultrastructure information but specific labelling in this context is difficult. CLEM was 
used in this study to take the best of both techniques. However, the complexity of EM 
and related sample preparation often limits the throughput of our study. To generate 
statistically significant data, super resolution microscopy can be used.  
 
There are different techniques in super-resolution imaging but the basic principle is to 
overcome the diffraction limit of light microscopy. For instance, the structured 
illumination microscopy (SIM) enhance resolution by collecting frequency space 
information (Gustafsson et al., 2008) and the stimulated emission depletion (STED) 
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microscopy achieves super-resolution by selectively deactivating fluorophores. 
(Yamanaka et al., 2014). Details of other super-resolution microscopy can be seen at a 
recent review by Fornasiero and Opazo (2015). However, these techniques usually 
require strong illumination of samples and specific fluorophores; live cell imaging is 
also difficult (Cox, 2014). Recently, the combination of Bessel beam and light sheet 
fluorescence microscopy allows fast and low phototoxicity imaging of molecules 
beyond the diffraction limit (Chen et al., 2014). It is possible to perform live 
colocalisation experiments to characterise fusogenic vesicles. Furthermore, we can 
repeat the rapalogue-dimerisation experiments on this setup to obtain statistically 
significant data.  
 
 A refined fusion model of mammalian NE assembly 8.6
We depleted the Golgi-DAG with the rapalogue dimerisation device using GRASP65 
as the Golgi membrane targeting marker. In a cytokinesis cell that highly express the 
DAG kinase, an incomplete NE was observed, characterised by multiple NE gaps. 
Although compared to the NE/ER-DAG depleted cells the fragmented phenotype was 
less severe, such observation implies the involvement of Golgi in NE reassembly. 
Indeed, Golgi-derived vesicles (MV2α) are required to form a complete NE in the male 
pronucleus formation. This is the first study to demonstrate the involvement of the 
Golgi (cis-Golgi) in NE assembly of live cells. The next step will be to validate the 
hypothesis that the MVs in the vicinity of the NE gaps are originated from the Golgi. 
 
Based on our findings, we propose a refined model for mammalian NE assembly 
(Figure 8.1). During mitosis, mitotic ER forms cisternae at anaphase and makes contact 
with the separating chromosomes. The ER cisternae envelope the chromosomes and 
contribute to most of the reforming NE. In parallel, Golgi and ER vesicles that are 
enriched in DAG and possibly PtdIns(3,4,5)P3 related fusion machineries seal the NE 
gaps through heterotypic and homotypic fusion respectively. 
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Figure 8.1 Schematic summary of the NE assembly fusion model in mammalian cells 
 
 Future prospective 8.7
This thesis has achieved several novel findings and initiated a link between the 
structural role of phospholipids, in particular the phosphoinositides, and membrane 
morphology in addition to their signalling role. Yet, how phosphoinositide dynamics is 
regulated and the influence of their dynamics on NE assembly and membrane 
organelle morphology will require further dissection. The future directions of this 
study will be as follows. 
 
Firstly, the MVs in the vicinity of the NE are uncharacterised. To confirm these MVs 
are participating in membrane fusion we will need to determine if they are enriched in 
DAG. It is likely that the MVs in the vicinity of the NE are enriched in DAG due to 
their elevated quantity in the regions of gaps. We can draw this parallel from the 
formation of the male pronucleus. However, the presence of DAG does not provide 
information regarding their ultimate fusion site. To confirm any DAG-enriched MVs 
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are responsible for NE gaps closure, the presence of NE transmembrane proteins 
(NETs) such as LBR is likely and can be tested. At the moment we cannot perform co-
localisation experiments at EM resolution. Nevertheless, we can probe DAG and LBR 
individually in the candidate MVs. If the DAG-enriched and LBR-positive MVs have 
similar distribution pattern during mitosis it is possible that they are the fusogenic 
vesicles responsible for NE gaps closure. Using a similar approach, we can determine 
the membraneous origin of the fusogenic vesicles. For instance, similar distribution 
pattern of DAG-enriched and Golgi marker-positive MVs can validate the Golgi origin 
of the fusogenic vesicles. Super-resolution techniques mentioned above also will allow 
us to characterise fusogenic vesicles.  
 
Depletion of cis-Golgi-DAG resulted in fragmented NE in mammalian cells in our 
study and trafficking of Golgi vesicles has been shown required for maintenance of NE 
shape in yeast (Webster et al., 2010). Together, we can infer that membrane trafficking 
from the Golgi to the NE/ER is critical for NE assembly during mitosis. NE reassembly 
may involve the input from COPI-coated vesicles, which transport fusion machineries 
from the cis-Golgi to the ER. Therefore, modulation of COPI-associated membrane 
trafficking is a functional assay to test the potential role of Golgi-to-ER trafficking in 
NE assembly. In addition, defects in ER-to-Golgi transport have been reported to cause 
abnormal nuclear morphology (Kimata et al., 1999). Hence, COPII- and clathrin-coated 
vesicles may also participate in NE assembly. Our study opens a window to explore 
the role of Golgi as a “mediator” to maintain membrane morphology of different 
organelles or as a “buffering organelle” to provide precursor membranes to maintain 
the proper formation of the nuclear envelope. 
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